KOL | Rikard HolmdahlNational and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China | Medical ... |
kolの履歴書 Rikard Holmdahl
| Year | |
|---|---|
| 2022 | National and Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China Medical Inflammation Research, MediCity Research Laboratory, University of Turku, Turku, Finland |
| 2021 | The Second Affiliated Hospital of Xi’an Jiaotong University (Xibei Hospital), Xi’an, China Department Medical Biochemistry and Biophysics, Division Medical Inflammation Research, Karolinska Institute, 171 77 Stockholm, Sweden;, (M.A.);, (X.C.);, (B.X.);, (G.F.L.);, (M.Y.B.);, (Y.H.);, (L.B.) Division of Medical Inflammation Research, Dept. of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden |
| 2020 | Dept. of Medical Inflammation Research, Section of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm Section for Medical Inflammation Research, BMCI11, Lund University, Lund, Sweden National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi’an, China Karolinska Institutet |
| 2019 | Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solnavägen 9, 171 65, Solna, Sweden Center for Medical Inflammation Research, Southern Medical University, Guangzhou, China R. Holmdahl and C.I. Svensson contributed equally to this paper. |
| 2018 | School of Pharmaceutical Science, Southern Medical University, Guangzhou, China Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden Medicity Research Laboratory, University of Turku, Turku, Finland |
| 2017 | Karolinska Institutet Division of Medical Inflammation Research Stockholm Sweden Center for Medical Immunopharmacology Research, Southern Medical University, 510515 Guangzhou, China. Medicity Research Laboratory, University of Turku, Turku, Finland, . |
Rikard Holmdahl：統計に影響を与えます
レポートを実行します
| Concept | World rank |
|---|---|
| ftirm ciic1 | #1 |
| lewis rat cia | #1 |
| resistance collageninduced arthritis | #1 |
| arthritis animal mice | #1 |
| arthritis estrogen treatment | #1 |
| selfcii | #1 |
| multiple sclerosis rabeximod | #1 |
| eae2 eae3 | #1 |
| downregulating oestradiol | #1 |
| rt1f haplotype | #1 |
| identification genetic regions | #1 |
| region eae2 | #1 |
| liver histone deacetylase | #1 |
| lower capacity ros | #1 |
| cartilage collagen type | #1 |
| b10q mice | #1 |
| qa2 ncf1 | #1 |
| tnfα tlr3 expression | #1 |
| cia olive oil | #1 |
| autologous type collagen | #1 |
| emission tomography mannan | #1 |
| induced relapsing | #1 |
| rat rt1ba genes | #1 |
| functional ncf1 | #1 |
| region eae3 | #1 |
| oestrogen cia | #1 |
| cix disease | #1 |
| dr4 glycopeptides | #1 |
| cii cix | #1 |
| ciif4 cartilage explants | #1 |
| cii rat cii | #1 |
| sensitive wkymvm | #1 |
| cell tolerance cii | #1 |
| tolerance immunodominant | #1 |
| anticii autoantibodies | #1 |
| antibodies citrullinated peptide | #1 |
| clonal expansion arthritis | #1 |
| bcell activities | #1 |
| cia cells | #1 |
| vpba pnipaam | #1 |
| oils induce | #1 |
| mice deficient ncf1 | #1 |
| spe acute phase | #1 |
| rns type collagen | #1 |
| qa2 natural mutations | #1 |
| h2p cia | #1 |
| chromosome caia | #1 |
| ncf1m1j | #1 |
| ncf1 sle | #1 |
| mannan joints | #1 |
| oestrogen induced | #1 |
| psa mip | #1 |
| wo2012127214 | #1 |
| arthritis castration | #1 |
| daxlewf1 | #1 |
| cii monoclonal arthritis | #1 |
| gene ncf1 | #1 |
| effects ciif4 | #1 |
| genistein collagen | #1 |
| animals arthritis | #1 |
| mice ncf1m1j mutation | #1 |
| cii experimental autoantigens | #1 |
| tlr3 expression tnfα | #1 |
| 15a11 | #1 |
| aq glycopeptide | #1 |
| mucosal tolerance cii | #1 |
| chick cii cii | #1 |
| j1 epitope | #1 |
| olive oil cii | #1 |
| nox2complex | #1 |
| acute arthritis neutrophils | #1 |
| chronic stage arthritis | #1 |
| cells chronic arthritis | #1 |
| ncf1339 allele | #1 |
| peptide characterisation | #1 |
| proteolipoprotein peptide | #1 |
| placental mhc class | #1 |
| minimal glycopeptide core | #1 |
| cii experimental arthritis | #1 |
| arthritis pia | #1 |
| collagen‐induced | #1 |
| insulitis strains | #1 |
| mhv runting neonates | #1 |
| new arthritis therapy | #1 |
| functional nox2 complex | #1 |
| day cii immunisation | #1 |
| streptococcal endo | #1 |
| rheumatoid arthritis immunization | #1 |
| polymer adjuvant activity | #1 |
| bal cells work | #1 |
| arthritis ncf1 allele | #1 |
| ncf1da | #1 |
| cxi rats | #1 |
| nox2 complex | #1 |
| experimental arthritis autoimmune | #1 |
| genetically segregating crosses | #1 |
| ethylene isostere | #1 |
| polyi arthritis | #1 |
| glycoprotein alpha1microglobulin | #1 |
| ciiinduced | #1 |
| ncf1mutation | #1 |
| act389949 agonist | #1 |
| plasminogendeficient mice arthritis | #1 |
| targeted mutation ncf4 | #1 |
| epitopes arthritis | #1 |
| pia disease | #1 |
| c3bireceptors | #1 |
| animal models complexity | #1 |
| cia40 | #1 |
| expression ncf1 | #1 |
| spontaneous tissue inflammation | #1 |
| hladr1transgenic mice | #1 |
| acpas specificity | #1 |
| ul1 vivo | #1 |
| development collagen | #1 |
| rabeximod inflammatory cells | #1 |
| estrogenmediated suppression | #1 |
| histology vaccination | #1 |
| pc117 | #1 |
| mab ecm | #1 |
| rheumatoid arthritis complexity | #1 |
| citrullinated cii | #1 |
| cii rats | #1 |
| nox2 complex–derived ros | #1 |
| protective alleles eae2 | #1 |
| ppt medium | #1 |
| arthritis immunisation | #1 |
| tcell congenic arthritis | #1 |
| h2g7 haplotype nod | #1 |
| cell‐deficient mice | #1 |
| tolerance arthritis | #1 |
| cnbr‐fragment | #1 |
| denidritic cells | #1 |
| ncf1 ros | #1 |
| peritonitis sod3 | #1 |
| specificity arthritis | #1 |
| headache paradigm | #1 |
| rfig lambda | #1 |
| arthritis immunization | #1 |
| single bout hiit | #1 |
| comp arthritis models | #1 |
| ros immunohistochemistry implants | #1 |
| transgenic nadph oxidase | #1 |
| bb2bb3 | #1 |
| comp lack | #1 |
| macrophage ros | #1 |
| rat type collagen | #1 |
| 270 peptide | #1 |
| fcγr3 | #1 |
| g6pi acute arthritis | #1 |
| type cii | #1 |
| epitopes collagen | #1 |
| oxazolone inflammatory response | #1 |
| arthritis arthritis loci | #1 |
| rats synthetic peptide | #1 |
| innate rats | #1 |
| rats antibody response | #1 |
| caia monoclonal | #1 |
| cxi 6 | #1 |
| ciif4 cartilage damage | #1 |
| b10q mice authors | #1 |
| mab cb268 | #1 |
| ifa rats | #1 |
| autoimmune accelerating | #1 |
| kupffer cells mir144 | #1 |
| rats established pia | #1 |
| genetic encephalomyelitis autoimmune | #1 |
| w33t | #1 |
| cii treatment | #1 |
| recombinants rt1u | #1 |
| damage type collagen | #1 |
| antibodies consensus motif | #1 |
| macrophages cii | #1 |
| increased salt exposure | #1 |
| modified glycopeptides | #1 |
| therapeutic cleavage | #1 |
| arthritis ides | #1 |
| ncf4 mip | #1 |
| psich2nh2 | #1 |
| periodontitis pristaneinduced arthritis | #1 |
| pia model | #1 |
| anticcp2negative patients | #1 |
| ncf1 association | #1 |
| cholera toxin study | #1 |
| tolerance collagen | #1 |
| genes antibodies | #1 |
| collagen antibodies | #1 |
| cii disease | #1 |
| cb11 sequence cii | #1 |
| developed severe | #1 |
| antibody responses cii | #1 |
| cii specific | #1 |
| mice cii immunization | #1 |
| cia rat cii | #1 |
| haplotype ltab | #1 |
| ncf1 nos2 | #1 |
| cia31 | #1 |
| therapeutic c4bp | #1 |
| experimental arthritis antibodies | #1 |
| cii sera | #1 |
| ros autoimmune diseases | #1 |
| chronic development | #1 |
| oestrogen‐induced | #1 |
| ros rheumatoid humans | #1 |
| 17βestradiolregulation | #1 |
| arthritogenic mabs cii | #1 |
| h‐2q | #1 |
| genes congenic | #1 |
| elimination carbohydrates | #1 |
| alphachains cell surface | #1 |
| position cii256270 | #1 |
| effects cia | #1 |
| pregq2 fragment | #1 |
| cii mouse | #1 |
| terpenes toll | #1 |
| eae2 chromosome | #1 |
| treatment physiological doses | #1 |
| sialadenitis strains | #1 |
| cia opportunities | #1 |
| effects fab2 | #1 |
| hufcgammariia | #1 |
| mutated ncf1 | #1 |
| fecq3 locus | #1 |
| rats mhc genes | #1 |
| m1j mice | #1 |
| large numbers hybridomas | #1 |
| tlr expression synovium | #1 |
| g6pi chronic arthritis | #1 |
| ros experimental arthritis | #1 |
| nss1 | #1 |
| cia locus | #1 |
| model rheumatoid arthritis | #1 |
| cii induce | #1 |
| mice salt intake | #1 |
| ncf4 nox2 complex | #1 |
| experimental autoimmunity cells | #1 |
| cii cb fragments | #1 |
| animal models acpa | #1 |
| functional nox2 | #1 |
| inflammation caia | #1 |
| cia9 | #1 |
| cii epitope | #1 |
| phagocytic nox2 complex | #1 |
| autoimmune diseases identification | #1 |
| arthritis onset severity | #1 |
| cia21 cia22 | #1 |
| disease glycoproteins | #1 |
| ros antigens | #1 |
| treatment cii immunization | #1 |
| nzb mice trait | #1 |
| autoimmune arthritis activation | #1 |
| phagocyte oxidative burst | #1 |
| collagen chains antibody | #1 |
| 339 polymorphism | #1 |
| collagen epitopes | #1 |
| tracheolaryngeal cartilage | #1 |
| backcrosses nzb mice | #1 |
| act389949 fpr2 | #1 |
| upregulation tlr3 | #1 |
| rabeximod | #1 |
| cia2 arthritis | #1 |
| rats pia | #1 |
| m2139 arthritogenic mab | #1 |
| functional selective fpr1 | #1 |
| mediating arthritis | #1 |
| dba 1j | #1 |
| chemiluminescent probe l012 | #1 |
| citrulline collagen | #1 |
| normal cartilage arthritis | #1 |
| c1iii | #1 |
| prevents arthritis | #1 |
| dba 1 | #1 |
| hladrbound peptides | #1 |
| ncf1 gene | #1 |
| injection lewis rat | #1 |
| development pristaneinduced arthritis | #1 |
| mice mutated type | #1 |
| substrains ztmrhd | #1 |
| ym1 alternative activation | #1 |
| human gpi protein | #1 |
| polymorphism mitochondrial genome | #1 |
| caia induced | #1 |
| arthritis rat | #1 |
| cartilaginous joints | #1 |
| antitype collagen | #1 |
| experimental arthritis articular | #1 |
| skg mutation | #1 |
| elisagenetyping | #1 |
| rats clec4b | #1 |
| h2q mice | #1 |
| cii pia | #1 |
| valphachain | #1 |
| hiit nox2 activity | #1 |
| cia experimental autoantibodies | #1 |
| mbq mouse | #1 |
| antibody binding vivo | #1 |
| antigenic adjuvant | #1 |
| polyi pia rats | #1 |
| cii256 | #1 |
| glycosylation cell recognition | #1 |
| restricted role fcγr | #1 |
| type epitopes | #1 |
| experimental collagen type | #1 |
| complex aq molecules | #1 |
| cii anticd4 treatment | #1 |
| kgf cia | #1 |
| nodp nod | #1 |
| exacerbation arthritis | #1 |
| cell recognition cii | #1 |
| mouse chromosome eae39 | #1 |
| pia experimental chromosomes | #1 |
| cii caia | #1 |
| potent disease accelerator | #1 |
| m1j | #1 |
| ciipeptide | #1 |
| targeted deletion ncf1 | #1 |
| lack arthritis | #1 |
| cia congenic arthritis | #1 |
| pia blocking arthritis | #1 |
| nephritis nodq | #1 |
| mice b10q | #1 |
| tracheolaryngeal | #1 |
| induction phase cia | #1 |
| nox2 complex addition | #1 |
| mice cryogels | #1 |
| mab mab ciic1 | #1 |
| ros ncf1 | #1 |
| heterologous collagen | #1 |
| phytol rna | #1 |
| arthritis locus | #1 |
| human cii cartilage | #1 |
| hydrolyzed igg | #1 |
| arthritis rat strains | #1 |
| development collageninduced arthritis | #1 |
| cia pathogenesis | #1 |
| cia21 lymph nodes | #1 |
| tlr2 tlr2 regulation | #1 |
| anti collagen | #1 |
| inflammatory phase arthritis | #1 |
| positional identification | #1 |
| antiidiotypic antibodies cd4 | #1 |
| pia experimental arthritis | #1 |
| controlling collagen | #1 |
| frequency igaproducing cells | #1 |
| b10dr4ncf1 mice | #1 |
| cartilage cii | #1 |
| mabs monoclonal arthritis | #1 |
| myelomonocytic arthritis interleukin2 | #1 |
| beta 10b beta | #1 |
| cii256 270 | #1 |
| neonatal mortality milk | #1 |
| regulates severity | #1 |
| genetic variants ncf1 | #1 |
| ability gut protection | #1 |
| tlr3 rna interference | #1 |
| oestrogen lupus disease | #1 |
| rt1u lew1w | #1 |
| keratinocytes dth reaction | #1 |
| rats ncf1 gene | #1 |
| heterologous cii cells | #1 |
| eae b10riii mice | #1 |
| tumor models ncf1 | #1 |
| phemagelatin | #1 |
| pristaneinduced arthritis pia | #1 |
| ncf1 polymorphism | #1 |
| mice cii epitopes | #1 |
| qa2 gene clusters | #1 |
| h2q h2r | #1 |
| collagen immunization | #1 |
| reduced oxidative burst | #1 |
| collagen arthritis iii | #1 |
| severity arthritis | #1 |
| proteins gay | #1 |
| ifn signature mice | #1 |
| pristane cell death | #1 |
| experimental carcinogens | #1 |
| type collagens rats | #1 |
| nodq locus | #1 |
| h2p mice cia | #1 |
| chronicity arthritis | #1 |
| arthritis aim | #1 |
| complex cia | #1 |
| presence mhv | #1 |
| chromosome arthritis severity | #1 |
| post‐partum exacerbation | #1 |
| arthritis severity rats | #1 |
| chromosome cia | #1 |
| human α‐enolase | #1 |
| cii h2p | #1 |
| autologous peptide cells | #1 |
| tcell hybridomas cells | #1 |
| cii development | #1 |
| cia32 | #1 |
| induced arthritis | #1 |
| developed arthritis | #1 |
| nzw parental | #1 |
| cii olive oil | #1 |
| rats rheumatoid | #1 |
| cartilage antibody | #1 |
| oestradiol dth | #1 |
| disease affinity | #1 |
| existence periodontitis | #1 |
| cii | #1 |
| diagnostic accuracy acpa | #1 |
| pc117 extracellular structures | #1 |
| pepsin lewis | #1 |
| nrc ova | #1 |
| severity ides | #1 |
| severity pia | #1 |
| tlr3 expression fls | #1 |
| lymphocytes cartilage | #1 |
| mcaia ncf1 | #1 |
| ltabncr3 | #1 |
| anticii antibodies | #1 |
| arthritis protection | #1 |
| phytol arthritis | #1 |
| ncf1 p47phox | #1 |
| f1 hybrids disease | #1 |
| inbred dba pepsin | #1 |
| cartilagespecific protein | #1 |
| topoisomerase antagonist | #1 |
| thymectomy transgenes | #1 |
| anticii abs | #1 |
| glycosylation hla | #1 |
| genes ncf1 | #1 |
| immunospecific reactions | #1 |
| cii antibodies | #1 |
| experimental autoantigens | #1 |
| rat pristaneinduced arthritis | #1 |
| cii dendritic cells | #1 |
| cuiiidaligands | #1 |
| cia12 | #1 |
| antibodies pc4 | #1 |
| arthritis mhc | #1 |
| mice burkholderia cepacia | #1 |
| rats severity | #1 |
| aplec locus | #1 |
| cia oia | #1 |
| arthritis rheumatoid arthritis | #1 |
| activation cii | #1 |
| pia11 | #1 |
| mhc influence | #1 |
| cia model strains | #1 |
| major epitopes patients | #1 |
| cii259273 peptide | #1 |
| vivo imaging l012 | #1 |
| signaling characterization | #1 |
| thps cii | #1 |
| carcinoma tumors ros | #1 |
| hg6pi325 | #1 |
| cii response | #1 |
| act389949 fpr | #1 |
| flss polyi | #1 |
| inbred dba prolactin | #1 |
| type collagen cxi | #1 |
| collagen epitope expression | #1 |
| e3xda | #1 |
| cia21 | #1 |
| ox8 monoclonal | #1 |
| kgf thymus | #1 |
| ncf1 spread | #1 |
| encephalomyelitis arthritis | #1 |
| chronic arthritis rats | #1 |
| congenic cia40 | #1 |
| antigen presentation cii | #1 |
| fpr1 agonist neutrophils | #1 |
| da1u rats expression | #1 |
| cxi | #1 |
| bb2bb3 regulation | #1 |
| ciispecific monoclonal | #1 |
| dth response mrl | #1 |
| t‐cell epitope cii260‐270 | #1 |
| collagen iiinduced arthritis | #1 |
| arthritis pristane | #1 |
| diabetes sialadenitis | #1 |
| c3hq | #1 |
| clec4b | #1 |
| frequency chronic arthritis | #1 |
| ciispecific | #1 |
| cii256−270 | #1 |
| disease cd8 deficiency | #1 |
| hyaluronanreceptor | #1 |
| anti cii acpa | #1 |
| autoantibodies cartilage | #1 |
| cia ifa | #1 |
| nod nss1 loci | #1 |
| joint inflammatory phase | #1 |
| lew mol strain | #1 |
| function targeted deletion | #1 |
| loci eae39 | #1 |
| beta haplotype | #1 |
| mannan mice | #1 |
| epitopes vivo | #1 |
| haplotypes h2q | #1 |
| cii mab | #1 |
| ncf1 ncf1 mice | #1 |
| estrogen differential outcome | #1 |
| urokinase enzyme | #1 |
| arthritis monoclonal arthritis | #1 |
| nod loci genes | #1 |
| ncf1 mice | #1 |
| rats ncf1 | #1 |
| arthritis male | #1 |
| models rheumatoid arthritis | #1 |
| dth nzb mice | #1 |
| dba 1jpfp | #1 |
| ncf1 deficient | #1 |
| cii vivo | #1 |
| cia rheumatoid arthritis | #1 |
| immunization autologous peptide | #1 |
| sialadenitis incidence | #1 |
| loci arthritis | #1 |
| nod incidence | #1 |
| arthritogenic antibody | #1 |
| wt ncf1 | #1 |
| cii vaccination | #1 |
| mumt mice oestrogen | #1 |
| injection mannan | #1 |
| driven psoriatic arthritis | #1 |
| mice anticd4 treatment | #1 |
| lewis oia | #1 |
| immunization mouse | #1 |
| pia8 | #1 |
| role major epitopes | #1 |
| mutation ptdins3pbinding site | #1 |
| arthritis gene regions | #1 |
| cd68‐expressing cells | #1 |
| cia antibody response | #1 |
| cia11 | #1 |
| obs electrophoresis | #1 |
| mice ros | #1 |
| non‐mhc genes | #1 |
| monoclonal cartilage cattle | #1 |
| striking phenotypic similarities | #1 |
| cia5 qtl | #1 |
| milk titers | #1 |
| collagen ii‐induced | #1 |
| cii human | #1 |
| p47phoxv232 | #1 |
| eae chromosomes | #1 |
| dendritic cells collagen | #1 |
| mice functional ncf1 | #1 |
| development aureus arthritis | #1 |
| p47phox ncf1 | #1 |
| b10riii riiis | #1 |
| hybridomas multispecific antibodies | #1 |
| cii rheumatoid autoantibodies | #1 |
| mbp c5a | #1 |
| genetic control pia | #1 |
| nox2derived ros mice | #1 |
| genetic background rats | #1 |
| da1u rat liver | #1 |
| cia comp | #1 |
| pepsin cii | #1 |
| collagen reactive | #1 |
| phosphatase 22 | #1 |
| b10dr4ncf1 | #1 |
| mab ciif4 ciic1 | #1 |
| denatured cii | #1 |
| snat proteins | #1 |
| cia mip | #1 |
| protein ncf1m1j mice | #1 |
| specific cii | #1 |
| pregq2 | #1 |
| cii260‐270 | #1 |
| ciic1 antibody | #1 |
| specificity ros rns | #1 |
| caia model | #1 |
| ncf1 genes | #1 |
| pparγ cbrh7919 cells | #1 |
| disease c4bp | #1 |
| cii comp | #1 |
| b10q dba 1f1 | #1 |
| fcbinding | #1 |
| suppression collagen | #1 |
| genetic regions | #1 |
| arthritis development cross | #1 |
| phase cia | #1 |
| tlr3 flss | #1 |
| fibroblast induced arthritis | #1 |
| cii256270 | #1 |
| reactivity cb268 | #1 |
| cia7 chromosome | #1 |
| controlling onset | #1 |
| suggestive locus chromosome | #1 |
| ncf4 gene | #1 |
| autoimmune arthritis apcs | #1 |
| rabeximod treatment | #1 |
| function acpas | #1 |
| b10q mice ncf1 | #1 |
| rat comp arthritis | #1 |
| dth dba 1 | #1 |
| oestrogen‐induced suppression | #1 |
| cii259 273 | #1 |
| autoimmunity mineral oils | #1 |
| congenic polymorphism illness | #1 |
| cia12 pia4 | #1 |
| oxidases receptors | #1 |
| cells ncf1 | #1 |
| lathyritic cii | #1 |
| cii major epitope | #1 |
| pc4 pc117 | #1 |
| drb10401positive | #1 |
| chondrocytes kgf | #1 |
| mice l012 | #1 |
| ncf1 mutation mice | #1 |
| estrogeninduced suppression | #1 |
| function p47phox | #1 |
| cix cartilage | #1 |
| pia3 | #1 |
| cia swr mouse | #1 |
| presentation arthritis | #1 |
| hyaluronanreceptor cd44 | #1 |
| relapsing arthritis | #1 |
| reproductive performance identification | #1 |
| cii immunisation | #1 |
| nox2derived ros | #1 |
| cryogel column antibodies | #1 |
| ros mip | #1 |
| cii 256270 peptide | #1 |
| cells caia | #1 |
| administration antibodies hyaluronanreceptor | #1 |
| phenotypes ncf1m1j mice | #1 |
| eae strains severity | #1 |
| cii severity | #1 |
| psicoch2 | #1 |
| ifnbeta arthritis | #1 |
| nasal treatment ctbcii | #1 |
| function nox2 | #1 |
| cxb10qf2 | #1 |
| citrullinated collagen | #1 |
| disease development effects | #1 |
| chronic arthritis development | #1 |
| cii mabs | #1 |
| function ncf1 gene | #1 |
| ciif4 ciic1 | #1 |
| vivo monoclonal mouse | #1 |
| pepsin immunization | #1 |
| tlr3 tlr3 expression | #1 |
| comp cxi | #1 |
| autoantibodies cii | #1 |
| active arthritis complex | #1 |
| induced arthritis rats | #1 |
| rheumatoid arthritis cii | #1 |
| models rheumatoid | #1 |
| mice h2q | #1 |
| strains b10q | #1 |
| antibody response cii | #1 |
| cartilage stability cartilage | #1 |
| satellite encephalomyelitis autoimmune | #1 |
| oxa nzb mice | #1 |
| arthritis animal | #1 |
| caia mab | #1 |
| disease arthritis | #1 |
| arthritis ul1 | #1 |
| rat placenta uterus | #1 |
| naive experimental chromosomes | #1 |
| arthritis suppression | #1 |
| cii chronic | #1 |
| psiechch | #1 |
| cii immunization | #1 |
| rat cii cii | #1 |
| cxi chronic arthritis | #1 |
| congenic mice genes | #1 |
| inbred dba cii | #1 |
| pathogenesisis | #1 |
| cia tsc transgenic | #1 |
| ciif4 adverse effects | #1 |
| epitope type | #1 |
| hla–dr1 | #1 |
| clec4b ncf1 | #1 |
| ncf1m1j mice ncf1 | #1 |
| illness cia | #1 |
| c3hq mice cii | #1 |
| tcell experimental cartilage | #1 |
| mediate pulmonary inflammation | #1 |
| development inflammatory attack | #1 |
| homologous cii | #1 |
| rheumatoid arthritis autoimmunity | #1 |
| mice interferon gamma | #1 |
| mhc class injections | #1 |
| autoantibodies collagen | #1 |
| arthritis antibody | #1 |
| immunodominant cii | #1 |
| cells rat cii | #1 |
| established arthritis | #1 |
| autoimmune diseases cnvs | #1 |
| cia13 | #1 |
| type collagen cia | #1 |
| arthritis experimental | #1 |
| rheumatoid drug evaluation | #1 |
| chronic relapsing arthritis | #1 |
| loci cia2 | #1 |
| congenic polymorphism | #1 |
| spread induced psoriasis | #1 |
| rats phytol | #1 |
| ncf1 copy variation | #1 |
| immunization heterologous cii | #1 |
| induce arthritis | #1 |
| cell specificity cii | #1 |
| pepsin arthritis | #1 |
| congenic mice vdr | #1 |
| rheumatoid arthritis eae | #1 |
| spread psoriasis | #1 |
| caia mutant mice | #1 |
| critical restriction site | #1 |
| kgf chondrocytes | #1 |
| rat cii | #1 |
| ciic1scfv | #1 |
| adjuvant oils | #1 |
| rs201802880 | #1 |
| autoimmune priming | #1 |
| animal histocompatibility | #1 |
| cb268 | #1 |
| cells cii | #1 |
| gergaagiagpk | #1 |
| polymorphic fragment | #1 |
| pristane primed | #1 |
| periodontitis rats pia | #1 |
| rats pristane | #1 |
| cii peptides | #1 |
| major role rp | #1 |
| arthritis promoting | #1 |
| cii acpa | #1 |
| cii induced | #1 |
| methods | #1 |
| il10 mmc | #1 |
| idd5 loci | #1 |
| pathway arthritis | #1 |
| glycopeptide stimulation | #1 |
| epitope cartilage | #1 |
| minor cartilage proteins | #1 |
| cb268 cii | #1 |
| synovial cells macrophages | #1 |
| glycosylated epitope | #1 |
| cia22 | #1 |
| engagement fcgammar | #1 |
| arthritis‐susceptibility loci | #1 |
| homologous type collagen | #1 |
| innate‐associated disease | #1 |
| salivary glands antigen | #1 |
| lew avridineinduced arthritis | #1 |
| dependent autoimmune | #1 |
| new loci controlling | #1 |
| differential susceptibility cia | #1 |
| citrullination cii | #1 |
| arthritis qtl chip | #1 |
| chromosome pia | #1 |
| tolerance cia | #1 |
| superovulation rate | #1 |
| ncf1 m1j | #1 |
| fpr act389949 | #1 |
| rats ncf1 allele | #1 |
| adjuvanticity autoimmunity | #1 |
| immunological transmitter | #1 |
| polymorphism ncf1 | #1 |
| gia expansion | #1 |
| heterologous cii | #1 |
| tlr3 upregulation flss | #1 |
| pia4 chromosome | #1 |
| rheumatoid collagen | #1 |
| cia molecular basis | #1 |
| l012 vivo imaging | #1 |
| plasminogen deficiency cia | #1 |
| authors hgpi325339 peptide | #1 |
| cia animal models | #1 |
| arthritis mcaia | #1 |
| arthritis naive mice | #1 |
| transient joint inflammation | #1 |
| anti type | #1 |
| cia2 cia9 | #1 |
| pristane hexadecane | #1 |
| native cii | #1 |
| arthritis monoclonal | #1 |
| arthritis amino | #1 |
| chromosome congenic strains | #1 |
| ciilysdnp | #1 |
| ncf1 339 | #1 |
| homologous type | #1 |
| partial advanced | #1 |
| cia | #1 |
| ccp positive patients | #1 |
| arthritis development immunisation | #1 |
| tregs ros | #1 |
| ii‐induced arthritis | #1 |
| pia cii | #1 |
| innate immunity mip | #1 |
| humanized models disease | #1 |
| b10dr4ncf1 mice cii | #1 |
| cii carbohydrates | #1 |
| cartilage explants mabs | #1 |
| maintenance arthritis | #1 |
| cia homologous cii | #1 |
| mouse cii reactivity | #1 |
| dimethyl6n | #1 |
| arthritis chronic | #1 |
| caia kgf | #1 |
| immunization heterologous | #1 |
| collagen dendritic cells | #1 |
| cia eae39 | #1 |
| disease th1 immunity | #1 |
| expression liver receptor | #1 |
| deficient ncf1 | #1 |
| pv cd4 cells | #1 |
| native comp | #1 |
| collagen cxi | #1 |
| onset animals arthritis | #1 |
| ciiglycopeptides | #1 |
| ncf4 mice | #1 |
| mmc transgene | #1 |
| glycosylated epitope structures | #1 |
| nox2 agonists | #1 |
| arthritogenic mabs | #1 |
| acpa general population | #1 |
| cell determinants cii | #1 |
| compia | #1 |
| rat cb11 immunization | #1 |
| rt1l haplotypes | #1 |
| dominant traits | #1 |
| 22 variant r620w | #1 |
| ncf1m1j mice | #1 |
| mice arthritis | #1 |
| 371115tetramethyl2hexadecene1ol | #1 |
| lys264 | #1 |
| scarce clinical samples | #1 |
| pia rats tlr3 | #1 |
| caia cii | #1 |
| inbred strains severity | #1 |
| illness terpenes | #1 |
| ciic1 mabs | #1 |
| collagens antibody | #1 |
| da1f | #1 |
| congenic strains rats | #1 |
| collagen autoantibody | #1 |
| autologous cii | #1 |
| preformed cartilage | #1 |
| mice mutated cii | #1 |
| genetic association ncf1 | #1 |
| fecq4 | #1 |
| severe arthritis immunization | #1 |
| cia cartilage | #1 |
| cells autologous cii | #1 |
| evokes peptide | #1 |
| h2w3 | #1 |
| arthritis animals | #1 |
| h2w17 | #1 |
| mannaninduced | #1 |
| cia reduction | #1 |
| mannan immune | #1 |
| methodspurified | #1 |
| concentrations cii | #1 |
| suppressive development | #1 |
| cartilage‐specific antibodiesis | #1 |
| tolerance arthritis protection | #1 |
| carbohydrates cii | #1 |
| presentation cii | #1 |
| ciispecific antibodies | #1 |
| cia development | #1 |
| cia vivo priming | #1 |
| immunization rat cii | #1 |
| animal genes cia | #1 |
| rats pia9 alleles | #1 |
| day ciispecific cells | #1 |
| arthritis intraperitoneal injection | #1 |
| macrophages mannans | #1 |
| pia eae | #1 |
| peritonitis transgenic | #1 |
| chemical collagen | #1 |
| mrl mice estrogen | #1 |
| cd43expressing cells | #1 |
| cii peptide molecules | #1 |
| genes animal models | #1 |
| environments mice | #1 |
| copy variation ncf1 | #1 |
| cia compdeficient mice | #1 |
| chlorophyll component | #1 |
| igg response cii | #1 |
| new therapy arthritis | #1 |
| cells arthritis progression | #1 |
| arthritis estrogen | #1 |
| major epitopes | #1 |
| response splenocytes | #1 |
| blocking arthritis | #1 |
| cii severe arthritis | #1 |
| severe arthritis | #1 |
| dth mice trait | #1 |
| cii ciif4 | #1 |
| arthritis independent | #1 |
| polychondritis mice | #1 |
| arthritis development severity | #1 |
| cii260 | #1 |
| recognition lysine | #1 |
| role nox2derived ros | #1 |
| ncf1m1j mice function | #1 |
| nox2 functionality | #1 |
| cix cii | #1 |
| cells cb11 | #1 |
| arthritis males | #1 |
| mhc aq | #1 |
| il10 cia | #1 |
| vivo treatment | #1 |
| rat cii arthritis | #1 |
| lew1w rt1u | #1 |
| pristane tlr3 expression | #1 |
| cia ul1 mab | #1 |
| inconsistent susceptibility | #1 |
| pristaneinduced arthritis | #1 |
| cii cross reactivity | #1 |
| ides treatment severity | #1 |
| cia b10q | #1 |
| murine psoriasis model | #1 |
| cd4 treatment | #1 |
| functional ncf1 macrophages | #1 |
| oestradiol suppression | #1 |
| collagen hybridomas | #1 |
| mhc mbp | #1 |
| arthritis susceptibility rats | #1 |
| mbq mouse macrophages | #1 |
| pia cia | #1 |
| rats comp | #1 |
| cii heterologous cii | #1 |
| rp autoimmune disease | #1 |
| muscle nox2 | #1 |
| tumors immunosuppressive leukocytes | #1 |
| fecq4 locus | #1 |
| strains polychondritis | #1 |
| ll37 rcramp | #1 |
| ciic1 fab | #1 |
| dth nzb | #1 |
| type disease | #1 |
| glycosylated cii | #1 |
| dominant susceptibility loci | #1 |
| animal epitopes injections | #1 |
| sterically privileged | #1 |
| ciispecific cells day | #1 |
| flss tlr3 expression | #1 |
| riiis alleles eae2 | #1 |
| fecq4 fragment | #1 |
| sialadenitis congenic mice | #1 |
| lps caia | #1 |
| disease monitoring rats | #1 |
| pia cix | #1 |
| autoantibody formation cia | #1 |
| dba 1 background | #1 |
| increase ncf1 | #1 |
| daf2cross | #1 |
| h2q c3hnb | #1 |
| pristane induced | #1 |
| dapia6 | #1 |
| drb10401 col2259 | #1 |
| mice developed | #1 |
| hydrocarbon oil structure | #1 |
| b10q h2q | #1 |
| ncf1 knockout | #1 |
| recombinant vaccine inflammation | #1 |
| major antigenic epitope | #1 |
| respiratory burst severity | #1 |
| oxidative burst inducers | #1 |
| c3hnb mice | #1 |
| experimental autoantibodies | #1 |
| immunologic animals arthritis | #1 |
| arthritis b6n mice | #1 |
| h2q haplotype | #1 |
| rheumatoid arthritis cia | #1 |
| arthritis collagen arthritis | #1 |
| eae2 resistant locus | #1 |
| rats cxi | #1 |
| differences ncf1 | #1 |
| collagen type‐ii epitope | #1 |
| insulitis nodq | #1 |
| inbred strains cia | #1 |
| arthritis traits | #1 |
| cartilage damage vivo | #1 |
| tumor colonization | #1 |
| arthritogenicity cells | #1 |
| pinealectomy exposure | #1 |
| specific antibody protection | #1 |
| ciispecific cell responses | #1 |
| synthetic peptides cii | #1 |
| rats terpenes | #1 |
| marginal ankylosis | #1 |
| ym1deficient mice | #1 |
| congenic arthritis rats | #1 |
| lymphocytes collagen | #1 |
| cii pepsin | #1 |
| arthritis toe stiffness | #1 |
| dba mouse epitopes | #1 |
| ncf1 lyme arthritis | #1 |
| phytol molecular pathways | #1 |
| cii swr mice | #1 |
| c3hnb | #1 |
| 2 nox2 | #1 |
| rat comp | #1 |
| cia caia model | #1 |
| ciic1 mab ciif4 | #1 |
| avridine arthritis | #1 |
| cxi arthritis | #1 |
| region ncf1 | #1 |
| antibody ciic1 | #1 |
| oxa backcrosses | #1 |
| pristaneinduced arthritis rats | #1 |
| double deficiency qa2 | #1 |
| transgenic nadph | #1 |
| rats hfdmets | #1 |
| mir144 tlr2 expression | #1 |
| disease transgenic models | #1 |
| position 264 | #1 |
| hladrβ10402 | #1 |
| cells heterologous cii | #1 |
| cii cells | #1 |
| immunization lathyritic cii | #1 |
| findings new therapy | #1 |
| arthritis rabeximod | #1 |
| locus arthritis | #1 |
| arthritis incidence | #1 |
| cb11 fragment | #1 |
| estrogen physiological doses | #1 |
| eae mtx | #1 |
| arthritis | #1 |
| acute phase arthritis | #1 |
| data act389949 | #1 |
| cia mtx | #1 |
| pc4 pc8 | #1 |
| breeding capacity | #1 |
| inflammation living mice | #1 |
| cryogel matrix cells | #1 |
| ul1 ciif4 | #1 |
| nodq nod nodp | #1 |
| cii cartilage | #1 |
| ncf1 mice wt | #1 |
| col2259 | #1 |
| rats pristaneinduced arthritis | #1 |
| hfdmets | #1 |
| cia lysine | #1 |
| h2p h2q | #1 |
| constant light order | #1 |
| interacting subloci | #1 |
| sialadenitis nodq | #1 |
| aq molecules | #1 |
| eae3 chromosome | #1 |
| argltgrpgda | #1 |
| synovium pia rats | #1 |
| paamcryogel | #1 |
| autoimmune response cii | #1 |
| arthritis darkness | #1 |
| impact topoisomerase antagonist | #1 |
| cia induced | #1 |
| epitopes cb10 fragment | #1 |
| injection adjuvant oils | #1 |
| congenic fragments | #1 |
| ciic1 ciif4 | #1 |
| 237 females | #1 |
| inflammatory arthritis assessment | #1 |
| comp disease monitoring | #1 |
| cells mouse cii | #1 |
| lew ztm ncf1 | #1 |
| stromal cells osteoclasts | #1 |
| sialadenitis arthritis | #1 |
| arthritis synovial tlr3 | #1 |
| swr mice immunization | #1 |
| nfr origin | #1 |
| cii u1 | #1 |
| wild type ncf1 | #1 |
| joint proteins | #1 |
| polychondritis autoimmune disease | #1 |
| mgpi325 | #1 |
| epitopes cb11 fragment | #1 |
| mechanism autoimmune | #1 |
| ciiinduced arthritis | #1 |
| c4bp alternative pathway | #1 |
| ros adaptive immunity | #1 |
| 4 histone deacetylases | #1 |
| cii ecm | #1 |
| immunization rat | #1 |
| cells dba mouse | #1 |
| oxidases polymers | #1 |
| rat recombinants | #1 |
| extraarticular cartilage | #1 |
| cii histocompatibility complex | #1 |
| serum interferon activity | #1 |
| cells synthetic glycopeptides | #1 |
| pia cia13 pia7 | #1 |
| aq molecule | #1 |
| collagen‐induced arthritis | #1 |
| animal genetic predisposition | #1 |
| cii mhc | #1 |
| collagen citrullination | #1 |
| immunization type | #1 |
| igg1 igg2b isotypes | #1 |
| 2 months beta | #1 |
| mouse cii | #1 |
| ftirm cii | #1 |
| ncf1m1j mutation | #1 |
| deficient neonatal | #1 |
| endos hydrolyzed igg | #1 |
| mhc cii | #1 |
| b10q1 | #1 |
| dba1 mice | #1 |
| ctbcii | #1 |
| cxi pia | #1 |
| monoclonal arthritis arthritis | #1 |
| daiu | #1 |
| immune priming events | #1 |
| dba 1jpfp cia | #1 |
| eae2 locus | #1 |
| h2r h2q | #1 |
| intracellular processing cii | #1 |
| fibroblasts ifnbetadeficient mice | #1 |
| vivo experimental arthritis | #1 |
| mice chronic arthritis | #1 |
| cells cia | #1 |
| tolerance induction cii | #1 |
| genes arthritis | #1 |
| siliac | #1 |
| susceptibility cia | #1 |
| concentrations mouse cii | #1 |
| chronic intervention | #1 |
| c3hnb h2p | #1 |
| peptides aq | #1 |
| cia ul1 | #1 |
| dth antibody response | #1 |
| plcpip | #1 |
| nonglycosylated peptide | #1 |
| oxidative burst disease | #1 |
| eae39 locus cia | #1 |
| dnp epitopes lysine | #1 |
| cii 6 | #1 |
| arthritis pepsin | #1 |
| ifnbeta deficiency | #1 |
| m1s1a | #1 |
| ros continental ancestry | #1 |
| cia recognition | #1 |
| 1 ncf1 | #1 |
| chronic pristane | #1 |
| arthritis injection | #1 |
| eae2 | #1 |
| receptor γ pparγ | #1 |
| riiis segment chromosome | #1 |
| chronic arthritis mice | #1 |
| inflammatory phase cia | #1 |
| congenic | #1 |
| cii cell | #1 |
| rat cb10 cb11 | #1 |
| ros glucose transporter | #1 |
| anticii response | #1 |
| antibodies cii | #1 |
| arthritis estrus cycle | #1 |
| single monoclonal | #1 |
| csfspecific | #1 |
| synovial membranes joints | #1 |
| citrullinated collagen arthritis | #1 |
| chemical cartilage | #1 |
| arthritis induced | #1 |
| pia model rats | #1 |
| vridine‐induced arthritis | #1 |
| pia rats arthritis | #1 |
| clever1 type macrophages | #1 |
| cii immunodominant | #1 |
| cd2 human cells | #1 |
| c57bl 10q | #1 |
| severe polyarthritis | #1 |
| biodegradation cryogels | #1 |
| patients china cohort | #1 |
| anticd4 treatment immunization | #1 |
| new arthritis | #1 |
| idiotype‐specific binding | #1 |
| macrophages autoimmune priming | #1 |
| mhc genetic region | #1 |
| arthritis mutant strains | #1 |
| nzw parental strain | #1 |
| eae39 | #1 |
| incidence arthritis | #1 |
| chromosomes eae loci | #1 |
| development cia | #1 |
| protective role cia | #1 |
| ccp2 negative | #1 |
| cia cii | #1 |
| disease genotype immunoglobulin | #1 |
| h2p h2q haplotype | #1 |
| cartilage explants ciic1 | #1 |
| g6pi peptide | #1 |
| animal immunosuppressive agents | #1 |
| cia experimental arthritis | #1 |
| fls ppt medium | #1 |
| aq class | #1 |
| arthritis humans | #1 |
| kgf treatment onset | #1 |
| mice ncf4 | #1 |
| c57bl strains loci | #1 |
| melatonin cia | #1 |
| chromosome 17 mhc | #1 |
| cii responsiveness | #1 |
| cia mhc | #1 |
| citrullinated type collagen | #1 |
| epitopes cii | #1 |
| rats rt1f mhc | #1 |
| defined polymeric adjuvant | #1 |
| mcia1 | #1 |
| models collagen | #1 |
| role ncf1 | #1 |
| contrast nodq | #1 |
| increased incidence cia | #1 |
| day acute arthritis | #1 |
| ifnbeta experimental arthritis | #1 |
| ciif4 mab | #1 |
| beta 812 | #1 |
| mice salt concentrations | #1 |
| 256 270 | #1 |
| b10qc5δ | #1 |
| isolated fragment chromosome | #1 |
| susceptible strain cross | #1 |
| effector phase arthritis | #1 |
| presence sex hormones | #1 |
| cii recognition | #1 |
| oxoethyl6h | #1 |
| lpr mice granulocytes | #1 |
| type collagen cii256−270 | #1 |
| arthritis pnipaam | #1 |
| sod3 peritonitis | #1 |
| dancf1da rats | #1 |
| cii immunization treatment | #1 |
| qtl animal genes | #1 |
| stages arthritis | #1 |
| ciiderived | #1 |
| toxin‐1‐producing staphylococci | #1 |
| fumia | #1 |
| ciid3 | #1 |
| transgenic tolerance tlymphocytes | #1 |
| pathogenesis cia | #1 |
| swr nfr | #1 |
| f1 males influence | #1 |
| tissue attack | #1 |
| estrogen immune responses | #1 |
| role eosinophilia | #1 |
| incidence nod | #1 |
| congenic c57bl mice | #1 |
| arthritis autoimmune | #1 |
| human immunopeptidome lung | #1 |
| susceptible cia | #1 |
| induction oia | #1 |
| cia5 cia21 | #1 |
| tlr3 expression flss | #1 |
| congenic strains cia | #1 |
| collagen cii | #1 |
| c3hq mice | #1 |
| cii matrix protein | #1 |
| antibody induced | #1 |
| mhc‐congenic mouse strains | #1 |
| oestradiol exacerbation | #1 |
| ciic1 m2139 | #1 |
| ox8 antibodies | #1 |
| cii h2q | #1 |
| development humanized models | #1 |
| qtl chip | #1 |
| rat congenic data | #1 |
| surface redox levels | #1 |
| arthritis cell | #1 |
| arthritis ncf1 | #1 |
| arthritis anticii abs | #1 |
| caia cia | #1 |
| melatonin release pinealectomy | #1 |
| cia oestrogen | #1 |
| rheumatoid disease models | #1 |
| cells galactosylated peptide | #1 |
| disease dba 1jpfp | #1 |
| estrogen manifestations | #1 |
| cia caia | #1 |
| ciipeptide cells | #1 |
| loci sialadenitis | #1 |
| comp mabs | #1 |
| cia animal epitopes | #1 |
| anti comp | #1 |
| arthritis incidence severity | #1 |
| cii259 | #1 |
| ncf1 | #1 |
| development oia | #1 |
| mice th1 cytokines | #1 |
| u1 epitope | #1 |
| cia il10 | #1 |
| macrophages hladr1transgenic mice | #1 |
| hg6pi | #1 |
| genetic control sialadenitis | #1 |
| cell recognition carbohydrates | #1 |
| mutant p47phox | #1 |
| β1helix | #1 |
| ftirm mice | #1 |
| dapia3 | #1 |
| pia9 | #1 |
| peripheral cells alphachains | #1 |
| saline arthritis | #1 |
| b10q | #1 |
| cxi comp | #1 |
| ncf1 ncf1m1j mutation | #1 |
| dba 1 mouse | #1 |
| molecule aq | #1 |
| immune response mbp | #1 |
| caia acute arthritis | #1 |
| cii ncf1 | #1 |
| collagen reactivity cxi | #1 |
| ros rns inflammation | #1 |
| cii antibody | #1 |
| rats adjuvant oil | #1 |
| cii 256 | #1 |
| expressions cyp7a1 | #1 |
| formation arthritis | #1 |
| cia13 pia7 | #1 |
| rat cii response | #1 |
| arthritis multiple | #1 |
| cxi cii | #1 |
| beta 10b mrl | #1 |
| presence arthritogenic mabs | #1 |
| anticardiolipin antibodies p005 | #1 |
| severity cia | #1 |
| induced arthritis cia | #1 |
| pia rheumatoid arthritis | #1 |
| anticii antibody response | #1 |
| anticlever1 antibody treatment | #1 |
| protein expression genes | #1 |
| ros nox2 complex | #1 |
| development chronic arthritis | #1 |
| cii citrullinated | #1 |
| arthritis autoantibody | #1 |
| pia2–8 | #1 |
| cia rheumatoid autoantibodies | #1 |
| cells mgps | #1 |
| lewis rats pepsin | #1 |
| fab2 ciic1 | #1 |
| confers arthritis susceptibility | #1 |
| inability collagen | #1 |
| b10b | #1 |
| ul1 ciif4 mab | #1 |
| features arthritis | #1 |
| eae39 study | #1 |
| collagen langerhans cells | #1 |
| immunization cii | #1 |
| arthritis transfer | #1 |
| h2p susceptibility | #1 |
| locus cia development | #1 |
| arthritis cia | #1 |
| b10q strain | #1 |
| sle‐prone mrl | #1 |
| established sialadenitis | #1 |
| enhanced autoimmunity arthritis | #1 |
| igg2a vivo | #1 |
| liver contributes hfdmets | #1 |
| cii antigen presentation | #1 |
| cageeffects | #1 |
| sialadenitis cell phenotypes | #1 |
| comp experimental autoantibodies | #1 |
| genome b10riii | #1 |
| response cii | #1 |
| nodq×b10q | #1 |
| rt1bβ | #1 |
| ecm mab | #1 |
| cia melatonin | #1 |
| dominant hypersensitivity dth | #1 |
| arthritis collagen | #1 |
| arthritis tlr3 | #1 |
| cii arthritis | #1 |
| collagen induced | #1 |
| pia4 | #1 |
| nonglycosylated epitope | #1 |
| nzb dth | #1 |
| cartilage explants m2139 | #1 |
| collagen 256 | #1 |
| nodq nod | #1 |
| visual signs arthritis | #1 |
| position mouse cii | #1 |
| immunisation cells | #1 |
| selected anti‐t‐cell | #1 |
| immunization heterologous peptide | #1 |
| dth dominant hypersensitivity | #1 |
| rats rt1 | #1 |
| concentrations rat cii | #1 |
| arthritis congenic | #1 |
| hfdmets expression | #1 |
| cia pia | #1 |
| arthritis driven | #1 |
| strains developed | #1 |
| heterologous peptide response | #1 |
| mbpc5a | #1 |
| bond requirements | #1 |
| olive oil arthritis | #1 |
| cartilage specific | #1 |
| compsufficient mice | #1 |
| h‐2q mice | #1 |
| humans animals arthritis | #1 |
| glut4dependent glucose transport | #1 |
| eae39 control disease | #1 |
| citrullinated type | #1 |
| strains nodq | #1 |
| nod nss1 | #1 |
| arthritismodulating | #1 |
| animal epitopes | #1 |
| autoimmunogenic hydrocarbon oils | #1 |
| myeloid effector functions | #1 |
| collagen arthritis progesterone | #1 |
| mcaia | #1 |
| spleen cluster | #1 |
| hexadecane induce arthritis | #1 |
| ncf1 ptpn22 | #1 |
| immunization mouse cii | #1 |
| cathelicidin expression blood | #1 |
| dominant hypersensitivity | #1 |
| cii triple | #1 |
| comp cii | #1 |
| inclusion negative predictive | #1 |
| psoriasis spread | #1 |
| bqncf1m1j | #1 |
| healthy nzw | #1 |
| pc8 pc117 | #1 |
| serum chromosome | #1 |
| established pia disease | #1 |
| abetachains | #1 |
| disease collagen | #1 |
| caia gene segments | #1 |
| elevated th17 cells | #1 |
| glycosylated determinant peptides | #1 |
| pia3 pia4 | #1 |
| rats arthritis | #1 |
| disease susceptibility castration | #1 |
| b10q b10riii | #1 |
| pia3 chromosome | #1 |
| citrullinated variants | #1 |
| publication animals arthritis | #1 |
| susceptible collagen | #1 |
| arthritis epitopes | #1 |
| cii saline | #1 |
| macrophages cii degradation | #1 |
| predominant selection | #1 |
| pia7 | #1 |
| re04001activatedfpr1 | #1 |
| strong response epitopes | #1 |
| ifa cii ifa | #1 |
| mabs cii | #1 |
| ncf1 mutated | #1 |
| cii molecule | #1 |
| arthritis susceptibility mice | #1 |
| b10qnss1 | #1 |
| antitlr3 antibody | #1 |
| inflammatory tissue attack | #1 |
| mhc cia | #1 |
| glycosylated cii259 | #1 |
| cia h2p | #1 |
| cia ros | #1 |
| arthritis adjuvants | #1 |
| b10riii | #1 |
| tlr3 pristane | #1 |
| ym1 pneumonitis | #1 |
| lnchc cholesterol metabolism | #1 |
| mip cia | #1 |
| satellite encephalomyelitis | #1 |
| b10qbalb | #1 |
| early onset development | #1 |
| immune cartilage | #1 |
| representative swedish | #1 |
| mice darkness | #1 |
| chromosome f1 males | #1 |
| rt1ba | #1 |
| cia chromosome | #1 |
| autoantibody responses cii | #1 |
| emulsions induction | #1 |
| transgenic mice mhcii | #1 |
| induction postpartum flare | #1 |
| cia rat | #1 |
| reactivity cii | #1 |
| promoter regions antigens | #1 |
| genetic crossbreeding | #1 |
| cii polymer | #1 |
| cd200 btla | #1 |
| pristane macrophages | #1 |
| spleen pristane injection | #1 |
| phase arthritis | #1 |
| experimental chromosomes | #1 |
| arthritis control mice | #1 |
| loci controlling diabetes | #1 |
| cii cartilage explants | #1 |
| oia induction | #1 |
| chronic active arthritis | #1 |
| caia riiis segment | #1 |
| cxiia | #1 |
| ciispecific cells | #1 |
| arthritis tlr3 upregulation | #1 |
| arthritogenic mab ciic1 | #1 |
| mip ncf4 | #1 |
| pia5 | #1 |
| function single | #1 |
| c1iii type collagen | #1 |
| cii articular cartilage | #1 |
| realtime pcr flss | #1 |
| antibody cartilage blymphocyte | #1 |
| tolerance arthritis susceptibility | #1 |
| partial advanced intercross | #1 |
| arthritogenic antibodies | #1 |
| socalled collagen antibody | #1 |
| etoposide topoisomerase antagonist | #1 |
| celldependent disease | #1 |
| rats chronic disease | #1 |
| ncf1 polymorphisms | #1 |
| cii immunization mice | #1 |
| rats congenic arthritis | #1 |
| b10qacb | #1 |
| acpa discriminate | #1 |
| nadph activation | #1 |
| nucleotide reactive | #1 |
| compdeficient mice | #1 |
| cia induced arthritis | #1 |
| hdac3 pparγ | #1 |
| cartilage‐specific | #1 |
| nox2 complex ncf4 | #1 |
| collageninduced arthritis loci | #1 |
| homologous type pia | #1 |
| disease lew | #1 |
| rabeximod arthritis | #1 |
| model rheumatoid | #1 |
| vivo monoclonal | #1 |
| decreasing activation | #1 |
| suppression collagen arthritis | #1 |
| female preponderance development | #1 |
| pristane stimulation | #1 |
| rat pia | #1 |
| cii induced arthritis | #1 |
| maintained pregnancy levels | #1 |
| animal models polychondritis | #1 |
| emerging glyco‐based strategies | #1 |
| p47phox mutant | #1 |
| position ciilysdnp | #1 |
| induction cii | #1 |
| adaptive immunity fcγrs | #1 |
| susceptibility collagen | #1 |
| arthritis b10q mice | #1 |
| arthritis genetics | #1 |
| cia collagen | #1 |
| mem lglutamine | #1 |
| dependent autoimmune arthritis | #1 |
| ncf1m1j m1j mice | #1 |
| cia f1 males | #1 |
| m2139 ciic1 | #1 |
| arthritis encephalomyelitis | #1 |
| ncf1 allele | #1 |
| collagen arthritis hyaluronanreceptor | #1 |
| oestrogen treated | #1 |
| cia antigens haplotypes | #1 |
| arthritis qtl pia7 | #1 |
| male mice arthritis | #1 |
| physiological doses development | #1 |
| cells arthritogenicity | #1 |
| psoriasis single locus | #1 |
| δ228 | #1 |
| caia experimental arthritis | #1 |
| pristane hydrocarbon oils | #1 |
| experimental collagen | #1 |
| ztmrhd | #1 |
| susceptibility collageninduced arthritis | #1 |
| cii lewis | #1 |
| mice c3h background | #1 |
| congenic fragment | #1 |
| collagen type cii | #1 |
| leukosialin rats | #1 |
| collageninduced arthritis | #1 |
| lpscaia | #1 |
| treatment pia | #1 |
| cii261 | #1 |
| caia effects | #1 |
| polymorphism autoimmune diseases | #1 |
| citc1iiip | #1 |
| tlr3 synovium | #1 |
| position ros production | #1 |
| qtl positional cloning | #1 |
| caia lps | #1 |
| ncf1 mutation | #1 |
| peptide agonist fmlf | #1 |
| rats antibody cartilage | #1 |
| mcii707 | #1 |
| ciilysdnp mice | #1 |
| cii epitopes | #1 |
| cii cxi | #1 |
| clec4b activation | #1 |
| collagen antibody arthritis | #1 |
| cii ros | #1 |
| animal models arthritis | #1 |
| ala261gly262 | #1 |
| manifestations lupus disease | #1 |
| mice ncf1 | #1 |
| arthritis loci | #1 |
| 6 cii | #1 |
| arthritis caia | #1 |
| ncf4 | #1 |
| greater osteoclasts | #1 |
| alpha type collagen | #1 |
| ncf1 mutant mice | #1 |
| pristaneprimed cells | #1 |
| h‐2b | #1 |
| congenic arthritis | #1 |
| disease suggestive locus | #1 |
| act389949 | #1 |
| nox2 function | #1 |
| enhanced autoimmunity | #1 |
| major cii | #1 |
| ncf1deficient mice | #1 |
| u1 antibodies patients | #1 |
| fecq3 | #1 |
| b10qnfr | #1 |
| therapeutic cleavage igg | #1 |
| cii cia | #1 |
| cxi collagen fibers | #1 |
| cia5 region | #1 |
| impact etoposide | #1 |
| cii lewis rats | #1 |
| ncf1 mutant | #1 |
| mir144 tlr2 | #1 |
| major locus cia | #1 |
| galactosylated peptide | #1 |
| cia dominant epitope | #1 |
| c2ta genetic polymorphisms | #2 |
| lymphocytes animals | #2 |
| h2q mice mice | #2 |
| nox2 neuropathological alterations | #2 |
| arthritis oia | #2 |
| sle nadph oxidase | #2 |
| glycopeptides histocompatibility | #2 |
| cii injection | #2 |
| dxeb | #2 |
| comp cia | #2 |
| ros source | #2 |
| fibα563 | #2 |
| induction p47phoxmutated mph | #2 |
| hladr2dq6 | #2 |
| genotypes ovx | #2 |
| fibroblast induced | #2 |
| pia rat | #2 |
| antibody cartilage | #2 |
| species susceptible haplotypes | #2 |
| pathogenic igg antibodies | #2 |
| fil307 | #2 |
| oestradiol cia | #2 |
| das28 24 months | #2 |
| receptor‐specific manner | #2 |
| human animal models | #2 |
| lew mol | #2 |
| tgfbeta spinal cord | #2 |
| cartilage respiratory tract | #2 |
| mbp89 peptides | #2 |
| arthritis models rats | #2 |
| mice genistein treatment | #2 |
| das28 acpa reactivities | #2 |
| pnipaam vpba | #2 |
| castrated mice day | #2 |
| percentage peripheral cells | #2 |
| antibodies fibß62 | #2 |
| glycan activation | #2 |
| dr4 cii259 | #2 |
| tregs mph ros | #2 |
| arthritis mice | #2 |
| selective fpr1 | #2 |
| altered formation | #2 |
| suggestive locus | #2 |
| snp position | #2 |
| symptoms antibodies | #2 |
| oestrogen suppressive | #2 |
| multiple sclerosis maps | #2 |
| macrophagespecific nox2 | #2 |
| immunization mouse collagen | #2 |
| citcii311 | #2 |
| mhcii experimental arthritis | #2 |
| immunosuppressive leukocytes | #2 |
| cii citrullination | #2 |
| liver mice rna | #2 |
| cell tolerance c5a | #2 |
| fpr1 agonist | #2 |
| mbp 87110 peptide | #2 |
| transgenic osteoporosis oestradiol | #2 |
| mabs comp | #2 |
| c2ta mhcii expression | #2 |
| tregs mph | #2 |
| human lung nox2 | #2 |
| c129s mutant disulfide | #2 |
| new immunomodulatory drug | #2 |
| rno12 | #2 |
| antibodies disease onset | #2 |
| eae cia | #2 |
| vivo cii | #2 |
| disease development presence | #2 |
| sialadenitis mice | #2 |
| l10d9 antibody cxi | #2 |
| da1u rats | #2 |
| cia disease | #2 |
| b10qf1 | #2 |
| neutrophil functions modulation | #2 |
| tracheolaryngeal cartilage rp | #2 |
| agonist study | #2 |
| single nucleotide rats | #2 |
| fibα580 | #2 |
| autoimmune membrane proteins | #2 |
| kinloch | #2 |
| macrophagespecific nox2 development | #2 |
| bmd caia | #2 |
| terpenes animals | #2 |
| apc naïve cells | #2 |
| citrullinated peptides development | #2 |
| cia animals | #2 |
| rp animal ear | #2 |
| hydroxyethylene | #2 |
| oxidation c129s | #2 |
| disease humanized mice | #2 |
| rats disease onset | #2 |
| chronic relapsing disease | #2 |
| linomide homologous cia | #2 |
| arthritis antibody response | #2 |
| oestrogen ean | #2 |
| da1u | #2 |
| mbp peptide eae | #2 |
| igkeegfp lentivirus expression | #2 |
| cia mice mice | #2 |
| comp titers | #2 |
| eno5 | #2 |
| caia effector phase | #2 |
| binding cartilage | #2 |
| influence chromosome | #2 |
| ncf1 ean6 | #2 |
| arthritis female | #2 |
| caia eae | #2 |
| cia mechanisms | #2 |
| epitope glycosylation | #2 |
| osteoclastogenesis endogenous dna | #2 |
| igke promoter | #2 |
| glycopeptide complexes | #2 |
| mog rats | #2 |
| microscopic scoring arthritis | #2 |
| functional ncf1 variants | #2 |
| putative vulnerability locus | #2 |
| utility comp | #2 |
| ptpn22 ncf1 | #2 |
| immunological requirements | #2 |
| citcii | #2 |
| arthritis ethanol | #2 |
| c5ay35 | #2 |
| severity collagen | #2 |
| arthritis scoring | #2 |
| arthritis development rats | #2 |
| autoimmune congenic arthritis | #2 |
| 034positive | #2 |
| symptoms anti ccp2 | #2 |
| redox regulation ptpn22 | #2 |
| comp cartilage | #2 |
| anticcp2negative | #2 |
| integrin‐binding‐domain | #2 |
| maintenance induced resistance | #2 |
| lymphocytelike | #2 |
| b10qncf1 mice | #2 |
| antitoxin immunoglobulin | #2 |
| antibodies cartilage | #2 |
| adjuvant oils arthritis | #2 |
| design glycopeptides | #2 |
| mycobacteria granulomas | #2 |
| cartilage proteins sera | #2 |
| chain l10d9 antibody | #2 |
| dominant suppressive | #2 |
| arthritogenic mab cii | #2 |
| mbp peptides immunization | #2 |
| animal haplotypes | #2 |
| ptpn22 protein disulfide | #2 |
| incidence insulitis | #2 |
| mice susceptible | #2 |
| matrilin vivo | #2 |
| cd8 cells incidence | #2 |
| wildtype mice macrophages | #2 |
| conditions igke promoter | #2 |
| collagen citrullination adhesion | #2 |
| rats da1u | #2 |
| rats heterologous cii | #2 |
| tcells recognition | #2 |
| epitopes rat | #2 |
| igg glycosylation arthritis | #2 |
| mbp89 | #2 |
| rats utility | #2 |
| rats ifngamma | #2 |
| vaccination strategy c5a | #2 |
| sequence analysis indel | #2 |
| epitope‐specific recognition | #2 |
| injection w3 13 | #2 |
| beta 10b | #2 |
| h2q | #2 |
| ovx ncf1 mice | #2 |
| biologicals 24 months | #2 |
| ability arthritis | #2 |
| ere activation treatment | #2 |
| animal granulomatous disease | #2 |
| granulocytes alp | #2 |
| immunization sch | #2 |
| oestrogen pregnancy | #2 |
| multiple antibody reactivities | #2 |
| collagen antibody | #2 |
| 18ffluoromannan | #2 |
| cytosolic ros production | #2 |
| granulomas cgd mice | #2 |
| immunocap isac performance | #2 |
| sialadenitis animals | #2 |
| nox2 complex sle | #2 |
| acpa reactivities | #2 |
| cii ciic1 | #2 |
| prophylactic treatment linomide | #2 |
| snecs neutrophils | #2 |
| hiit skeletal | #2 |
| ros tregs | #2 |
| ean6 | #2 |
| psychosocial stress hpaaxis | #2 |
| nodq | #2 |
| rats arthritogenic challenge | #2 |
| ncf1gene | #2 |
| anticii antibody | #2 |
| cartilage respiratory | #2 |
| ncf1 oxidation | #2 |
| oestradiol induction phase | #2 |
| chitosanagarosegelatin | #2 |
| eae dxea strain | #2 |
| cell dependent | #2 |
| antibodies cep1 | #2 |
| chronic autoimmune polyarthritis | #2 |
| hiit skeletal muscle | #2 |
| celldependent phase | #2 |
| elastaseinduced emphysema nox2 | #2 |
| smash recommendations | #2 |
| sequences mbp89 | #2 |
| disease promoting | #2 |
| oestrogen myelin | #2 |
| transgenic protein processing | #2 |
| ciif4 | #2 |
| α3xi | #2 |
| intrinsic tolerance | #2 |
| neutrophil fpr2 | #2 |
| autoimmunity autoantibodies | #2 |
| p47phoxmutated | #2 |
| arthritis fb | #2 |
| disease genotype hybridization | #2 |
| cms eae | #2 |
| endoglycosidase treatment | #2 |
| nox2 macrophages | #2 |
| ifngamma spinal cord | #2 |
| congenic polychondritis | #2 |
| mhc congenic | #2 |
| das28 values p001 | #2 |
| osteoclasts flow cytometry | #2 |
| b10qncf1 mice cia | #2 |
| fpr1 neutrophils | #2 |
| pristane rats | #2 |
| mice collagen | #2 |
| collagen ii‐induced arthritis | #2 |
| psoriatic disease models | #2 |
| nadph oxidase 2 | #2 |
| arthritis raloxifene | #2 |
| genetic regions psoriasis | #2 |
| development combination | #2 |
| mhc iii | #2 |
| cells arthritis | #2 |
| pristane injection | #2 |
| homologous cia | #2 |
| chromosome rats | #2 |
| eosinophilia arthritis | #2 |
| anticcp2negative presence | #2 |
| l10d9 | #2 |
| induction cia | #2 |
| cii depletion | #2 |
| cd19 cells egfp | #2 |
| mog79 | #2 |
| lack ifngamma | #2 |
| heterologous collagens arthritis | #2 |
| paws mice | #2 |
| neuroendocrine profile | #2 |
| egfp cd19 cells | #2 |
| iaexpressing cells | #2 |
| caia oestradiol | #2 |
| oxidation increased severity | #2 |
| collageninduced arthritis mice | #2 |
| fibß62 | #2 |
| granulomas macrophages | #2 |
| peptides chronic eae | #2 |
| wtc5a | #2 |
| genetic encephalomyelitis | #2 |
| pia rats | #2 |
| ptpn22 c129s | #2 |
| raloxifene oestradiol | #2 |
| galactosyl moiety | #2 |
| models autoimmune | #2 |
| h2q response | #2 |
| 111 vivo treatment | #2 |
| immunization mbp89 | #2 |
| aetiology2–4 | #2 |
| salt intake vivo | #2 |
| m2139 ciif4 | #2 |
| analyses comp | #2 |
| ala261 | #2 |
| experimental cloning | #2 |
| titres ccp2 | #2 |
| knockout illness | #2 |
| cia day | #2 |
| arthritis g6pi | #2 |
| lymphoproliferative gene | #2 |
| ros granulomas | #2 |
| adjuvant rats | #2 |
| mph induction | #2 |
| type collagen cii | #2 |
| glut4dependent | #2 |
| alp monoclonal arthritis | #2 |
| eae protein rna | #2 |
| sle cgd | #2 |
| cia monkeys | #2 |
| suppressive oestrogen | #2 |
| dxeb strain immunization | #2 |
| implanted melanoma | #2 |
| mitochondria polymorphism | #2 |
| raloxifene estradiol treatment | #2 |
| alterations neuroendocrine profile | #2 |
| cgd mice kynurenine | #2 |
| mrl mice stages | #2 |
| ides treatment | #2 |
| igke | #2 |
| lack functional nox2 | #2 |
| anticd4 treatment | #2 |
| rheumatoid binding | #2 |
| allelic variant type | #2 |
| antibody‐mediated arthritis | #2 |
| severity collagen arthritis | #2 |
| autoimmune recognition | #2 |
| ptpn22 disulfide | #2 |
| increased severity development | #2 |
| micro dams transgenic | #2 |
| control subjects samples | #2 |
| cia arthritis | #2 |
| antipan | #2 |
| flow cytometry ovx | #2 |
| granulomas ros | #2 |
| ciic1 | #2 |
| antibody fine | #2 |
| cxi l10d9 antibody | #2 |
| antileukoproteinase alp | #2 |
| c1epitope | #2 |
| antileukoproteinase modulation | #2 |
| cia anti | #2 |
| macrophages enhances | #2 |
| eae caia | #2 |
| l10d9 antibody | #2 |
| antibody response development | #2 |
| g6pi arthritis | #2 |
| enhanced arthritis | #2 |
| dxea strain | #2 |
| tolerance cii | #2 |
| matrilin 1 | #2 |
| nadph oxidase elevations | #2 |
| cii311 | #2 |
| cep1 fibß62 | #2 |
| skg model | #2 |
| l10d9 antibody cartilage | #2 |
| collagen arthritis immunization | #2 |
| murine locus eae2 | #2 |
| b10g | #2 |
| exclusive reactivity | #2 |
| mannan induced | #2 |
| w3 13 | #2 |
| arthritogenic capacity | #2 |
| derived ros | #2 |
| dxea strain tgfbeta | #2 |
| ros peroxide | #2 |
| mrl joints stages | #2 |
| fpr1 signaling | #2 |
| rats polymorphism | #2 |
| early onset severity | #2 |
| toe stiffness | #2 |
| igkeegfp lentivirus | #2 |
| mice bacterial infections | #2 |
| chronic arthritis treatment | #2 |
| synovial immune reactions | #2 |
| disease cyclosporin treatment | #2 |
| antibodies development | #2 |
| agonist fpr2 | #2 |
| animal model arthritis | #2 |
| c2ta genetic | #2 |
| positive anticcp2 test | #2 |
| rats da1u rats | #2 |
| arthritis treatment | #2 |
| liver histone | #2 |
| i‐a molecule | #2 |
| arthritis heterologous cia | #2 |
| arthritis progression | #2 |
| anti cii | #2 |
| mhciii | #2 |
| dancf1da | #2 |
| mabs collagen | #2 |
| cartilage‐specific autoimmunity | #2 |
| incidence nephritis | #2 |
| cpg2088 | #2 |
| binding sites autoimmune | #2 |
| congenic mice autoimmune | #2 |
| arthritis gender | #2 |
| myelin ppd | #2 |
| ncf1 mutants | #2 |
| m2139 | #2 |
| shared epitope cxi | #2 |
| arthritogenic challenge | #2 |
| 18fbicyclo610nonyne | #2 |
| ß62 | #2 |
| c57bl 10 background | #2 |
| gender rats | #2 |
| rt1bb | #2 |
| citc1359 | #2 |
| disease 111 | #2 |
| caia | #2 |
| class immunoenzyme | #2 |
| etoposide serum concentrations | #2 |
| ccp2 diagnostic accuracy | #2 |
| h12919 | #2 |
| collagen arthritis cii | #2 |
| 12 590 | #2 |
| monodeoxygenation | #2 |
| sera rheumatoid arthritis | #2 |
| diseases collagen | #2 |
| clever1 tumor | #2 |
| hkatpasecontaining vesicles | #2 |
| mph ros | #2 |
| rats lymphocytes | #2 |
| tlymphocyte arthritis arthritis | #2 |
| higher levels anas | #2 |
| circulating medium | #2 |
| igsecretors | #2 |
| arthritogenic | #2 |
| re04 | #2 |
| matrilin cartilage proteins | #2 |
| staphylococcal infections mice | #2 |
| igke promoter expression | #2 |
| nadph oxidase deficiency | #2 |
| fibβ36 | #2 |
| mab cii | #2 |
| transgenic oxidases zymosan | #2 |
| cii elisa | #3 |
| genetic influence susceptibility | #3 |
| sialadenitis | #3 |
| crossreactive idiotope | #3 |
| acpas twins | #3 |
| citcii355 | #3 |
| anticollagen antibody | #3 |
| binding aq | #3 |
| development acpas | #3 |
| treatment arthritis | #3 |
| anti‐type | #3 |
| fibα591 | #3 |
| patients monoclonal chimeric | #3 |
| citrullinated peptides time | #3 |
| genotype knowledge | #3 |
| ifngammali | #3 |
| arthritis animal model | #3 |
| arthritis levels | #3 |
| transgenic osteoporosis | #3 |
| oxidase 2 | #3 |
| allogeneic pregnancy | #3 |
| disease height | #3 |
| mhc class betachain | #3 |
| citc1iii fibα573 | #3 |
| glycosylated type | #3 |
| pia6 | #3 |
| citrullinated cyclic | #3 |
| twins acpapositive | #3 |
| twins acpas | #3 |
| cd8 cells ean | #3 |
| rodents6 | #3 |
| cells naïve mice | #3 |
| cii reactive | #3 |
| antigens collagen | #3 |
| swedish patients antibodies | #3 |
| cia strains | #3 |
| ctla4 deletion | #3 |
| development collagen arthritis | #3 |
| type collagen vivo | #3 |
| loci antibodies | #3 |
| aureus arthritis mice | #3 |
| eae5 ncf1 | #3 |
| ros deficiency | #3 |
| differences citrullinated peptides | #3 |
| mice environments | #3 |
| disease development contribution | #3 |
| ean mca | #3 |
| disease genotype immunity | #3 |
| arthritis resistance | #3 |
| chromosome eae17 | #3 |
| restricted role | #3 |
| mice development | #3 |
| cvrelated death adjustment | #3 |
| acpa multiplex | #3 |
| allopregnancy | #3 |
| arthritis autoimmunity | #3 |
| rt11 rats | #3 |
| mice rheumatoid | #3 |
| carriers hladrb104 | #3 |
| complex autoimmune diseases | #3 |
| rtlu | #3 |
| vim60 | #3 |
| acpas genetic factors | #3 |
| levels fibα591 | #3 |
| eae16 | #3 |
| development arthritis | #3 |
| pfp mice | #3 |
| db1 treatment | #3 |
| cyp7a1 abca1 | #3 |
| cryogel bioreactor | #3 |
| nox2 cgd | #3 |
| wildtype mice granulomas | #3 |
| bcg ros | #3 |
| igl genes | #3 |
| ncf4 rs729749 | #3 |
| antibodies specific sets | #3 |
| apc cia | #3 |
| eae5r1 | #3 |
| citrulline inflammation | #3 |
| cii species | #3 |
| neutrophil cytosolic factor | #3 |
| disease risk subsets | #3 |
| citrullinated peptides multiplex | #3 |
| autoimmunity cartilage | #3 |
| disease anti lymphocyte | #3 |
| cd4∶cd8 lineage commitment | #3 |
| acpas fine specificities | #3 |
| animal glycosylation humans | #3 |
| stroke cvrelated death | #3 |
| antibodies induce | #3 |
| eae17 chromosome | #3 |
| antibodies citc1iii | #3 |
| hdac1 pathogenesis | #3 |
| lew ztm | #3 |
| arthritis review | #3 |
| arthritis susceptibility | #3 |
| response immune response | #3 |
| mmc mice | #3 |
| pnippam | #3 |
| eae5 pia4 | #3 |
| combination acpa | #3 |
| hfdmets rats | #3 |
| cytotoxic t‐lymphocyte | #3 |
| cd4∶cd8 lineage | #3 |
| antibodies vim60 | #3 |
| hladrb104 mann whitney | #3 |
| immunization addition | #3 |
| eae17 | #3 |
| reactive idiotope | #3 |
| experimental arthritis | #3 |
| incidence antinuclear antibodies | #3 |
| species lymphocytes | #3 |
| day disease duration | #3 |
| onset combination | #3 |
| h2qbearing | #3 |
| dancf1e3 | #3 |
| c2ta | #3 |
| hydrocarbon oils | #3 |
| minimal adjuvant requirement | #3 |
| processing cii | #3 |
| ncf1 cldn4 | #3 |
| common mouse model | #3 |
| pristane‐induced arthritis | #3 |
| inflamed synovial tissues | #3 |
| cia hdac1 | #3 |
| rheumatoid cloning | #3 |
| ifnbetadeficient mice | #3 |
| human cii | #3 |
| fibα573 | #3 |
| low production | #3 |
| eae1 | #3 |
| keratinocytes langerhans cells | #3 |
| disease disease development | #3 |
| nadph oxidase complex | #3 |
| dthreaction | #3 |
| mnc salivary glands | #3 |
| cep1 filaggrin | #3 |
| role ros | #3 |
| autoimmunity pia | #3 |
| h2p mice | #3 |
| arthritis effects | #3 |
| female immunoenzyme | #3 |
| model arthritis | #3 |
| autoimmune models | #3 |
| pia | #3 |
| 95 cvrelated death | #3 |
| major cell epitope | #3 |
| models arthritis | #3 |
| acpa titers | #3 |
| ifngammali neurons | #3 |
| class antigens keratinocytes | #3 |
| induced immunospecific tolerance | #3 |
| advanced intercross eae5 | #3 |
| cvrelated death association | #3 |
| neutrophils eae | #3 |
| anticollagen antibodies | #3 |
| rheumatoid arthritis complement | #3 |
| recombination rt1a | #3 |
| immuniozation | #3 |
| macrophages involvement | #3 |
| vivo control mice | #3 |
| citc1iii | #3 |
| citc1iii filaggrin | #3 |
| lew1f | #3 |
| hdac1 rheumatoid arthritis | #3 |
| mice copolymers | #3 |
| macroporous gel particles | #3 |
| h2aalpha | #3 |
| oxidases reactive | #3 |
| natural alleles genes | #3 |
| targeting toll | #3 |
| experimental cell | #3 |
| presence drb104 | #3 |
| dxea | #3 |
| total abrogation | #3 |
| eae17 genetic heterogeneity | #3 |
| occurrence subspecificities | #3 |
| arthritogenic mab | #3 |
| cdk6 padi4 | #3 |
| fibβ62 81b | #3 |
| disease immunization | #3 |
| genes disease development | #3 |
| acpa specificities presence | #3 |
| subspecificities occurrence | #3 |
| mca ean | #3 |
| antigen monoclonal arthritis | #3 |
| cia animals arthritis | #3 |
| fibα573 fibα591 | #3 |
| nox2 pathogenesis | #3 |
| rs729749 ncf4 | #3 |
| multiple sclerosis hladr2 | #3 |
| height disease | #3 |
| cystatin cdeficient mice | #3 |
| origin suggestive linkage | #3 |
| arthritis susceptible | #3 |
| disease w3 13 | #3 |
| complex genetic control | #3 |
| dnfb ears | #3 |
| spe dce | #3 |
| endogenous ifnbeta | #3 |
| lupus nets | #3 |
| points acs | #3 |
| dce spe | #3 |
| fibα573 fibβ74 | #3 |
| fibα591 vim60 | #3 |
| female preponderance | #3 |
| fibβ74 onset | #3 |
| acpa combination | #3 |
| antigens keratinocytes | #3 |
| acpas plasma | #3 |
| antibodies citrullinated | #3 |
| rheumatoid crosses | #3 |
| cbrh7919 cells | #3 |
| rats rheumatoid arthritis | #3 |
| arthritis model | #3 |
| antigen presentation mhcii | #3 |
| acpa subspecificities | #3 |
| nerve terminallike profiles | #3 |
| chronic collagen | #3 |
| dual manner | #3 |
| monoclonal cartilage sections | #3 |
| cvrelated death | #3 |
| activated cells mice | #3 |
| arthritogenicity | #3 |
| ifngamma neurons | #3 |
| ciic1 cii | #3 |
| 81b | #3 |
| c57bl mice illness | #3 |
| hladrb104 cochranmantelhaenszel test | #3 |
| rt1a tap2 | #3 |
| osteoclasts release | #3 |
| type c2ta | #3 |
| cartilage proteins | #3 |
| ctla4 adult mice | #3 |
| mice constant light | #3 |
| fibβ74 | #3 |
| rats mog | #3 |
| clever1 macrophages | #3 |
| pathogenesis pia | #3 |
| acpapositive twins | #3 |
| rheumatoid autoimmune | #3 |
| early phase disease | #3 |
| eae31 | #3 |
| acpas human serum | #3 |
| rats disease | #3 |
| rs729749 | #3 |
| isotypes acpas | #3 |
| db1 treatment day | #3 |
| subspecificities associations | #3 |
| il‐4‐deficient mice | #4 |
| elevated th1 | #4 |
| inbred dba peptides | #4 |
| diseases rheumatoid | #4 |
| type‐ii collagen | #4 |
| arthritis collageninduced arthritis | #4 |
| arthritis severity | #4 |
| multispecific antibodies | #4 |
| cell response immunization | #4 |
| treg cells ctla4 | #4 |
| fpr2 recognition | #4 |
| tsc mice | #4 |
| stages disease development | #4 |
| collagen immune | #4 |
| cellular transfer | #4 |
| collagen rheumatoid | #4 |
| cii ifa | #4 |
| adjuvant oil | #4 |
| cyclic software | #4 |
| cia6 | #4 |
| shared autoimmunity | #4 |
| type collagen arthritis | #4 |
| synovial endothelium | #4 |
| arthritis comp | #4 |
| bxsb chromosome | #4 |
| knowledge genetic association | #4 |
| anti‐t‐cell | #4 |
| onset clinical arthritis | #4 |
| c129s | #4 |
| dae3 | #4 |
| cii animal epitopes | #4 |
| experimental arthritis humans | #4 |
| cia b10q mice | #4 |
| locus mouse chromosome | #4 |
| dead cell remnants | #4 |
| type collagen rat | #4 |
| arthritis mouse | #4 |
| experimental cattle cells | #4 |
| cells cryogel column | #4 |
| mip mice | #4 |
| positional cloning genes | #4 |
| estrus cycling | #4 |
| normal mouse igg | #4 |
| interaction monoclonal antibody | #4 |
| antigen sequence deletion | #4 |
| potent immunomodulator | #4 |
| cathelicidins ll37 | #4 |
| parathyroid antibodies | #4 |
| mutation ncf1 | #4 |
| citrullinated peptides autoantibodies | #4 |
| catabolism kynurenine | #4 |
| acpas serum | #4 |
| vav1 rheumatoid arthritis | #4 |
| mp‐lpr | #4 |
| autoimmune mrl | #4 |
| ethylene isosteres | #4 |
| strain eae | #4 |
| cells maternal origin | #4 |
| cia suppression | #4 |
| mice etoposide | #4 |
| rs12979659 | #4 |
| congenic rats rats | #4 |
| rheumatoid arthritis rats | #4 |
| macrophages mycobacteria | #4 |
| rp sle | #4 |
| collagen type | #4 |
| cia lia | #4 |
| rs682626 | #4 |
| antibody response mog | #4 |
| fcγr regulation | #4 |
| dth mrl | #4 |
| placental mhc | #4 |
| type collagen autoimmunity | #4 |
| ox8 | #4 |
| cia mouse | #4 |
| autoimmune experimental phenotype | #4 |
| immune response cii | #4 |
| tcell activation development | #4 |
| response arthritis | #4 |
| genetic association vav1 | #4 |
| species regulate | #4 |
| autoimmunity rats | #4 |
| subsets presence | #4 |
| lxrα pparγ | #4 |
| immunoglobulin deficient | #4 |
| genistein addition | #4 |
| sh3gl1 | #4 |
| lnchc | #4 |
| pathogenic antibody | #4 |
| k8 k8 mice | #4 |
| arthritis defined | #4 |
| glands sialadenitis | #4 |
| variance animals arthritis | #4 |
| smoking antibodies | #4 |
| epitope collagen | #4 |
| peptide mbp | #4 |
| mhc eae | #4 |
| antitype collagen antibodies | #4 |
| α1ii chain | #4 |
| endos igg | #4 |
| fibβ62 | #4 |
| cytosolic ros | #4 |
| affinity case | #4 |
| experimental genetic | #4 |
| glend2 | #4 |
| pathogenesis histone | #4 |
| strains arthritis | #4 |
| inpp4b474r 548p | #4 |
| immunodominant cell | #4 |
| elimination cd8 cells | #4 |
| cii peptide | #4 |
| pristane‐induced | #4 |
| antibodies citrullinated peptides | #4 |
| candidate genes rats | #4 |
| estrogen levels levels | #4 |
| experimental arthritis cii | #4 |
| congenic c57bl | #4 |
| cb10 fragment | #4 |
| krönke | #4 |
| cells cryogel | #4 |
| mrl b6 | #4 |
| development sialadenitis | #4 |
| dth reaction | #4 |
| autoantibodies type collagen | #4 |
| tnfα p38 mapk | #4 |
| collagen glycopeptides | #4 |
| citrullinated protein antibodies | #4 |
| estrogen cia | #4 |
| cryogel matrix | #4 |
| mrl dth | #4 |
| cd4 cells stage | #4 |
| higher levels melatonin | #5 |
| field nox | #5 |
| commonly model | #5 |
| oestradiol vehicle | #5 |
| avridineinduced arthritis | #5 |
| delayed immunization rats | #5 |
| tlr3 expression | #5 |
| type collagen cix | #5 |
| immunization male | #5 |
| monoclonal antibody alpha | #5 |
| lew1n | #5 |
| multiplex array | #5 |
| exercise hiit | #5 |
| glycopeptide fragment | #5 |
| backcrossed | #5 |
| dba 1 mice | #5 |
| beta 11 cells | #5 |
| raloxifene disease activity | #5 |
| citrullinated peptides ccp | #5 |
| painlike behavior | #5 |
| uterus cells | #5 |
| aureus arthritis | #5 |
| wellknown role | #5 |
| pathogenesis autoimmune arthritis | #5 |
| dba mouse | #5 |
| immunological involvement | #5 |
| resistance cia | #5 |
| cgd mice | #5 |
| symptoms rheumatoid arthritis | #5 |
| development acpa | #5 |
| cd8 deficiency | #5 |
| epitope cii | #5 |
| arthritis rats | #5 |
| patients acpa levels | #5 |
| immunization type collagen | #5 |
| biomarkers 2 polyradiculoneuropathy | #5 |
| nox animal models | #5 |
| b‐cell epitope | #5 |
| regulating rat | #5 |
| symptom onset frequency | #5 |
| overexpression hdac3 | #5 |
| o2• h2o2 nox | #5 |
| cbrh7919 | #5 |
| cartilage type | #5 |
| smoking prior | #5 |
| rt1eu | #5 |
| oia | #5 |
| mrvalues | #5 |
| swr mouse | #5 |
| cia type collagen | #5 |
| lethal inflammatory disorder | #5 |
| chick cii | #5 |
| ros macrophages | #5 |
| antileukoproteinase | #5 |
| severe sialadenitis | #5 |
| autoimmune disease models | #5 |
| tcell mrl | #5 |
| mice acpa | #5 |
| ii‐induced | #5 |
| ros mca | #5 |
| tcell hybridomas | #5 |
| citrullinated peptides | #5 |
| congenic nod | #5 |
| interaction cartilage | #5 |
| ovalbumin pepsin | #5 |
| cgd hyperinflammation | #5 |
| recovery ean | #5 |
| nox complex | #5 |
| autologous type | #5 |
| antibodies filaggrin | #5 |
| apc cii | #5 |
| c‐glycoside analogue | #5 |
| igg endos | #5 |
| position type collagen | #5 |
| tlr3 macrophages | #5 |
| hydroxynorvaline | #5 |
| arthritis onset | #5 |
| collageninduced arthritis cia | #5 |
| puccetti | #5 |
| subsets rheumatoid arthritis | #5 |
| oxidative radicals | #5 |
| multiparous mice | #5 |
| osteoclasts stromal cells | #5 |
| immunized animals controls | #5 |
| low dose tolerance | #5 |
| collagen anti | #5 |
| absence c5 | #5 |
| glycopeptidomimetics | #5 |
| classical adjuvant | #5 |
| eae5 | #5 |
| arthritogenic cells | #5 |
| experimental breeding | #5 |
| pineal gland development | #5 |
| multiplex analyses | #5 |
| rats developed | #5 |
| cia model | #5 |
| α10i | #5 |
| asparaginelinked glycan | #5 |
| chromosome cia7 | #5 |
| ly female | #5 |
| symptoms development | #5 |
| tbb infection | #5 |
| nox o2• h2o2 | #5 |
| tubule cells kidney | #5 |
| glycopeptide | #5 |
| streptococcus pyogenes ides | #5 |
| egfp flow cytometry | #5 |
| lipidomic remodeling | #5 |
| severe arthritis mice | #5 |
| measurement nox activity | #5 |
| il4deficient mice | #5 |
| tsst1producing | #5 |
| cia cd4 cells | #6 |
| mrna tgfbeta | #6 |
| loci controlling | #6 |
| treatment oestradiol | #6 |
| arthritis autoantibodies | #6 |
| betaoestradiol | #6 |
| induced psoriasis | #6 |
| pathogenic events | #6 |
| dominant suppression | #6 |
| female lymphocyte | #6 |
| affinity ligand protein | #6 |
| rheumatoid arthritis collagen | #6 |
| knockout receptors igg | #6 |
| c57bl 6 background | #6 |
| rcramp | #6 |
| anti ccp2 | #6 |
| ltab | #6 |
| transgenic mice arthritis | #6 |
| rheumatoid arthritis comp | #6 |
| l3t4positive cells | #6 |
| autoimmune experimental genes | #6 |
| igg autoantibodies sera | #6 |
| mice sialadenitis | #6 |
| arthritis antibodies | #6 |
| relapsing polychondritis rp | #6 |
| cartilage collagens | #6 |
| data ros | #6 |
| mice investigated | #6 |
| b10 mouse | #6 |
| monoclonal encephalomyelitis autoimmune | #6 |
| metabolic nuclear receptors | #6 |
| experimental postmenopausal | #6 |
| tsst1 mice | #6 |
| joints rats | #6 |
| erosive polyarthritis | #6 |
| cell recognition | #6 |
| mice congenic | #6 |
| nox2 mediates | #6 |
| collagen cells | #6 |
| animal genetic | #6 |
| k8 mice | #6 |
| hdac1 class | #6 |
| pristane squalene | #6 |
| cd4∶cd8 | #6 |
| rheumatoid arthritis model | #6 |
| recombinant rat interferongamma | #6 |
| eae mhc | #6 |
| glycopeptide specificity | #6 |
| immunization peptides | #6 |
| murine loci | #6 |
| cells affinity surface | #6 |
| macrophages mph | #6 |
| functional selective | #6 |
| glycoproteins nadph | #6 |
| staphylococcus aureus arthritis | #6 |
| acpa anti | #6 |
| arthritis models | #6 |
| autoimmunity arthritis | #6 |
| pv loss | #6 |
| activity neuroinflammation | #6 |
| controls arthritis | #6 |
| complex mhc | #6 |
| peptides arthritis | #6 |
| lys270 | #6 |
| active arthritis | #6 |
| cia26 | #6 |
| heterogeneous stock mice | #6 |
| contrasting roles | #6 |
| isotypes patients | #6 |
| disease protective | #6 |
| develop arthritis | #6 |
| mhcii alleles | #6 |
| collagen cia | #6 |
| pyramidal neurons loss | #6 |
| collagen arthritis | #6 |
| ccp2 positive | #6 |
| acpa specificities | #6 |
| chronic experimental | #7 |
| cryogel column | #7 |
| murine psoriasis | #7 |
| response immunization | #7 |
| acpa titres | #7 |
| collagen arthritis cia | #7 |
| mediated vasculitis | #7 |
| ciireactive cells | #7 |
| macrophages alternative activation | #7 |
| glycosylated collagen | #7 |
| regulatory cells macrophages | #7 |
| role raloxifene | #7 |
| region syntenic | #7 |
| cia mice | #7 |
| induction arthritis | #7 |
| collagen arthritis rats | #7 |
| mice constant darkness | #7 |
| oestrogen rats | #7 |
| animal immunization injections | #7 |
| isomerase peptide | #7 |
| rats phases | #7 |
| hydrolases polymorphism | #7 |
| conventional environment | #7 |
| periodontitis arthritis | #7 |
| 3xi | #7 |
| arthritis strains | #7 |
| cognate activation | #7 |
| congenic mouse | #7 |
| antigens differentiation arthritis | #7 |
| analysis crosses | #7 |
| yaa gene | #7 |
| antibodyinduced arthritis | #7 |
| nonarthritogenic | #7 |
| antibodies citrullinated antigens | #7 |
| psoriasiform skin disease | #7 |
| ean animals | #7 |
| arthritis type collagen | #7 |
| cii apc | #7 |
| cii anti | #7 |
| mouse collagen | #7 |
| autoantibodies citrullinated peptides | #7 |
| symptoms disease onset | #7 |
| impaired induction | #7 |
| citrullinated peptide antigens | #7 |
| autoantibodies lymphocytes | #7 |
| chronic phase arthritis | #7 |
| collagen epitope | #7 |
| effector phase | #7 |
| arthritis genes | #7 |
| castrated females | #7 |
| protective influences | #7 |
| strains disease | #7 |
| cab3 | #7 |
| g6pi | #7 |
| mbp peptide | #7 |
| impact cia | #7 |
| transgenic class | #7 |
| snecs | #7 |
| rheumatoid arthritis role | #7 |
| polychondritis relapsing | #7 |
| congenic strains | #7 |
| autoimmune human | #7 |
| type collagen | #7 |
| locus chromosome | #7 |
| raassociated molecules | #7 |
| responses cii | #7 |
| cia5 | #7 |
| autoimmunity collagen | #7 |
| aplec | #7 |
| illness igg | #8 |
| non‐mhc | #8 |
| murine locus | #8 |
| heterologous peptide | #8 |
| t‐cell priming | #8 |
| experimental binding | #8 |
| persistent joint pain | #8 |
| rt1f | #8 |
| hybridomas antibodies | #8 |
| typeii collagen | #8 |
| autoantibodies subset | #8 |
| α1‐microglobulin | #8 |
| mumt mice | #8 |
| hladrb11001 | #8 |
| mice techniques | #8 |
| antibody vivo | #8 |
| cia animal model | #8 |
| destructive effects | #8 |
| rats mhc | #8 |
| medium mem | #8 |
| 42 rats | #8 |
| diseases loci | #8 |
| eae genetic encephalomyelitis | #8 |
| onset day day | #8 |
| incidence cia | #8 |
| ptpn22620w | #8 |
| neutrophil cytosolic | #8 |
| oxidized peptides | #8 |
| murinised | #8 |
| haematogenously | #8 |
| cia2 | #8 |
| hdac3 expression | #8 |
| induced neuropathology | #8 |
| ros interplay | #8 |
| autoimmune congenic mice | #8 |
| experimental autoimmune disease | #8 |
| 297 cases | #8 |
| autoantibodies collagen type | #8 |
| antibodies acpas | #8 |
| lyme arthritis severity | #8 |
| rheumatoid autoimmunity | #8 |
| chronic autoimmune arthritis | #8 |
| onset incidence | #8 |
| fcγr2b | #8 |
| expression hdac3 | #8 |
| arthritis lymphocytes | #8 |
| underlying genes | #8 |
| rheumatoid chromosome | #8 |
| autologous peptide | #8 |
| supermacroporous cryogel | #8 |
| treatment monoclonal | #8 |
| parathyroid glands receptors | #8 |
| cosphox | #8 |
| hlase alleles | #8 |
| antigenspecific priming | #8 |
| patients type collagen | #8 |
| eae3 | #8 |
| clinical signs ean | #8 |
| b10 background | #8 |
| ifa cii | #8 |
| sialadenitis mrl | #8 |
| inflamed synovia | #8 |
| dominant cell epitope | #8 |
| humans experimental arthritis | #8 |
| oia2 | #8 |
| chromosomes loci | #8 |
| mice ifnbeta | #8 |
| polymeric cryogels | #8 |
| mbp mog | #8 |
| response mouse | #9 |
| antibody alpha | #9 |
| bovine cii | #9 |
| rheumatoid autoantibodies | #9 |
| hgpi325 | #9 |
| 2 nadph | #9 |
| pristane | #9 |
| b10riii mice | #9 |
| serum interferon | #9 |
| experimental genes | #9 |
| experimental arthritis rats | #9 |
| ox19 | #9 |
| acpas | #9 |
| rheumatoid joints | #9 |
| postmenopausal arthritis | #9 |
| specific nox2 | #9 |
| hitr | #9 |
| early joint erosions | #9 |
| idiotype‐specific | #9 |
| specific sets | #9 |
| psychological tyrosine | #9 |
| rt1u | #9 |
| inbred lew tlymphocytes | #9 |
| bound carbohydrates | #9 |
| alpha1inhibitor3 | #9 |
| mouse peptide | #9 |
| avridine | #9 |
| class allele | #9 |
| inbred dba mice | #9 |
| acpas patients | #9 |
| patients acpas | #9 |
| rats rat | #9 |
| animal models urgent | #9 |
| effects mabs | #9 |
| arthritis skg mice | #9 |
| murine collagen | #9 |
| collagen female | #9 |
| illness receptor | #9 |
| collagen complement | #9 |
| posttranslational glycosylation | #9 |
| cia transgenic mice | #9 |
| variants acpa | #9 |
| nodp | #9 |
| ean myelin | #9 |
| reduced arthritis | #9 |
| mammalian disease models | #9 |
| adaptive inflammation | #9 |
| eae immunization | #9 |
| induced metabolic syndrome | #9 |
| differentiation autoimmune | #9 |
| disease strains | #9 |
| loci rats | #9 |
| development autoimmune arthritis | #9 |
| autoimmunogenic | #9 |
| histone 1 hdac1 | #9 |
| il10 role | #9 |
| oligomeric matrix | #9 |
| human immunopeptidome | #9 |
| oil adjuvants | #9 |
| antibodies vivo | #9 |
| intranasal animals arthritis | #9 |
| arthritis cross | #9 |
| endogenous collagen | #10 |
| citrullinated antigen | #10 |
| ifnbeta mice | #10 |
| activation male | #10 |
| mbp peptides | #10 |
| passive transfer experiments | #10 |
| antibody collagen | #10 |
| axotomized motor neurons | #10 |
| native collagen type | #10 |
| acpa diagnosis | #10 |
| cells increased production | #10 |
| monoclonal arthritis | #10 |
| onset chromosome | #10 |
| autoimmune disease humans | #10 |
| tertbutylacrylamide | #10 |
| acutephase response rats | #10 |
| oestrogen | #10 |
| cii mice | #10 |
| knockout nadph | #10 |
| inbred dba | #10 |
| mice cii | #10 |
| development severity | #10 |
| abp gene | #10 |
| presence acpa | #10 |
| cell‐deficient | #10 |
| nih heterogeneous stock | #10 |
| cartilage oligomeric | #10 |
| hlase smoking | #10 |
| rheumatoid arthritis dr4 | #10 |
| cartilage collagen fibrils | #10 |
| genetic experiments | #10 |
| stock mice | #10 |
| pain animal models | #10 |
| o2• h2o2 | #10 |
| dense fractions | #10 |
| experimental cartilage | #10 |
| animal models | #10 |
| monoclonal antigens rats | #10 |
| h2ap | #10 |
| collagen autoimmunity | #10 |
| mice nadph | #10 |
| alpha collagen chains | #10 |
| prl effects | #10 |
| mutated mice | #10 |
| rats lewis rats | #10 |
| severe erosive | #10 |
| cells development | #10 |
| mice genistein | #10 |
| extracellular cartilage | #10 |
| cd4 cells spleen | #10 |
| cartilage arthritis | #10 |
| reactivity acpas | #10 |
| immunization rats | #10 |
| beta 11 | #10 |
| antibodies specific | #10 |
| isotypes | #11 |
| cia7 | #11 |
| chronic arthritis | #11 |
| gad6 | #11 |
| cia30 | #11 |
| antigen variability | #11 |
| chondrocytes ecm | #11 |
| cells pia | #11 |
| mice cd1 | #11 |
| potential autoantigens | #11 |
| individuals onset | #11 |
| stromal cells macrophages | #11 |
| mice mhc | #11 |
| nodb10h2b mice | #11 |
| fragments anti | #11 |
| 2xi | #11 |
| arthritis absence | #11 |
| antibodies association | #11 |
| rat arthritis | #11 |
| mhc control | #11 |
| 84–102 | #11 |
| tailbase | #11 |
| dss wt | #11 |
| naïve cells cells | #11 |
| ptpn22 smoking | #11 |
| antibody type collagen | #11 |
| inflammatory arthritis role | #11 |
| rat collagen | #11 |
| lentiviral vector expression | #11 |
| loci regulating | #11 |
| species respiratory | #11 |
| monoclonal rheumatoid factors | #11 |
| rat liver rats | #11 |
| liver receptor lxrα | #11 |
| development rheumatoid | #11 |
| α1ii | #12 |
| stages pathogenesis | #12 |
| fpr2 agonists | #12 |
| mice comp | #12 |
| antibodies structures | #12 |
| onset symptoms | #12 |
| psoriasis mouse model | #12 |
| encephalomyelitis induced | #12 |
| reduces severity | #12 |
| role arthritis | #12 |
| loci disease | #12 |
| study arthritis | #12 |
| immunodominant | #12 |
| animal immunohistochemistry | #12 |
| stage cia | #12 |
| mbp response | #12 |
| qa2 | #12 |
| lung macrophages mice | #12 |
| associations antibodies | #12 |
| genetic contamination | #12 |
| cii patients | #12 |
| icmediated | #12 |
| structure antibodies | #12 |
| pia1 | #12 |
| nonselfdiscrimination | #12 |
| major haplotype | #12 |
| lymphoid cells development | #12 |
| cell responses cii | #12 |
| bovine type collagen | #12 |
| backgroundantibodies | #12 |
| matrilin | #12 |
| type collagen immunization | #12 |
| natural polymorphism | #12 |
| serum concentrations comp | #12 |
| cross rats | #12 |
| treatment experimental arthritis | #12 |
| peptide study | #12 |
| chronic erosive arthritis | #12 |
| myelin ean | #12 |
| hydroxylysines | #12 |
| increased litter size | #12 |
| natural loss | #12 |
| rats expression | #12 |
| riiis | #12 |
| illness sex characteristics | #12 |
| autoimmune monoclonal antigens | #12 |
| mutation nadph | #12 |
| mutated mouse | #12 |
| psoriasis arthritis | #12 |
| frequencies antibodies | #12 |
| rats cia | #12 |
| antibodies citrullinated proteins | #13 |
| cell epitope | #13 |
| oxidative regulation | #13 |
| strains incidence | #13 |
| multispecific | #13 |
| cyclic citrullinated | #13 |
| cells salivary glands | #13 |
| dba molecular | #13 |
| species deficiency | #13 |
| levels nabs | #13 |
| 24dinitro1fluorobenzene | #13 |
| complement complement activation | #13 |
| nonobese diabetic mouse | #13 |
| expression egfp | #13 |
| b10p | #13 |
| oxidase nox2 | #13 |
| μ chain | #13 |
| lew1w | #13 |
| ccp2 antibodies | #13 |
| anticii | #13 |
| idd5 | #13 |
| t‐cell epitope | #13 |
| native type collagen | #13 |
| doses ici | #13 |
| factor isotypes | #13 |
| dr1 transgenic | #13 |
| bcelldeficient mice | #13 |
| genes mouse chromosome | #13 |
| behavioral alterations rats | #13 |
| nos2derived | #13 |
| epitope immunization | #13 |
| rfigg | #13 |
| arthritis knowledge | #13 |
| ho4 | #13 |
| development type collagen | #13 |
| mtec aire | #13 |
| l012 | #13 |
| mouse strains | #13 |
| mannan | #13 |
| advanced intercross | #13 |
| citrullinated | #13 |
| hladrb1 ptpn22 | #13 |
| immunohistochemistry interferon | #13 |
| joints blood | #13 |
| macroscopic scoring | #13 |
| sequence collagen | #13 |
| major loci | #13 |
| loci interaction | #14 |
| smallmolecule compound | #14 |
| candidate autoantigens | #14 |
| autoimmune arthritis | #14 |
| involvement cells | #14 |
| collagen comp | #14 |
| protein collagen | #14 |
| nasal inhalation | #14 |
| murine collageninduced arthritis | #14 |
| efficient promotion | #14 |
| immune regulators | #14 |
| arlacel | #14 |
| thr233 | #14 |
| antifilaggrin antibodies | #14 |
| loci rheumatoid | #14 |
| deficient production | #14 |
| blymphocyte female humans | #14 |
| immunized rat | #14 |
| macrophages immune response | #14 |
| gut protection | #14 |
| aggregated nets | #14 |
| humans nadph | #14 |
| experimental interferon | #14 |
| cia expression | #14 |
| presence mcv | #14 |
| b6n mice | #14 |
| arthritic paws | #14 |
| mhc class region | #14 |
| peptides anti | #14 |
| sirt1 mmp9 | #14 |
| molecular disease models | #14 |
| specific inflammation | #14 |
| osteoclasts vivo | #14 |
| autoimmunity animals | #14 |
| collagen disease | #14 |
| rheumatoid arthritis presence | #15 |
| presence anticarp antibodies | #15 |
| monoclonal arthritis rats | #15 |
| citrullinated peptides patients | #15 |
| rats monoclonal antigens | #15 |
| nodb10h2b | #15 |
| integrated bioprocess | #15 |
| apcs macrophages | #15 |
| immune complex formation | #15 |
| translationally modified | #15 |
| rt1a | #15 |
| amps development | #15 |
| monolithic cryogel | #15 |
| rat genetics | #15 |
| cdr regions | #15 |
| dcii | #15 |
| osteoporosis development | #15 |
| arthritis role | #15 |
| antigenic epitope | #15 |
| type collagen development | #15 |
| congenic rats | #15 |
| polychondritis | #15 |
| cultured human chondrocytes | #15 |
| anticollagen | #15 |
| raloxifene estradiol | #15 |
| lentiviral gene delivery | #15 |
| treatment cia | #15 |
| mice immunization | #15 |
| tflask | #15 |
| involvement pathogenesis | #15 |
| neuritis rats | #15 |
| murine cia | #15 |
| arthritis development | #15 |
| 2 weight | #15 |
| exaggerates | #15 |
| aire mtec | #15 |
| mice type collagen | #15 |
| antibodies arthritis | #15 |
| regulation adaptive immunity | #15 |
| experimental allergic neuritis | #15 |
| ros cii | #15 |
| mhc class molecule | #15 |
| n305 | #16 |
| acute inflammation mice | #16 |
| arthritis severity mice | #16 |
| males onset | #16 |
| disease mice mice | #16 |
| rt1 | #16 |
| subspecificities | #16 |
| antinuclear autoimmunity | #16 |
| mumt | #16 |
| rheumatoid factor production | #16 |
| oligomeric matrix protein | #16 |
| lethal inflammatory | #16 |
| arthritis cii | #16 |
| pparγ lxrα | #16 |
| indirect genetic predisposition | #16 |
| cep1 | #16 |
| staphylococcal arthritis | #16 |
| rheumatoid arthritis genes | #16 |
| mhc genes | #16 |
| epitopes mice mice | #16 |
| levels natural antibodies | #16 |
| class transplantation | #16 |
| autologous collagen | #16 |
| lew1 | #16 |
| anti‐t | #16 |
| rats experimental arthritis | #16 |
| hla–drb1 shared epitope | #16 |
| congenic mice mice | #16 |
| h2p | #16 |
| genes animals | #16 |
| rno10 | #16 |
| mhcii ciita | #16 |
| matrilin proteins | #16 |
| development rheumatoid arthritis | #16 |
| nonglycosylated form | #16 |
| fewer osteoclasts | #16 |
| arthritis rheumatoid autoantibodies | #17 |
| progesterone development | #17 |
| periodontitis antibodies | #17 |
| strains lymphocytes | #17 |
| polyphosphate4 | #17 |
| collagen induced arthritis | #17 |
| rheumatoid arthritis subsets | #17 |
| nox2 derived | #17 |
| native denatured | #17 |
| cartilage collagen | #17 |
| cells female mice | #17 |
| clever1 | #17 |
| genistein mice | #17 |
| leuphe | #17 |
| rats lewis | #17 |
| animals congenic | #17 |
| collagen specific | #17 |
| onset rheumatoid arthritis | #17 |
| human fcγriia | #17 |
| cab4 | #17 |
| inbred lew | #17 |
| spleen peyers patches | #17 |
| cells presenting cells | #17 |
| triplehelical conformation | #17 |
| rt1av1 | #17 |
| skg | #17 |
| cells collagen | #17 |
| ethanol development | #17 |
| mice rheumatoid arthritis | #17 |
| allergic neuritis | #17 |
| autoimmune illness | #18 |
| day immunization | #18 |
| hybridomas mice mice | #18 |
| defined epitope | #18 |
| anti cd44 | #18 |
| cartilage type collagen | #18 |
| cuiiida | #18 |
| collagen autoantibodies | #18 |
| phenotypic feature | #18 |
| ealkene | #18 |
| day arthritis | #18 |
| humanized transgenic mice | #18 |
| short‐term administration | #18 |
| salivary glands mice | #18 |
| galactose moiety | #18 |
| keratinocytes induction | #18 |
| moginduced eae | #18 |
| addition ros | #18 |
| h2z | #18 |
| adjuvant arthritis rats | #18 |
| langerhans cells cells | #18 |
| joint inflammatory | #18 |
| disease duration onset | #18 |
| ros data | #18 |
| dra0101 | #18 |
| arthritis anti | #18 |
| expression lxrα | #18 |
| purified anti | #18 |
| genes spleen | #18 |
| single intradermal injection | #19 |
| blood monocytes neutrophils | #19 |
| mice develop | #19 |
| supermacroporous | #19 |
| vivo elimination | #19 |
| cd4 transgenic | #19 |
| new avenues | #19 |
| protective alleles | #19 |
| future utility | #19 |
| mrl mp mice | #19 |
| suppression dth | #19 |
| patients polychondritis | #19 |
| cia eae | #19 |
| inflammatory attack | #19 |
| citrullinated proteins acpa | #19 |
| trimolecular complex | #19 |
| beta oestradiol | #19 |
| collagen response | #19 |
| gly262 | #19 |
| elisa cia | #19 |
| three‐dimensional culture | #19 |
| mice congenic mice | #19 |
| protein comp | #19 |
| tbetarii gene | #19 |
| castrated female rats | #19 |
| peyers patches spleen | #19 |
| rats snp | #19 |
| ncr3 | #20 |
| progesterone oestrogen | #20 |
| 5r5 | #20 |
| 5p14 | #20 |
| glycosylated | #20 |
| response mbp | #20 |
| role nox | #20 |
| prominent infiltration | #20 |
| inflammation mice | #20 |
| littermate | #20 |
| matrilin1 | #20 |
| knockout mice transgenic | #20 |
| development disease | #20 |
| loci chromosomes | #20 |
| human rheumatoid arthritis | #20 |
| fls tnfα | #20 |
| mhc class alleles | #20 |
| nox1deficient mice | #20 |
| underlying gene | #20 |
| imaging reactive | #20 |
| mice cia | #20 |
| experimental autoimmunity | #20 |
| monkeys rodents | #20 |
| stress phospholipids | #20 |
| mbp rats | #20 |
| enhanced tcr | #20 |
| ciita mhcii | #20 |
| rt1d | #20 |
| highly susceptible | #20 |
| serm raloxifene | #20 |
| antibody treatment | #20 |
| pvg1av1 | #20 |
| nox2 mice | #21 |
| rats development | #21 |
| muscle ros | #21 |
| individual acpa | #21 |
| triplehelical peptides | #21 |
| nox2 activity | #21 |
| chronic relapsing | #21 |
| diseases lymphocytes | #21 |
| serum levels comp | #21 |
| granule mobilization | #21 |
| positional cloning | #21 |
| onset severity | #21 |
| arthritis pregnancy | #21 |
| illness autoimmune | #21 |
| supermacroporous cryogels | #21 |
| α1acidglycoprotein | #21 |
| nitratenitriteno pathway | #21 |
| igg fcgammar | #21 |
| cells adaptive immune | #21 |
| suppressor cytotoxic cells | #21 |
| mice mutant strains | #21 |
| drb11001 | #21 |
| n141 | #21 |
| genes controlling | #21 |
| cia treatment | #21 |
| pathogenesis rheumatoid | #21 |
| linomide treatment | #21 |
| n286 | #21 |
| conserved haplotype | #21 |
| ean rats | #21 |
| experimental rheumatoid | #21 |
| olahsd | #21 |
| response myelin | #22 |
| samples onset | #22 |
| determinant selection | #22 |
| semiallogenic | #22 |
| induced eae | #22 |
| ccp negative | #22 |
| c57bl mice subfamily | #22 |
| mice independent | #22 |
| rats loss | #22 |
| antiidiotypic antibody | #22 |
| vh j558 | #22 |
| animal epitopes humans | #22 |
| 270 | #22 |
| experimental phenotype | #22 |
| 81a | #22 |
| ul1 | #22 |
| association pv | #22 |
| identification susceptibility genes | #22 |
| cultured hepatic cells | #22 |
| rats nonalcoholic steatohepatitis | #22 |
| loss collagen | #23 |
| cryogel beads | #23 |
| onset cia | #23 |
| immunopeptides | #23 |
| phage clones | #23 |
| anti‐cd5 | #23 |
| cells presentation | #23 |
| arthritis type | #23 |
| 4npa | #23 |
| b10r | #23 |
| diseases autoimmunity | #23 |
| rats inbred lew | #23 |
| monoclonal antigens autoimmune | #23 |
| cells b10 | #23 |
| castration rats | #23 |
| experimental chromatography | #23 |
| 17 betaoestradiol | #23 |
| antibodies acpa | #23 |
| mace association | #23 |
| peptide activation | #23 |
| experimental autoimmune diseases | #23 |
| citrullinated protein | #23 |
| tgfbeta resistance | #23 |
| mbp eae | #23 |
| animal genes | #23 |
| inflammation absence | #23 |
| citrullinated epitopes | #23 |
| lymphocytes amino | #23 |
| comp | #23 |
| complex influences | #23 |
| citrullinated antigens | #23 |
| secondary immune response | #24 |
| subloci | #24 |
| c57bl 10 mice | #24 |
| levels comp | #24 |
| postpartum flare | #24 |
| rat induction | #24 |
| y35 | #24 |
| flss patients | #24 |
| monoclonal anti | #24 |
| ftirm | #24 |
| mediated arthritis | #24 |
| mice nox2 | #24 |
| antinuclear apoptosis | #24 |
| animal epistasis | #24 |
| chronic autoimmune diseases | #24 |
| experimental cells | #24 |
| new mouse | #24 |
| loci chromosome | #24 |
| cells c3h | #24 |
| experimental lupus | #24 |
| controls anti | #24 |
| severity chronicity | #24 |
| autoantibodies rheumatoid | #24 |
| inflammation arthritis | #24 |
| 339 | #24 |
| severity ali | #24 |
| mouse models development | #24 |
| rno4 | #25 |
| massive infiltration | #25 |
| beta lymphocytes | #25 |
| murine lyme arthritis | #25 |
| interleukin2 mice receptors | #25 |
| autoantibody response | #25 |
| arginine arthritis | #25 |
| cell hybridomas | #25 |
| cix | #25 |
| relapsing polychondritis | #25 |
| tolerized rats | #25 |
| monocytes nadph | #25 |
| immunization development | #25 |
| bnda | #25 |
| autoimmune messenger | #25 |
| rat mhc | #25 |
| specific epitopes | #25 |
| 8 antibodies | #25 |
| immunodominant epitope | #25 |
| proteinarginine deiminase type | #25 |
| complex male | #25 |
| arthritis experimental arthritis | #25 |
| autoimmune diseases humans | #25 |
| b6 balb | #25 |
| congenic animals | #25 |
| common autoimmune disease | #25 |
| ros | #25 |
| inbred lew rats | #25 |
| collagen cartilage | #25 |
| cells immunization | #25 |
| parasitemia survival | #25 |
| production monoclonal | #25 |
| hydrocarbon oil | #26 |
| local exposure | #26 |
| autoantibodies citrullinated proteins | #26 |
| post translationally | #26 |
| granulocytes cells | #26 |
| anti citrullinated | #26 |
| cb11 | #26 |
| polychondritis rp | #26 |
| mice gammadelta cells | #26 |
| igg2a mice | #26 |
| viable chondrocytes | #26 |
| glutamax | #26 |
| gene regions | #26 |
| helperinducer animals antibodies | #26 |
| nitrophenylalanine | #26 |
| cells joints | #26 |
| eae development | #26 |
| c1i | #27 |
| physiological level | #27 |
| trypsination | #27 |
| rheumatoid factor isotypes | #27 |
| antibodies type | #27 |
| hladrb1 shared epitope | #27 |
| individuals antibodies | #27 |
| innate interleukin10 | #27 |
| ccp2 | #27 |
| immunodominant response | #27 |
| immunospecific | #27 |
| perforin deficiency | #27 |
| pannus tissue | #27 |
| pointmutation | #27 |
| nonmhc genes | #27 |
| intercrossed | #27 |
| disease immunoglobulin | #27 |
| interleukin21 tlymphocytes | #27 |
| lysine position | #28 |
| severity day | #28 |
| protein peptides | #28 |
| ros induction | #28 |
| chronicity | #28 |
| cia3 | #28 |
| antily6g | #28 |
| anti rat | #28 |
| antigenspecific tolerance | #28 |
| nr8383 | #28 |
| rat strain | #28 |
| eae susceptibility | #28 |
| antibodies mab | #28 |
| cartilage vivo | #28 |
| w3 25 | #28 |
| onset day | #28 |
| mrna ifngamma | #28 |
| autoimmune inflammatory | #28 |
| mediated effects | #28 |
| upregulation cytokines | #28 |
| animal models neurodegeneration | #28 |
| membrane lymphocytes | #29 |
| phenomes | #29 |
| ros production macrophages | #29 |
| glucose transport capacity | #29 |
| peptide anti | #29 |
| ls2616 | #29 |
| absence inflammation | #29 |
| 246trinitrophenyl | #29 |
| cfa cia | #29 |
| antibody producing cells | #29 |
| presence synovial fluid | #29 |
| chronic dss | #29 |
| hiit exercise | #29 |
| acpa | #29 |
| mice mab | #29 |
| immunopathogenicity | #29 |
| parotid secretory protein | #29 |
| smoking presence | #29 |
| suboptimal doses | #29 |
| rfigm | #29 |
| vgenes | #30 |
| chain collagen | #30 |
| metabolic syndrome rats | #30 |
| alphabetat | #30 |
| hlase | #30 |
| adult thymectomy | #30 |
| vivo exercise | #30 |
| increased salt | #30 |
| cultivation cells | #30 |
| disease immunity | #30 |
| treatment raloxifene | #30 |
| vpba | #30 |
| development experimental | #30 |
| synovial cells patients | #30 |
| acpa fine | #30 |
| linkage disease | #30 |
| dba mice | #30 |
| 11 cells | #30 |
| ctla4 mice | #30 |
| plasminogendeficient mice | #30 |
| paws | #30 |
| translational rats | #30 |
| chronic autoimmune | #30 |
| variable heavy chain | #30 |
| monoclonal antibody production | #31 |
| common chain | #31 |
| perpetuated | #31 |
| apc development | #31 |
| rats autoimmune | #31 |
| littermate controls | #31 |
| immunization | #31 |
| disease development | #31 |
| expressing cells | #31 |
| comparative genetic analysis | #31 |
| human type collagen | #31 |
| drugs addition | #31 |
| nox2 nox1 | #31 |
| hiit training | #31 |
| pristaneinduced lupus | #31 |
| selfprotein | #31 |
| trimolecular | #31 |
| ige cd23 | #31 |
| acute‐phase response | #31 |
| synovial fluid blood | #31 |
| psoriasis model | #31 |
| phytol | #31 |
| nadph oxidases nox | #32 |
| role osteoclastogenesis | #32 |
| methods serum samples | #32 |
| cells uterus | #32 |
| genomewide genotyping | #32 |
| hladrb104 | #32 |
| mucosal tolerance | #32 |
| polymorphic genes | #32 |
| ros rns | #32 |
| differentiation arthritis | #32 |
| h2aq | #32 |
| ra33 | #32 |
| congenic mice | #32 |
| presence acpas | #32 |
| rt11 | #32 |
| receptor preference | #32 |
| nodes mice | #32 |
| steen | #32 |
| bound peptides | #32 |
| cell ratio | #32 |
| type antibody | #32 |
| arthritis therapy | #32 |
| beta mice | #32 |
| caia mice | #32 |
| nonb cells | #32 |
| 11 cell | #32 |
| influence genes | #32 |
| specificity function | #32 |
| acpa rheumatoid arthritis | #32 |
| epitope antibodies | #32 |
| antigenpresenting cells cells | #33 |
| autoantibody activity | #33 |
| skews | #33 |
| tolerance immunization | #33 |
| autoimmune demyelinating disease | #33 |
| role vav1 | #33 |
| cytosolic factor | #33 |
| induced immunization | #33 |
| delayed type | #33 |
| rheumatoid joint | #33 |
| epitopes antibodies | #33 |
| multiplex analysis | #33 |
| tcell receptor | #33 |
| arthritic mice | #33 |
| modified collagen | #33 |
| type cross | #33 |
| neurodegeneration role | #34 |
| chronic polyarthritis | #34 |
| cells dendritic cells | #34 |
| fpr1 | #34 |
| heterogeneous stock | #34 |
| c4bp | #34 |
| natural antibodies nabs | #34 |
| promiscuous expression | #34 |
| nox2 deficiency | #34 |
| interferon activity | #34 |
| joint pathology | #34 |
| patients animal models | #34 |
| monoclonal rheumatoid | #35 |
| infectious disease models | #35 |
| patients populations | #35 |
| plasminogen deficiency | #35 |
| psoriasiform skin | #35 |
| autoreactive | #35 |
| destructive arthritis | #35 |
| phagotope | #35 |
| development chronic | #35 |
| complex arthritis | #35 |
| nets neutrophils | #35 |
| acs stroke | #35 |
| major regulators | #35 |
| triple helical | #35 |
| 1xi | #35 |
| hybridomas | #35 |
| antiarthritis | #35 |
| vdr cells | #35 |
| arthritis disease | #35 |
| accessible sites | #35 |
| antirat | #35 |
| dinitro1 | #36 |
| induction tregs | #36 |
| arthritis cartilage | #36 |
| oxidases rna | #36 |
| phagocyte | #36 |
| nk cells recognition | #36 |
| animals antigen | #36 |
| protein specific | #36 |
| variance animals antibodies | #36 |
| female histocompatibility | #36 |
| h2g7 | #36 |
| techniques mice | #36 |
| tolerance tlymphocytes | #36 |
| specificity sera | #36 |
| cii cfa | #36 |
| h2r | #36 |
| cartilage joints | #36 |
| comparative genetics | #36 |
| dth | #36 |
| flow cytometry expression | #36 |
| encephalomyelitis | #37 |
| peptides binding | #37 |
| cii protein | #37 |
| role gamma interferon | #37 |
| lymphocytes disease | #37 |
| rich lipid | #37 |
| synthetic glycopeptides | #37 |
| genetic control | #37 |
| c129 | #37 |
| mif pathogenesis | #37 |
| recombinant vaccine | #37 |
| immunopathological features | #37 |
| oxidases oxidation | #37 |
| susceptibility autoimmune diseases | #37 |
| joint cartilage | #37 |
| dba1 | #37 |
| spontaneous arthritis | #37 |
| acpa positive | #37 |
| antibodies animals | #38 |
| target autoantigens | #38 |
| innovative tools | #38 |
| human blood neutrophils | #38 |
| animal models pain | #38 |
| nitrogen species | #38 |
| snat | #38 |
| sialophorin | #38 |
| cochranmantelhaenszel test | #38 |
| cldn4 | #38 |
| ccia | #39 |
| wasting syndrome | #39 |
| acpa response | #39 |
| allogeneically | #39 |
| cell tolerance | #39 |
| benoist | #39 |
| data myelin | #39 |
| endoβnacetylglucosaminidase | #39 |
| clonal expansion cells | #39 |
| resultsrats | #39 |
| b6n | #39 |
| nzw | #39 |
| ym1 | #39 |
| measurement activity | #39 |
| autoreactive cells | #39 |
| oestrogen treatment | #39 |
| nfr | #39 |
| rt1c | #40 |
| adjuvant induced | #40 |
| isostere | #40 |
| peptide cell | #40 |
| antigens arthritis | #40 |
| addition impact | #40 |
| disease animal models | #40 |
| polyclonal cell activation | #40 |
| genetic complexity | #40 |
| positive rheumatoid | #40 |
| immunocap isac | #41 |
| autoimmune | #41 |
| aq | #41 |
| congenic mapping | #41 |
| severity incidence | #41 |
| mhc haplotype | #41 |
| autoimmune inflammatory diseases | #41 |
| ncii | #41 |
| effects experiments | #41 |
| priming phase | #41 |
| genes loci | #41 |
| rats anti | #41 |
| rat myelin | #41 |
| spleen weight | #42 |
| fibroblasts mice | #42 |
| articular collagen | #42 |
| species receptors | #42 |
| p38 mapk nfκb | #42 |
| drb1 shared | #42 |
| th17 axis | #42 |
| cartilage bone destruction | #42 |
| mhc class class | #42 |
| expected onset | #42 |
| ptpn22 locus | #42 |
| pineal gland melatonin | #42 |
| antibody isotypes | #42 |
| congeneic | #43 |
| immunodominant epitopes | #43 |
| type‐ii | #43 |
| lew lymphocytes | #43 |
| lew rats | #43 |
| spinal glia | #43 |
| kgf treatment | #43 |
| anticyclic | #43 |
| mice autoimmune | #43 |
| autoreactive cell | #43 |
| treatment autoimmune diseases | #43 |
| pc8 | #43 |
| arthritis data | #43 |
| collagen | #43 |
| anticitrullinated | #43 |
| rats sex | #43 |
| crosses genetic | #43 |
| cd11bly6g | #43 |
| epitopes lymphocyte | #44 |
| neuritis ean | #44 |
| inflammation animals | #44 |
| mathis | #44 |
| defensins humans | #44 |
| mice mice autoimmune | #44 |
| homozygous form | #44 |
| chloro23 | #44 |
| peptide induced | #44 |
| addition order | #44 |
| c4bbinding protein c4bp | #44 |
| genetic linkage analysis | #44 |
| mice adulthood | #44 |
| provocations | #44 |
| chromosome development | #45 |
| disease histocompatibility | #45 |
| outbred rats | #45 |
| susceptibility arthritis | #45 |
| potent suppression | #45 |
| nzb | #45 |
| relapsing disease | #45 |
| phagotopes | #45 |
| genetic encoding | #45 |
| isosteres | #46 |
| carp antibodies | #46 |
| rat2 | #46 |
| posttranslationally | #46 |
| c227 | #46 |
| cocrystallisation | #46 |
| eae mbp | #46 |
| lower severity | #46 |
| mhc class humans | #46 |
| locus controlling | #46 |
| neuritis autoimmune | #46 |
| alphachains | #46 |
| specific tolerance | #46 |
| disease induction | #46 |
| affinity purified | #46 |
| complex mediated | #47 |
| posttranslational rats receptors | #47 |
| f1 hybrid mice | #47 |
| intercrosses | #47 |
| antibody reactivities | #47 |
| idiotypic antibody | #47 |
| rheumatoid factors | #47 |
| association hladrb1 alleles | #47 |
| protective allele | #47 |
| diagnostic accuracy diagnosis | #47 |
| collagen peptide | #48 |
| f1 crosses | #48 |
| mice nzb | #48 |
| acetylchitobiose | #48 |
| cia rats | #48 |
| collagen glycosylation | #48 |
| synovial lining layer | #48 |
| lupus disease | #48 |
| tlr12 | #48 |
| peptide recognized | #48 |
| humanized model | #48 |
| antibody specificity | #48 |
| γchains | #48 |
| experimental arthritis mice | #48 |
| mice carrying | #48 |
| tcell stimulation | #49 |
| immune nervous | #49 |
| experimental crosses | #49 |
| histone hdacs | #49 |
| comp levels | #49 |
| polyvinylcaprolactam | #49 |
| sex genes | #49 |
| mouse cartilage | #49 |
| bystander activation | #49 |
| class major | #49 |
| mice caia | #49 |
| monoclonal autoimmune diseases | #49 |
| monoclonal epitopes | #50 |
| parathyroid cells | #50 |
| glycosylated form | #50 |
| inflammation kynurenine | #50 |
| animal cell culture | #50 |
| dependent chronic | #50 |
| ciiia | #50 |
| glutamine uptake | #50 |
| complex region | #50 |
| anticarbamylated protein | #50 |
| alagly | #50 |
| antigenantibody | #50 |
| cytometry analyses | #50 |
| loci animals | #50 |
| disease rats | #50 |
| mice tolerance | #50 |
| derived type | #51 |
| autoantibodies rheumatoid arthritis | #51 |
| rheumatoid factor activity | #51 |
| cells ova | #51 |
| runting | #51 |
| fewer cells | #51 |
| tracheal cartilage | #51 |
| evidence animal models | #51 |
| lentiviral particles | #51 |
| antibodies cells | #51 |
| aire mice | #51 |
| tolerized | #51 |
| delayed immunization | #51 |
| inbred c57bl autoimmune | #51 |
| c57bl 6j background | #51 |
| macrophages skin | #52 |
| xor activity | #52 |
| matrix protein | #52 |
| model collagen | #52 |
| antigenpresenting cells | #52 |
| ptpn22 | #52 |
| production reactive | #53 |
| triple helical structure | #53 |
| induced autoimmunity | #53 |
| patients rheumatic conditions | #53 |
| antibodies epitopes | #53 |
| lysosomal compartments | #53 |
| aged peptides | #53 |
| physiological doses | #53 |
| carbamylated proteins | #53 |
| arthritis induction | #53 |
| melatonin day | #53 |
| protein antibodies | #53 |
| cartilage erosion | #53 |
| gastric parietal cell | #53 |
| strain rats | #54 |
| development individuals | #54 |
| major epitope | #54 |
| imitating | #54 |
| predating | #54 |
| nodes lymphocyte | #54 |
| yaa | #54 |
| rats social isolation | #54 |
| melatonin animals | #54 |
| animals autoimmune | #54 |
| antigens myelomonocytic arthritis | #54 |
| crossbreeding | #54 |
| carbamylated protein | #54 |
| susceptibility autoimmune disease | #55 |
| autoimmune nzb | #55 |
| arthritis genetic | #55 |
| autoimmune reactions | #55 |
| macrophage mannose receptor | #55 |
| complex genetic disease | #55 |
| inflammatory manifestations | #55 |
| mhc | #56 |
| animals antibody | #56 |
| new animal | #56 |
| labels superoxide | #56 |
| alpha1microglobulin | #56 |
| cells salivary | #56 |
| selfreactive cells | #56 |
| antibodies | #57 |
| animals antirheumatic | #57 |
| vivo depletion | #57 |
| antibodies bind | #57 |
| collagen sequence | #57 |
| development autoimmune | #57 |
| arthritis pathogenesis | #57 |
| cd1 mice | #57 |
| igg abs | #57 |
| rat type | #58 |
| urokinase activity | #58 |
| chronic eae | #58 |
| peptide response | #58 |
| schafer | #58 |
| oestrogen progesterone | #58 |
| articular joints | #59 |
| anti cd8 | #59 |
| oligoclonal igg bands | #59 |
| encephalitogenicity | #59 |
| hydroxylase diet | #59 |
| anticarp antibodies | #59 |
| anti cell | #59 |
| resistance eae | #59 |
| genes mhc | #59 |
| cartilage matrix protein | #59 |
| immunohistopathology | #60 |
| dichotomous effects | #60 |
| alternative activation macrophages | #60 |
| protein peptide | #60 |
| hpaaxis | #60 |
| joint erosions | #60 |
| macrophage mannose | #60 |
| assay epitopes | #60 |
| inflammatory cells macrophages | #60 |
| cells innate immune | #61 |
| differentiation myelomonocytic arthritis | #61 |
| major histocompatibility | #61 |
| incidence severity | #61 |
| alpha1m | #61 |
| experimental rats rats | #61 |
| species reactive | #61 |
| experimental evoked potentials | #61 |
| epitope spreading | #61 |
| serum comp | #61 |
| fpr2 | #62 |
| antigens class histocompatibility | #62 |
| basic characterization | #62 |
| autoantibody formation | #62 |
| reduced oxidative | #62 |
| cyclic sensitivity | #62 |
| interferon‐β | #62 |
| mice susceptibility | #62 |
| toxin1 | #62 |
| adaptive immune | #62 |
| syngeneically | #62 |
| placenta uterus | #62 |
| transfer animals | #63 |
| hypersensitivity dth | #63 |
| post‐partum | #63 |
| glycoprotein myelin | #63 |
| duval | #63 |
| induced experimental | #63 |
| rats strain | #63 |
| nadph oxidases | #63 |
| protein disease | #63 |
| collagen cell | #63 |
| constant darkness | #63 |
| mog1 | #63 |
| mice polyi | #63 |
| specific stages | #63 |
| igaproducing cells | #63 |
| specificity tumor | #63 |
| delayed interferon | #63 |
| peptide specific | #63 |
| tolerance model | #64 |
| lower capacity | #64 |
| role apc | #64 |
| freund adjuvant | #64 |
| secondary immune | #64 |
| maternal origin | #64 |
| autoimmunity humans | #65 |
| hindpaws | #65 |
| model chronic | #65 |
| induced suppression | #65 |
| flss | #65 |
| weight variation | #65 |
| histocompatibility complex | #65 |
| major subset | #65 |
| chromosomes mammalian | #66 |
| multispecificity | #66 |
| phagocytosis oxidative burst | #66 |
| negative rheumatoid | #66 |
| peripheral joints | #66 |
| experimental lymphocytes | #66 |
| spontaneous disease | #66 |
| rheumatoid synovial cells | #66 |
| acute arthritis | #66 |
| resemblances | #66 |
| thy1 antigen | #66 |
| hladr2 | #66 |
| key interactions | #67 |
| experimental allergic | #67 |
| dendritic cells epitopes | #67 |
| development cell | #67 |
| rheumatoid arthritis susceptibility | #67 |
| myelomonocytic arthritis | #67 |
| strains susceptible | #67 |
| mice induced | #67 |
| experimental encephalomyelitis | #67 |
| endos | #67 |
| mice cell | #67 |
| fibrinogen genotype | #67 |
| iggrf | #68 |
| anti carp | #68 |
| female sex hormones | #68 |
| sodium diethyldithiocarbamate | #68 |
| rheumatoid chromosomes | #68 |
| individuals positive | #68 |
| severity periodontitis | #68 |
| tolerized mice | #68 |
| helper phenotype | #68 |
| class region | #68 |
| cells mhc class | #68 |
| frequent infections | #68 |
| complex class | #68 |
| rheumatoid disease | #69 |
| relapsing | #69 |
| direct damage | #69 |
| frequency antibodies | #69 |
| lymphocytes chronic | #69 |
| vertebrate immune | #69 |
| zap‐70 | #69 |
| cells mouse | #69 |
| translationally | #70 |
| presence rheumatoid factor | #70 |
| immunoglobulin interferon | #70 |
| response type | #70 |
| mrl mice | #70 |
| prolonged graft survival | #70 |
| role cells | #70 |
| expression pparγ | #71 |
| cb10 | #71 |
| cartilage mice | #71 |
| susceptibility female | #71 |
| ztm | #71 |
| swr | #71 |
| isolated rats | #71 |
| human psoriasis | #71 |
| lathyritic | #72 |
| study antibodies | #72 |
| dark agouti rats | #72 |
| antibodies binding | #72 |
| napdh | #72 |
| interphalangeal joints | #72 |
| delayedtype hypersensitivity dth | #72 |
| naïve mice | #72 |
| autoimmunity lymphocytes | #72 |
| type ifn signature | #73 |
| membrane animals | #73 |
| environmental lighting | #73 |
| mrl lpr | #73 |
| knockout protein processing | #73 |
| bovine type | #73 |
| oxidase complex | #73 |
| species ros | #73 |
| treatment stages | #73 |
| antigens class | #74 |
| hypersensitivity delayed | #74 |
| igarf | #74 |
| cartilage explants | #74 |
| pregnancyinduced | #74 |
| peptides sequences | #74 |
| cell reactivity | #75 |
| oestradiol | #75 |
| inbred dba receptors | #75 |
| dth mice | #75 |
| diabetes arthritis | #75 |
| effects development | #75 |
| acpapositive | #75 |
| genetic disease models | #75 |
| disease rheumatoid arthritis | #76 |
| type collagens | #76 |
| anti carbamylated | #76 |
| rat splenocytes | #76 |
| peptide mhc | #76 |
| eae induced | #77 |
| cell deficient | #77 |
| lpr mrl | #77 |
| pain inflammation | #77 |
| rt1n | #77 |
| regulatory vaccines | #77 |
| new animal model | #77 |
| oligomeric | #77 |
| collagen chains | #77 |
| development insulitis | #77 |
| cyp7a1 | #77 |
| rats eae | #77 |
| nerve conduction velocity | #77 |
| inbred mouse strains | #77 |
| mhc expression | #78 |
| cartilage integrity | #78 |
| pathogenesis rheumatoid arthritis | #78 |
| rats respiratory | #78 |
| clinical arthritis | #78 |
| pythons | #78 |
| autoantigenic | #78 |
| 1ii | #79 |
| autoimmune experimental epitopes | #79 |
| shared epitope | #79 |
| mononuclear lung | #79 |
| inflammatory autoimmune | #79 |
| susceptibility disease | #79 |
| oxidases | #80 |
| chromosome study | #80 |
| detection autoantibodies | #80 |
| erosive arthritis | #80 |
| inflammatory phase | #81 |
| type macrophages | #81 |
| arthritis cells | #81 |
| estrogen suppression | #81 |
| expression ll37 | #81 |
| induced leukocyte | #81 |
| spleen study | #81 |
| mhcii expression | #81 |
| class antigen expression | #81 |
| mog mbp | #81 |
| mrl mp | #81 |
| sex linkage | #81 |
| hnrnpa2 | #81 |
| dr1 antigen | #81 |
| aspartic acid position | #81 |
| 14weeks | #82 |
| pannus formation | #82 |
| nadphoxidase | #82 |
| bcg infection | #83 |
| cell independent | #83 |
| tlymphocyte genes | #83 |
| expression mhc | #83 |
| mice igg | #83 |
| drug encephalomyelitis | #83 |
| rat cardiac allografts | #84 |
| multiple sclerosis evidence | #84 |
| reactive cells | #84 |
| arthritis day | #84 |
| naïve cells | #84 |
| spontaneous development | #84 |
| strains animals | #84 |
| epidermal cells | #84 |
| knockout receptors | #85 |
| homopentamer | #85 |
| class molecule | #85 |
| inflammation joints | #85 |
| inflammation joint | #85 |
| antiifngamma | #85 |
| cells recognize | #85 |
| phagocyte nadph | #86 |
| animal humans | #86 |
| preclinical stage | #86 |
| gfoger | #86 |
| contribution genes | #86 |
| anti cd4 | #86 |
| severe eae | #86 |
| mutant strains | #86 |
| classical humans | #86 |
| monoclonal antibodies mab | #86 |
| smash | #87 |
| estrogen induced | #87 |
| alpha1acid glycoprotein | #87 |
| inbred rat strains | #87 |
| mhc class gene | #87 |
| levels anti | #88 |
| thps | #88 |
| fine specificities | #88 |
| inguinal lymph nodes | #88 |
| copy variation | #88 |
| narac | #88 |
| mice antibodies | #89 |
| mabs mab | #89 |
| arthritic | #89 |
| genetic quantitative | #89 |
| depletion cd8 cells | #89 |
| peptide immunization | #89 |
| experimental autoimmune | #89 |
| monkeys mice | #90 |
| pineal hormone melatonin | #90 |
| susceptible | #90 |
| adjuvant arthritis | #90 |
| arthritis compared | #90 |
| mediated mechanisms | #90 |
| autoimmune inbred c57bl | #90 |
| rheumatoid arthritis cells | #90 |
| genistein treatment | #90 |
| ilc2 activation | #90 |
| histological sections | #91 |
| cattle collagen | #91 |
| protein induced | #91 |
| activation cd4 cells | #91 |
| backgroundan | #91 |
| synovial fluid serum | #91 |
| cells apc | #91 |
| difco | #92 |
| humans immunodominant | #92 |
| experimental mouse models | #92 |
| anticitrullinated protein | #92 |
| abdominal region | #92 |
| nod mhc | #92 |
| knockout myelin | #93 |
| natural polymorphisms | #93 |
| xor | #93 |
| cellspecific | #93 |
| animals autoantibodies | #93 |
| 290 patients | #93 |
| mice melatonin | #93 |
| endosomal acidification | #94 |
| fcγrs | #94 |
| macrophages development | #94 |
| autosomal genes | #94 |
| activated cells cells | #94 |
| galactosylated | #94 |
| binding integrins | #95 |
| chronic phase disease | #95 |
| moderateintensity exercise | #95 |
| induced sarcoma | #95 |
| data rats | #96 |
| lung emphysema | #96 |
| macrophages stimulation | #96 |
| nonglycosylated | #96 |
| cell alpha | #96 |
| romani | #96 |
| pregnancy disease | #96 |
| messenger tolllike receptor | #96 |
| fetal rejection | #96 |
| ifnbeta | #96 |
| hydroxylysine | #97 |
| cathelicidins | #97 |
| il33r | #97 |
| complex mice | #97 |
| macrophages fibroblasts | #97 |
| citrullinated fibrinogen | #97 |
| antiimmunoglobulin | #97 |
| genetic female genes | #97 |
| rheumatoid lymphocytes | #97 |
| autoimmune experimental | #98 |
| acpa igg | #98 |
| autoimmune rats | #98 |
| swr mice | #98 |
| rheumatoid cartilage | #98 |
| ean | #98 |
| alternative pathways | #99 |
| rat chromosomes | #99 |
| interleukin‐4 | #99 |
| collagen cytokines | #99 |
| tap2 | #100 |
| protein antibody | #100 |
| cultured crosses | #100 |
| rats monoclonal antibodies | #100 |
| thy1 antigens | #100 |
| invading pathogens | #100 |
| tlymphocyte immunity | #100 |
| inducer animals | #100 |
| ccp anti | #100 |
| peptides cells | #100 |
| bone degradation | #101 |
| safety drugs | #101 |
| cell determinants | #101 |
| diarthrodial | #101 |
| eira | #101 |
| singlenucleotide polymorphism | #101 |
| susceptible strain | #101 |
| fprs | #101 |
| mouse monoclonal antibodies | #102 |
| brucei infection | #102 |
| candidate autoantigen | #102 |
| findings treatment | #102 |
| eae animal encephalomyelitis | #102 |
| drb10401 | #103 |
| agalactosyl | #103 |
| pathogenesis emphysema | #103 |
| oxidative burst | #103 |
| ros homeostasis | #103 |
| hla dr1 | #103 |
| male mice mice | #104 |
| synchrotron infrared | #104 |
| mhcii | #104 |
| nonarthritic | #104 |
| haplotypes histocompatibility | #104 |
| arthritic disease | #104 |
| f1 males | #104 |
| mutation mice | #104 |
| skg mice | #104 |
| thelper cells | #104 |
| fcγr | #105 |
| vivo macrophages | #105 |
| development antibodies | #105 |
| osteoclasts mice | #105 |
| autoreactivity | #105 |
| hybridoma cell | #105 |
| dmaam | #105 |
| type 22 | #105 |
| disease dose | #106 |
| tcell immunity | #106 |
| proteoglycan loss | #106 |
| arthritis hla | #106 |
| limited cross | #106 |
| primed cells | #106 |
| 273 | #106 |
| c3h mice | #107 |
| cells synovial | #107 |
| nzb mice | #107 |
| study tolerance | #108 |
| development autoimmune disease | #108 |
| fpr | #108 |
| littermates | #108 |
| monoclonal igg | #109 |
| citrullinated proteins | #109 |
| type hypersensitivity | #109 |
| enthesophytes | #109 |
| structural polymorphism | #109 |
| presentation cells | #109 |
| delayedtype hypersensitivity | #109 |
| reactive cell | #109 |
| autoantibodies autoantigens | #109 |
| autoimmune encephalomyelitis | #110 |
| carcinoma tumors | #110 |
| experimental female | #111 |
| inbred dba microscopy | #111 |
| dba 1j mice | #111 |
| female hypersensitivity | #111 |
| cartilage | #111 |
| toxic shock syndrome | #111 |
| streptococcal cell wall | #111 |
| mog eae | #111 |
| backcross | #111 |
| anti idiotypic antibodies | #112 |
| presymptomatic individuals | #112 |
| alphabeta receptors antigen | #112 |
| extensive literature search | #112 |
| humoral autoimmunity | #112 |
| amide bond | #112 |
| tcra | #113 |
| db1 | #113 |
| mice collageninduced arthritis | #113 |
| restricted cell | #113 |
| trait loci | #113 |
| adjuvant properties | #113 |
| autoimmune c57bl mice | #113 |
| xid mice | #113 |
| oligoclonality | #113 |
| ifngammaproducing cells | #114 |
| adjuvantinduced arthritis | #114 |
| mice disease | #115 |
| anti mcv | #115 |
| rats collagen | #115 |
| proinflammatory cytokine | #115 |
| autoantigens autoimmunity | #115 |
| drb10402 | #115 |
| susceptibility eae | #116 |
| lutz | #116 |
| experimental epitopes | #116 |
| pathogenesis autoimmune diseases | #116 |
| transgenic peptides receptors | #116 |
| ccp patients | #116 |
| lymphocyte female | #116 |
| immunosorbents | #116 |
| glyco | #116 |
| glycopeptides | #116 |
| antiarthritic | #117 |
| tolerance induced | #117 |
| congenic lines | #117 |
| antibodies reactive | #117 |
| encephalomyelitis autoimmune | #117 |
| fluorescence nf | #117 |
| mice type | #117 |
| α enolase | #118 |
| pineal hormone | #118 |
| psoriasiform dermatitis | #118 |
| alpha1acid | #118 |
| myelin oligodendrocyte | #118 |
| rats immunized | #118 |
| samples individuals | #118 |
| class expression | #118 |
| psa rheumatoid arthritis | #119 |
| rheumatoid arthritis review | #119 |
| cd4 tcells | #119 |
| 05m | #119 |
| radiological damage | #119 |
| response cells | #119 |
| protein mbp | #120 |
| neutrophils nets | #120 |
| experimental animal models | #121 |
| chondrocyte cultures | #121 |
| vivo animal models | #121 |
| treatment progesterone | #122 |
| t‐lymphocyte | #122 |
| transgenic neurons receptors | #122 |
| pharmacological potential | #122 |
| genes age | #122 |
| immune complex deposition | #122 |
| patients acpa | #122 |
| transfer arthritis | #122 |
| acpa negative | #122 |
| c5b | #123 |
| type cytokines | #123 |
| symptoms associations | #123 |
| alphabeta cells | #123 |
| nox2 activation | #123 |
| cell monoclonal | #123 |
| cartilage surface | #124 |
| inbred mouse | #124 |
| tlr4 stimulation | #124 |
| immunodominant peptide | #125 |
| general mechanisms | #125 |
| cryogel | #125 |
| blocking antigens | #125 |
| helperinducer | #125 |
| genetic rats | #125 |
| preimmunized | #125 |
| allelic variations | #125 |
| oxidases neutrophils | #125 |
| disease mechanisms | #125 |
| qtl genes | #125 |
| female immunization | #126 |
| cyclic polymorphism | #126 |
| nonobese diabetic | #126 |
| nzb nzw | #126 |
| pnipaam | #126 |
| atp8 | #127 |
| animal enzyme | #127 |
| knockout murine | #127 |
| absence cells | #127 |
| microarray detection | #127 |
| anticitrullinated peptide | #128 |
| dominant epitope | #128 |
| lining layer | #128 |
| deiminases | #128 |
| chronic inflammatory disease | #128 |
| multiple epitopes | #129 |
| bxsb | #129 |
| rats patients | #129 |
| spleen rats | #129 |
| disease induced | #130 |
| vivo absence | #130 |
| oestradiol testosterone | #130 |
| nos2 | #130 |
| cells eae | #130 |
| psd1 | #130 |
| onset arthritis | #131 |
| epitope specific | #131 |
| lipomannan | #131 |
| disease cgd | #132 |
| intercross | #132 |
| mineral oils | #132 |
| induction regulatory cells | #132 |
| linomide | #132 |
| pronociceptive | #132 |
| kgf | #132 |
| reduced severity | #133 |
| ggaa | #133 |
| leukosialin | #133 |
| rat chromosome | #133 |
| patients cytokines | #134 |
| myocellular | #134 |
| eae | #134 |
| mice estrogen | #134 |
| accentuate | #134 |
| knockout receptors antigen | #134 |
| species animals | #134 |
| plasma synovial fluid | #134 |
| interstitial collagens | #134 |
| peptides cyclic | #135 |
| spinal glial | #135 |
| igg immune complexes | #135 |
| immunizing | #136 |
| chronic autoimmune disease | #136 |
| macrophages dendritic | #136 |
| intracellular reactive | #136 |
| innate lymphocytes | #137 |
| receptor upregulation | #137 |
| immunopathological | #137 |
| stimulated muscle | #137 |
| ditiocarb | #138 |
| mice deficient | #138 |
| immunomodulatory drug | #139 |
| control development | #139 |
| dmannitol | #139 |
| autoimmune mice | #139 |
| tcrdelta | #140 |
| oligoclonal expansion | #141 |
| producing cell | #141 |
| thermoresponsive polymer | #141 |
| rejection tolerance | #142 |
| gamma lymphocyte | #142 |
| single subcutaneous injection | #142 |
| phadia | #142 |
| interferon‐γ | #142 |
| or113 | #142 |
| genetic factors development | #142 |
| smfish | #142 |
| class haplotypes | #143 |
| tcell alphabeta receptors | #143 |
| phosphate isomerase | #143 |
| cell hybridoma | #143 |
| mice beta | #143 |
| synovial hyperplasia | #144 |
| mhc haplotypes | #144 |
| rat strains | #144 |
| rheumatoid arthritis | #144 |
| lyme arthritis | #145 |
| inbred buf rats | #145 |
| tnf production | #145 |
| severe chronic | #145 |
| tcr gamma delta | #145 |
| syngenic | #145 |
| treatment ici | #145 |
| rats induced | #146 |
| neonatal growth | #146 |
| cellular heterogeneity | #147 |
| systemic challenge | #147 |
| ccp antibodies | #147 |
| function cells | #147 |
| pregnancy levels | #147 |
| gammainterferon | #147 |
| α2i | #148 |
| phagocyte nadph oxidase | #148 |
| cell surface antigen | #148 |
| autoimmune disease | #148 |
| redox regulation | #148 |
| interestingly | #148 |
| human autoimmune diseases | #149 |
| complex diseases | #149 |
| drb104 | #150 |
| larsen score | #150 |
| mhc binding | #150 |
| differential gene expression | #151 |
| mice animals | #151 |
| epicutaneously | #151 |
| humans hybridomas | #151 |
| levels antibodies | #151 |
| receptor rats | #151 |
| alphabeta receptors | #152 |
| pepsin | #153 |
| levels pregnancy | #153 |
| arthritic animals | #153 |
| key player | #153 |
| mononuclear cells | #153 |
| male rats rats | #154 |
| immune priming | #154 |
| fcgammar | #154 |
| expression class | #154 |
| critical event | #154 |
| joint inflammation | #154 |
| daf1 | #154 |
| c4bbinding protein | #154 |
| selfpeptides | #154 |
| autoantibodies autoimmune | #155 |
| arthritis rheumatoid | #155 |
| mace acs | #155 |
| serum synovial fluid | #155 |
| infiltrating cells | #155 |
| f1 mice | #155 |
| padi4 | #155 |
| stabilin1 | #156 |
| specificities | #156 |
| mhc region | #156 |
| suppressive role | #156 |
| adjuvanticity | #157 |
| downstream signals | #157 |
| murine keratinocytes | #157 |
| parentals | #158 |
| genetic diabetes mellitus | #158 |
| analysis structure | #158 |
| hypersensitivity reaction | #158 |
| inbred c3h mice | #159 |
| animals autoimmunity | #159 |
| meaib | #159 |
| consensus motif | #159 |
| systemic mice mice | #159 |
| arthritis infectious | #159 |
| specific autoimmunity | #161 |
| benzylated | #161 |
| factors anti | #161 |
| day onset | #161 |
| gamma interferon | #161 |
| knockout severity | #161 |
| nursed | #161 |
| rheumatoid autoantigens | #162 |
| psors1 | #162 |
| anti ccp | #162 |
| arthritis inflammation | #162 |
| βarrestin recruitment | #162 |
| binding collagen | #162 |
| epitope | #162 |
| cd152 | #162 |
| mouse type | #163 |
| chains humans | #163 |
| onset disease | #163 |
| laboratory rats | #163 |
| autoantibody responses | #164 |
| rats induction | #164 |
| genes qtl | #164 |
| endobetanacetylglucosaminidase | #164 |
| mrl | #164 |
| progesterone effects | #164 |
| agalactosyl igg | #164 |
| striking similarities | #164 |
| cells macrophages | #165 |
| animal humans immunity | #165 |
| nonimmunized | #166 |
| tolerance induction | #166 |
| pathogenic pathways | #166 |
| melatonin mice mice | #166 |
| epitope alleles | #166 |
| ag7 | #167 |
| seronegative | #167 |
| tlymphocyte humans | #167 |
| nox2 | #167 |
| class mice | #167 |
| human autoimmunity | #167 |
| mice cd4 cells | #168 |
| cd1 | #168 |
| genetic backgrounds | #168 |
| phase disease | #168 |
| acpa levels | #169 |
| denoted | #169 |
| p12 | #169 |
| oxazole | #169 |
| joints male | #170 |
| experimental animal | #170 |
| cryogels | #170 |
| mirp | #170 |
| pathogenesis arthritis | #170 |
| lymph node cells | #170 |
| inherited disorder | #170 |
| oxazolone | #171 |
| ros nitric oxide | #171 |
| encephalomyelitis eae | #171 |
| single nucleotide polymorphism | #172 |
| rat placenta | #172 |
| lst1 | #172 |
| peripheral lymphoid organs | #172 |
| rheumatoid | #172 |
| autoimmunity cell | #172 |
| autoimmune eae | #172 |
| inbred dba models | #173 |
| monoclonal autoantibodies | #173 |
| sod3 | #173 |
| studies pain | #174 |
| class gene | #174 |
| presence autoantibodies | #174 |
| nasal cartilage | #174 |
| resistant rats | #174 |
| understanding pathogenesis | #175 |
| ifn signature | #175 |
| mice mutation | #175 |
| maternal decidua | #175 |
| moab | #176 |
| skin disease | #176 |
| strains molecular | #176 |
| tryptophan catabolism | #176 |
| secondary challenge | #176 |
| new mouse model | #176 |
| mammalian crosses | #176 |
| lymphotoxinα | #177 |
| hladrb1 alleles | #178 |
| histocompatibility | #178 |
| ctla‐4 | #178 |
| protein anti | #179 |
| immunized | #179 |
| alternative pathway complement | #179 |
| dextran sulphate sodium | #179 |
| mice role | #179 |
| nod genes | #179 |
| arthritis methods | #180 |
| cgd patients | #180 |
| complex disease | #180 |
| epitopes female | #180 |
| autoimmunity disease | #181 |
| genetic influence | #181 |
| alleles arthritis | #181 |
| molecular adaptations | #181 |
| arginine deiminases | #182 |
| hormone melatonin | #182 |
| immunoglobulin mice mice | #185 |
| antigen processing presentation | #186 |
| multistep process | #186 |
| rats reactive | #186 |
| cells lymph nodes | #186 |
| b10 | #187 |
| dba | #187 |
| drb1 chains | #187 |
| tcell recognition | #187 |
| substrains | #188 |
| molecular peptide | #188 |
| chondritis | #188 |
| cells disease | #189 |
| mtec | #189 |
| synovial membranes | #190 |
| inflamed joint | #190 |
| positionally | #190 |
| hnrnpa2b1 | #190 |
| oligodendrocyte glycoprotein | #191 |
| cross‐reactivity | #192 |
| ly1 | #192 |
| autoantibody profiles | #192 |
| passive mice mice | #193 |
| fmlf | #193 |
| proteins myelin | #194 |
| cyclic predictive | #194 |
| glycoprotein peptide | #194 |
| chapter 16 | #195 |
| perpetuate | #195 |
| mice mutant | #195 |
| mhv | #195 |
| mhc class expression | #196 |
| oophorectomized | #196 |
| myelin glycoprotein | #196 |
| tcell response | #196 |
| lewis rat | #196 |
| acutephase response | #197 |
| evidence development | #197 |
| multiplex assay | #197 |
| pannus | #197 |
| genetic links | #198 |
| early appearance | #198 |
| swedish patients | #198 |
| igmrf | #198 |
| rat genome | #199 |
| interleukin17 | #199 |
| dr4 antigen | #199 |
| cell collagen | #200 |
| citrullinated peptide | #200 |
| hla association | #200 |
| pathogenesis autoimmune | #201 |
| myelin proteins myelin | #202 |
| myelin proteolipid protein | #202 |
| instigation | #202 |
| acpa status | #202 |
| dendritic cells macrophages | #202 |
| complete elimination | #203 |
| mice cells | #203 |
| immunization immunoglobulin | #204 |
| class molecules | #204 |
| 2 complex | #204 |
| spleen staining | #204 |
| dth response | #205 |
| macrophages mice | #205 |
| nonparametric tlymphocytes | #205 |
| native collagen | #205 |
| suppresses | #205 |
| ides | #205 |
| wild rats | #206 |
| defb4 | #206 |
| betaestradiol | #206 |
| mice peptide | #207 |
| intranasal challenge | #207 |
| induced upregulation | #207 |
| parental strains | #207 |
| noxs | #207 |
| insulitis diabetes | #207 |
| interleukin4 mice mice | #207 |
| alternative complement pathway | #207 |
| desmoglein 3 | #207 |
| highest probability | #208 |
| immunization mice | #208 |
| severity disease | #208 |
| antigen presenting | #208 |
| naive mice | #208 |
| vivo patients | #208 |
| disease rheumatoid | #209 |
| cotwins | #209 |
| immunoglobulin vh | #209 |
| citrullinated vimentin | #210 |
| highfatdiet | #210 |
| susceptible strains | #210 |
| vav1 | #210 |
| valuable tools | #210 |
| specific antibodies | #210 |
| natural antibodies | #211 |
| hla dr4 | #211 |
| diseases genetic | #211 |
| purified protein derivative | #211 |
| glucose6 phosphate | #211 |
| cells immobilized | #212 |
| large numbers | #212 |
| association rheumatoid arthritis | #212 |
| mice injected | #213 |
| antibody binding | #213 |
| psoriasiform | #213 |
| tsst1 | #214 |
| mhc class antigens | #215 |
| triethylsilane | #215 |
| antigen induced | #215 |
| central tolerance | #215 |
| inbred rat | #215 |
| cytofluorometric | #215 |
| training hiit | #216 |
| dissect | #216 |
| lower level | #216 |
| joints mice | #217 |
| lentiviral vector | #217 |
| induced autoimmune | #217 |
| cd23 | #217 |
| rats immunization | #217 |
| resistant strain | #217 |
| inflammatory infiltrates | #217 |
| antigen tcell | #218 |
| treatment onset | #218 |
| peptide antibodies | #219 |
| k8 | #219 |
| fcrγ | #219 |
| granuloma formation | #219 |
| autoimmunity | #219 |
| hyl | #220 |
| bone erosions | #220 |
| peptidylarginine deiminases | #220 |
| cells autoimmune | #220 |
| rheumatoid factor | #221 |
| redox signaling | #221 |
| cells dendritic | #221 |
| fine specificity | #221 |
| cyclosporin treatment | #221 |
| agouti rats | #221 |
| pinealectomy | #221 |
| targeted deletion | #221 |
| monoclonal antigens differentiation | #222 |
| thymectomized | #222 |
| cartilage damage | #222 |
| cybb | #222 |
| wkymvm | #222 |
| igg2a | #223 |
| carbamylated | #223 |
| experimental autoimmune neuritis | #223 |
| multiplex | #223 |
| inflammation vivo | #224 |
| expressing | #224 |
| clinical scoring | #225 |
| interleukin‐10 | #225 |
| established disease | #225 |
| cells antigen | #225 |
| lew | #225 |
| pathogenic antibodies | #226 |
| disease locus | #226 |
| j1 | #227 |
| macrophagelike cells | #227 |
| arthritis objective | #228 |
| delayed type hypersensitivity | #228 |
| presenting cells | #228 |
| cell selection | #229 |
| presence anti | #229 |
| site inflammation | #230 |
| eae rats | #230 |
| human rheumatoid | #231 |
| ls1 | #231 |
| reactive oxygen | #232 |
| monoclonal immunohistochemistry | #232 |
| lack expression | #233 |
| production ros | #233 |
| ameliorated | #233 |
| synovial joints | #233 |
| role eosinophils | #233 |
| centimorgan | #234 |
| lower numbers | #234 |
| chromosome 14 | #235 |
| staphylococcal infection | #235 |
| chronic psychosocial stress | #235 |
| mhc gene | #235 |
| immune complex | #236 |
| specificity animals | #236 |
| control strain | #237 |
| pathological mechanisms | #237 |
| progression arthritis | #238 |
| autoimmune chronic | #238 |
| trait locus | #239 |
| c5 | #239 |
| inbred dba tlymphocytes | #240 |
| study plasma | #241 |
| joint pain | #242 |
| strong influence | #242 |
| multicomponent | #243 |
| monoclonal antigen | #243 |
| protected | #243 |
| positive anti | #243 |
| class genetic | #243 |
| hla drb1 | #243 |
| inflammation cartilage | #244 |
| common denominator | #244 |
| crosses | #244 |
| cutaneous infection | #244 |
| estrus cycle | #244 |
| treatment autoimmune | #244 |
| binding antibodies | #245 |
| rt1l | #246 |
| allelic differences | #246 |
| development emphysema | #246 |
| new model | #247 |
| normal cartilage | #247 |
| antibodies anti | #247 |
| inbred strain | #247 |
| florescence | #247 |
| antibody response | #247 |
| activity assays | #248 |
| efficient expression | #248 |
| induced chronic | #249 |
| oxygen species | #249 |
| mouse rat | #250 |
| node cells | #250 |
| arthritic joints | #250 |
| inflammation score | #250 |
| fragments rats | #250 |
| picryl | #250 |
| develops | #251 |
| conditional knockout mice | #251 |
| treatment rats | #251 |
| hyperinflammation | #251 |
| nadph oxidase | #251 |
| response disease | #252 |
| mice lymphocytes | #252 |
| mice lack | #252 |
| role model | #252 |
| dark agouti | #252 |
| proteins glycoproteins | #254 |
| dinitrofluorobenzene | #254 |
| class mhc | #254 |
| onset clinical | #254 |
| lpr mice | #254 |
| cartilage matrix | #254 |
| lacking | #254 |
| autoimmune response | #255 |
| inbred c3h | #255 |
| postmenopausal bone | #256 |
| specific subgroups | #256 |
| specific neutralizing | #256 |
| anti arthritic | #256 |
| inflammatory disorder | #256 |
| disease cell | #257 |
| additive interaction | #258 |
| class mhc molecules | #259 |
| chronic granulomatous | #260 |
| relationship immunologic | #260 |
| mir144 | #260 |
| lymphocytes helper | #261 |
| mice expressing | #261 |
| mediated suppression | #261 |
| autoimmune neuritis | #261 |
| secondary osteoporosis | #261 |
| denatured | #261 |
| immunologic animals | #262 |
| selfantigen | #263 |
| pregnancy mice | #265 |
| primary immunization | #265 |
| mouse strain | #265 |
| genetic techniques | #265 |
| tolerance mice | #265 |
| crossreactive | #265 |
| rats animals | #267 |
| vim2 | #267 |
| cysteine proteases | #267 |
| antigen specific | #267 |
| xid | #268 |
| lentiviral gene | #268 |
| posttranslational modifications | #268 |
| pathogenic roles | #269 |
| mann whitney | #269 |
| oxpl | #270 |
| complement c5 | #270 |
| melatonin effects | #271 |
| monosodium urate crystals | #271 |
| selfantigens | #271 |
| castrated | #271 |
| amino acid transporters | #273 |
| experimental model | #273 |
| lewis rats | #274 |
| nasally | #275 |
| tcells | #275 |
| hdac1 | #275 |
| inhibitory peptide | #275 |
| synovial lining | #275 |
| fcgr3b | #276 |
| macrophages dendritic cells | #276 |
| viral female hepatitis | #277 |
| deiminase type | #277 |
| producing cells | #277 |
| rheumatoid arthritis association | #277 |
| recognize | #278 |
| metabolic properties | #278 |
| interferongamma | #279 |
| gp70 | #279 |
| colon length | #279 |
| induced tolerance | #280 |
| dinucleotide phosphate | #280 |
| neonatal mice | #281 |
| recipient mice | #281 |
| inflammatory conditions | #281 |
| passive transfer | #281 |
| immunological receptors antigen | #281 |
| hemiacetal | #282 |
| disease susceptibility | #283 |
| isoflavone genistein | #283 |
| igg2b | #283 |
| factor production | #283 |
| inbred nod | #283 |
| aire | #284 |
| increased serum levels | #284 |
| helper inducer | #284 |
| severe colitis | #284 |
| publication animals antibodies | #285 |
| idiotope | #285 |
| endophilin | #285 |
| aureus strain | #285 |
| complete protection | #285 |
| maintained | #285 |
| theilovirus | #285 |
| emulsified | #286 |
| hla dr2 | #287 |
| melatonin mice | #288 |
| antibody production | #288 |
| melatonin release | #288 |
| myelin basic protein | #288 |
| tlr9 mice | #288 |
| mice immunized | #289 |
| cells autoimmunity | #289 |
| disease cells | #291 |
| synovial cells | #291 |
| ctla4 expression | #291 |
| autoimmune mechanisms | #292 |
| rheumatic conditions | #292 |
| induced ros | #293 |
| collagen receptors | #293 |
| increased copy | #293 |
| cytokines disease | #293 |
| unique model | #294 |
| mouse genes | #294 |
| c57bl 6 mice | #295 |
| antigen processing | #295 |
| c3h | #295 |
| gastric parietal | #295 |
| tissue‐specific | #296 |
| immunological receptors | #296 |
| 6week | #296 |
| nerve conduction | #296 |
| helical peptides | #297 |
| phosphopyruvate | #297 |
| dnfb | #297 |
| murine dendritic cells | #297 |
| cd19 cells | #298 |
| vivo imaging | #298 |
| gene selection | #298 |
| ppad | #298 |
| citrullination | #299 |
| transplantation antigens | #299 |
| solidphase synthesis | #299 |
| tcr beta | #300 |
| posttranslational rats | #301 |
| neutrophil extracellular traps | #301 |
| extraembryonic tissues | #302 |
| draining lymph | #302 |
| peptide antibody | #302 |
| alphabeta | #302 |
| 1 interferon | #303 |
| pathogeneses | #303 |
| animals antibodies | #303 |
| epidemiological investigation | #303 |
| strains mice | #303 |
| igg glycosylation | #304 |
| conditioned disease models | #304 |
| autoimmune diseases | #304 |
| cgd | #304 |
| cartilage development | #305 |
| immunological function | #305 |
| cells tcr | #305 |
| mutant strains mice | #305 |
| immunological studies | #306 |
| αgalcer | #306 |
| gammaifn | #306 |
| murine colitis | #306 |
| hcdr3 | #306 |
| class histocompatibility | #307 |
| inpp4b | #307 |
| immunisation | #307 |
| basal metabolic rate | #308 |
| chromosome 10 | #309 |
| basal metabolic | #309 |
| articular cattle cells | #310 |
| arthritis study | #310 |
| multiple sclerosis eae | #311 |
| perpetuation | #311 |
| inflamed joints | #312 |
| synthetic peptide | #312 |
| alleles animals | #312 |
| disease symptoms | #312 |
| epitopes | #313 |
| exuberant | #313 |
| c3bi | #313 |
| induced colitis | #314 |
| activatory | #314 |
| intradermally | #315 |
| mice genes | #315 |
| r620w | #315 |
| trypanosoma brucei brucei | #316 |
| onset rheumatoid | #318 |
| classical risk factors | #318 |
| genetic interactions | #319 |
| galactosyl | #319 |
| tubule cells | #319 |
| deiminase | #320 |
| genomewide linkage analysis | #320 |
| spleen bone marrow | #320 |
| mice subjected | #320 |
| il21r | #323 |
| cells specific | #323 |
| impact disease | #324 |
| expressing human | #324 |
| daf2 | #324 |
| ccp1 | #324 |
| specific cell | #325 |
| expression cells | #325 |
| rat gene | #325 |
| surprisingly | #326 |
| mgps | #327 |
| resembles | #327 |
| c57bl mice | #328 |
| allelic variant | #328 |
| publication adjuvants | #329 |
| immunoenzyme | #329 |
| constant light | #329 |
| complex genes | #330 |
| early arthritis | #331 |
| nucleotide polymorphism | #332 |
| fcgammariia | #332 |
| glycoprotein mog | #332 |
| rheumatoid synovial | #332 |
| anticcp | #333 |
| mouse hepatitis virus | #333 |
| 35ssulfate | #334 |
| susceptibility genes | #335 |
| joint tissues | #335 |
| mrl lpr mice | #335 |
| autoimmune inflammation | #336 |
| cell response | #338 |
| epitope specificity | #340 |
| cells spleen | #340 |
| delayed onset | #340 |
| erosive | #341 |
| rat | #341 |
| adjuvants immunologic | #341 |
| ros oxygen species | #341 |
| activation macrophages | #341 |
| incident cardiovascular events | #342 |
| specific autoimmune | #342 |
| 6weeks | #342 |
| animal enzyme inhibitors | #342 |
| diabetic mouse | #343 |
| rats injection | #343 |
| sequence animals | #343 |
| drb1 alleles | #343 |
| rapid spread | #343 |
| 182780 | #344 |
| monoclonals | #344 |
| favor | #345 |
| acpa positivity | #345 |
| energetic costs | #346 |
| intraperitoneal injection | #347 |
| pemphigus vulgaris pv | #348 |
| neuritis | #349 |
| complement activity | #349 |
| reduced capacity | #349 |
| igg autoantibodies | #350 |
| phenotype rats | #351 |
| thymic selection | #352 |
| methylcholanthrene | #352 |
| anti cyclic | #353 |
| immunoregulation | #353 |
| mice induction | #353 |
| c3h hej | #353 |
| autoantigens autoimmune | #354 |
| arthritis synovial | #354 |
| mice cd4 | #354 |
| splenic macrophages | #355 |
| dsg3 | #357 |
| cells autoantibodies | #358 |
| adjuvant activity | #358 |
| tbetarii | #358 |
| enos | #359 |
| injected | #359 |
| neuritogenic | #359 |
| tcrbeta | #360 |
| tlr3 | #361 |
| pvg | #361 |
| freund | #361 |
| murine lupus | #362 |
| hla transgenic | #362 |
| determines | #363 |
| mouse chromosome | #363 |
| identification genes | #363 |
| allergic encephalomyelitis | #363 |
| generation ros | #363 |
| recognized | #364 |
| hladr4 | #364 |
| cells anti | #364 |
| european journal | #366 |
| sex chromosomes | #366 |
| glycoproteins mice | #366 |
| immune deviation | #366 |
| psychosocial stress | #367 |
| antiidiotypic antibodies | #367 |
| 100 micrograms | #368 |
| affinity ligand | #368 |
| loci | #368 |
| toxic shock | #368 |
| autoimmune responses | #368 |
| ncf2 | #368 |
| nasal administration | #369 |
| histocompatibility antigens | #369 |
| pentameric | #369 |
| immune pathogenesis | #370 |
| increased production | #370 |
| serum transfer | #371 |
| clinical onset | #371 |
| regulate | #371 |
| newborn antibodies | #372 |
| role mif | #372 |
| alternative activation | #373 |
| autoantigens | #375 |
| rheumatoid cell | #375 |
| acutephase proteins | #376 |
| undifferentiated arthritis | #376 |
| glucose6 | #377 |
| gia | #379 |
| reparixin | #380 |
| induced lupus | #381 |
| mouse monoclonal antibody | #381 |
| oxidase deficiency | #381 |
| fragments immunoglobulin | #382 |
| fia | #382 |
| granulomatous | #383 |
| specific loci | #384 |
| granulomatous disease | #384 |
| naive rats | #384 |
| c1a | #384 |
| postmenopausal bone loss | #385 |
| shock syndrome | #385 |
| cell specificity | #386 |
| pc4 | #386 |
| ptpn22 gene | #387 |
| backcrosses | #387 |
| antioxid | #387 |
| filaggrin | #387 |
| inbred nod receptors | #388 |
| phase response | #388 |
| downregulating | #389 |
| ovulation rate | #390 |
| deficient | #390 |
| greater 50 | #390 |
| radiological progression | #391 |
| peptidylarginine | #391 |
| anaphylatoxin c5a | #391 |
| finetune | #392 |
| il4 il10 | #394 |
| rf1 | #394 |
| ameliorating | #395 |
| autoantibody levels | #397 |
| induced metabolic | #397 |
| draining | #397 |
| juvenile chronic arthritis | #398 |
| regulation animals | #399 |
| immunized mice | #399 |
| protein myelin | #399 |
| inflammatory reactions | #400 |
| reactive oxygen species | #400 |
| antibody formation | #401 |
| genes cells | #401 |
| inflammation demyelination | #403 |
| immunopeptidome | #403 |
| biacore | #403 |
| beta chain | #404 |
| fcγriib | #404 |
| basic protein | #405 |
| experimental | #405 |
| effects models | #407 |
| n31 | #407 |
| rheumatoid case | #407 |
| pam3csk4 | #408 |
| immunogenetics | #409 |
| major locus | #409 |
| intracellular processing | #410 |
| diabetes loci | #410 |
| 3hproline | #410 |
| cd43 | #412 |
| cell phenotypes | #412 |
| hladrb1 | #412 |
| susceptibility loci | #413 |
| titres | #413 |
| characteristic feature | #414 |
| reproductive performance | #414 |
| cultured collagen | #415 |
| igk | #415 |
| levels autoantibodies | #416 |
| female mice | #416 |
| synovial inflammation | #417 |
| spontaneous mutation | #417 |
| lupus mice | #417 |
| genetically modified mice | #418 |
| molecular interactions | #419 |
| class hdacs | #419 |
| wtccc | #419 |
| induced pain | #419 |
| hiit | #420 |
| ameliorate | #420 |
| tcell | #421 |
| dr4 | #422 |
| lower affinity | #422 |
| lipidomic | #423 |
| subsets animals | #424 |
| restricted | #424 |
| hyaline cartilage | #425 |
| inflammatory cells | #426 |
| congenic strain | #426 |
| regulatory animals | #426 |
| carbohydrate moiety | #429 |
| nod mouse | #430 |
| postimmunization | #430 |
| epitopes humans | #430 |
| nonimmunogenic | #430 |
| immunoregulatory | #431 |
| patients healthy individuals | #433 |
| il10 mice | #433 |
| cells antibodies | #434 |
| factor 5 | #435 |
| spontaneous autoimmune | #435 |
| reactivities | #436 |
| cells beta | #436 |
| mass spectrometric analysis | #437 |
| decalcified | #437 |
| crystallizable | #437 |
| chromosomes chromosome | #437 |
| helperinducer tlymphocytes | #438 |
| specific antigens | #438 |
| immunised | #438 |
| mice effects | #438 |
| cells | #439 |
| joint swelling | #439 |
| wildtype mice | #440 |
| nod | #440 |
| effector functions | #441 |
| female immunoglobulin | #441 |
| vitro techniques leukocytes | #441 |
| normal rats rats | #441 |
| patients population | #442 |
| mice activation | #442 |
| complete adjuvant | #442 |
| methylβcyclodextrin | #443 |
| mhc class molecules | #443 |
| myelin basic | #444 |
| tlr2 expression | #444 |
| mice humans | #445 |
| skeletal muscle function | #445 |
| mouse models | #445 |
| genomewide scan | #445 |
| systemic mice | #445 |
| ros production | #447 |
| pain model | #448 |
| inbred strains receptors | #448 |
| induced mice | #448 |
| control mice | #448 |
| complement factor | #449 |
| tcell responses | #449 |
| synovial tissue | #449 |
| innate adaptive | #450 |
| apcs | #451 |
| igg anti | #451 |
| reduced production | #452 |
| heterologous | #452 |
| hybridoma cells | #452 |
| differs | #454 |
| cells chronic | #456 |
| lglutamine | #456 |
| raloxifene | #457 |
| inbred c57bl tlymphocytes | #457 |
| priming | #459 |
| eae cns | #459 |
| rheumatoid cells | #459 |
| lung macrophages | #459 |
| resembling | #459 |
| antibodies monoclonal | #460 |
| 256 | #462 |
| neutrophil functions | #462 |
| autoantigen | #462 |
| gilt | #463 |
| fab fragments | #464 |
| autoantibody production | #465 |
| salivary glands | #466 |
| receptor tcr | #466 |
| cells lymph | #467 |
| earlier onset | #469 |
| titers | #469 |
| antibody mediated | #474 |
| anticyclic citrullinated peptide | #474 |
| disease mice | #474 |
| arthritic rats | #474 |
| cartilage cells | #475 |
| human autoimmune | #476 |
| cluster genes | #477 |
| mice exhibited | #477 |
| mediated inflammation | #478 |
| therapeutic vaccination | #478 |
| laboratory rat | #479 |
| apoptosis arthritis | #479 |
| female hla | #479 |
| quantitative trait loci | #480 |
| deacetylase 1 | #480 |
| aggravated | #480 |
| anti idiotypic | #482 |
| polymorphonuclear cells | #482 |
| immune reactions | #484 |
| immunologists | #485 |
| immunoglobulin male | #486 |
| oxyntic | #487 |
| controlling | #487 |
| jca | #487 |
| tcralpha | #487 |
| insulitis | #488 |
| specific immune | #488 |
| invariant natural | #488 |
| gland animals | #489 |
| normal mice | #490 |
| cytoplasmic calcium | #494 |
| nacetylglucosaminidase | #495 |
| h2b | #496 |
| conclude | #496 |
| gammadelta cells | #496 |
| reactive nitrogen | #496 |
| early rheumatoid | #496 |
| small effects | #498 |
| mbp | #498 |
| receptor 9 | #499 |
| biologicals | #500 |
| immunoenzyme techniques | #503 |
| nadph | #503 |
| autoreactive cd4 | #503 |
| pathogenic | #506 |
| chondrocytes collagen | #507 |
| immunofluorescence analysis | #507 |
| isopropyl | #508 |
| persistent pain | #508 |
| mineral oil | #508 |
| mab mabs | #508 |
| orosomucoid | #509 |
| immunization passive | #509 |
| gingipain | #509 |
| mhc class | #510 |
| mice knockout mice | #510 |
| differential gene | #511 |
| deficient mice | #511 |
| systemic spread | #511 |
| c3h hej mice | #511 |
| 812 | #511 |
| blymphocytes | #512 |
| mrp8 | #515 |
| behavioral alterations | #517 |
| hydroxyquinolines | #517 |
| antibody complex | #518 |
| u1 | #518 |
| inflammation | #519 |
| chronic granulomatous disease | #519 |
| suggestive linkage | #519 |
| tcr recognition | #520 |
| modified form | #521 |
| pcorr | #522 |
| ttg | #522 |
| dextran sulfate sodium | #522 |
| data peptide | #523 |
| inflammation role | #523 |
| p47phox | #524 |
| litter size | #524 |
| encephalitogenic | #524 |
| neutrophil granulocytes | #525 |
| mnc | #526 |
| mechanical hypersensitivity | #526 |
| tconv | #526 |
| disease acute | #527 |
| spleen cells | #527 |
| maternal antibodies | #527 |
| primed | #528 |
| tolonium | #528 |
| vaccinates | #528 |
| larsen | #528 |
| rat rats | #529 |
| ifa | #529 |
| tolllike receptor tlr4 | #529 |
| displayed | #529 |
| pathogenesis sle | #530 |
| antigen presentation | #530 |
| autoantibody | #530 |
| isac | #530 |
| cell antibodies | #530 |
| ratg | #531 |
| epistatic | #532 |
| bred | #532 |
| lyt2 | #533 |
| complex role | #533 |
| posttranslational receptors | #534 |
| spleen lymphocytes | #536 |
| resorptions | #536 |
| translational modification | #536 |
| urokinase | #537 |
| synovial | #537 |
| animals | #538 |
| experimental rats | #538 |
| cells inflammatory | #538 |
| fibroblast synoviocytes | #540 |
| suppressive | #540 |
| antigen recognition | #540 |
| joints | #540 |
| membrane attack complex | #541 |
| rheumatoid humans | #543 |
| specific autoantibodies | #544 |
| protein tyrosine phosphatase | #545 |
| regulating | #545 |
| hypomorphic | #546 |
| shortcut | #547 |
| tlymphocytes | #547 |
| animal gene | #547 |
| formyl peptide receptors | #548 |
| immunohistochemical methods | #548 |
| entheses | #548 |
| mog | #550 |
| immunoglobulin fab | #552 |
| mixed lymphocyte reaction | #553 |
| nox activity | #554 |
| breeder | #555 |
| beta animals | #557 |
| cell epitopes | #557 |
| stronger association | #557 |
| cells control | #558 |
| early onset | #559 |
| healthy mice | #560 |
| elispot assay | #561 |
| transgenic molecular | #562 |
| negative selection | #563 |
| ptdins3p | #563 |
| inbred strains | #563 |
| neutrophil depletion | #564 |
| deeper layers | #565 |
| therapeutic treatment | #565 |
| immunoglobulin heavy chains | #566 |
| target tissue | #566 |
| darkness | #566 |
| earlier | #566 |
| crucial | #567 |
| disease loci | #568 |
| outbred | #568 |
| interferon signature | #568 |
| mycobacteria | #569 |
| cells pathogenesis | #569 |
| neutrophilia | #569 |
| concomitantly | #570 |
| mice compared | #571 |
| transgenic mouse models | #572 |
| btla | #572 |
| keratin8 | #573 |
| col2 | #574 |
| pepstatins | #576 |
| presenting | #576 |
| estrogen treatment | #577 |
| terpenes | #577 |
| prolactin prl | #578 |
| keratinocyte growth factor | #578 |
| sera patients | #579 |
| ptm | #579 |
| triple helix | #580 |
| f1 hybrids | #581 |
| methotrexate mice | #581 |
| production ifngamma | #583 |
| hybridoma | #583 |
| inflammatory joint | #583 |
| exaggerated | #584 |
| lymphocyte antigens | #584 |
| time onset | #584 |
| antibody reactions | #585 |
| traps nets | #590 |
| environmental triggers | #591 |
| antigen antibody | #591 |
| oligoclonal | #592 |
| lxrα | #592 |
| immunological tolerance | #592 |
| noncollagenous | #593 |
| transgenic models | #593 |
| macrophages | #594 |
| adaptive immunity | #594 |
| autoimmune disorders | #594 |
| th1 cytokines | #595 |
| multiplexing | #595 |
| clonal expansion | #595 |
| xanthine oxidoreductase | #596 |
| cells study | #599 |
| tcell activation | #599 |
| develop | #600 |
| th2 cytokines | #602 |
| augmented | #602 |
| spite | #602 |
| n85 | #602 |
| pemphigus vulgaris | #603 |
| common diseases | #603 |
| mouse monoclonal | #603 |
| cells male | #604 |
| cells involved | #604 |
| phagosomal | #604 |
| mice inbred | #606 |
| animal rats | #606 |
| oxa | #606 |
| class humans | #607 |
| genotype hla | #608 |
| frozen sections | #608 |
| spleen animals | #609 |
| inefficiently | #610 |
| regulatory role | #610 |
| production ifn | #611 |
| naive | #611 |
| positive individuals | #612 |
| quantitative trait locus | #615 |
| acetophenones | #616 |
| autoantibodies | #616 |
| idiotypic | #616 |
| mutant strains receptors | #616 |
| exponential phase | #616 |
| alpha chains | #616 |
| th1 type | #616 |
| class antigens | #616 |
| oral immunization | #617 |
| nonobese | #617 |
| beta type | #618 |
| day mice | #619 |
| wistar restraint | #620 |
| promiscuous | #620 |
| inflammatory role | #621 |
| receptor 3 | #621 |
| consequent | #621 |
| nicotinamide adenine | #622 |
| fluorine18 | #624 |
| receptors antigen | #624 |
| chronic stage | #625 |
| loci identified | #625 |
| animal mice | #628 |
| cytoplasmic ca2 | #628 |
| local injection | #629 |
| cross reactions | #630 |
| inflammatory disease | #630 |
| healthy rats | #632 |
| reactive antibodies | #632 |
| development eae | #633 |
| highintensity interval training | #634 |
| fibromodulin | #634 |
| langerhans cells | #635 |
| vivo binding | #635 |
| ifn beta | #637 |
| nabs | #637 |
| class genes | #638 |
| cells inhibition | #638 |
| inflammation autoimmunity | #640 |
| estrogens female | #640 |
| biotinylated | #643 |
| mouse lung | #644 |
| cell binding | #645 |
| immune serum | #646 |
| haplotype | #649 |
| antigen specificity | #650 |
| patients sera | #650 |
| genetic disease | #652 |
| hexadecane | #654 |
| idiotypic antibodies | #654 |
| antibody titres | #655 |
| interphalangeal | #655 |
| genetic linkage | #658 |
| new pathway | #658 |
| axotomized | #659 |
| cyba | #660 |
| sialoprotein | #660 |
| peptide binding | #661 |
| inbred cba mice | #661 |
| acute inflammation | #661 |
| mutated | #662 |
| cartilage destruction | #663 |
| ifng | #664 |
| animal ear | #665 |
| delayed hypersensitivity | #665 |
| superantigens | #666 |
| 264 | #666 |
| receptors igg | #666 |
| lymphoid organs | #666 |
| reactive | #666 |
| activation mice | #669 |
| apeced | #670 |
| drb1 | #670 |
| disease autoimmune | #671 |
| purified proteins | #673 |
| cells induce | #674 |
| treatment protocol | #674 |
| pyramidal neurons | #675 |
| desmoglein | #675 |
| genetic epistasis | #675 |
| strikingly | #676 |
| adherent cells | #677 |
| idiotypes | #677 |
| germinal center | #677 |
| china cohort | #678 |
| igg response | #679 |
| il12p70 | #679 |
| major genes | #679 |
| thelper | #680 |
| lymphocytes mice | #682 |
| cells role | #682 |
| puzzle | #683 |
| normal animals | #683 |
| inbred c57bl mice | #683 |
| specific antibody | #684 |
| helper cell | #684 |
| intradermal injection | #686 |
| transgenic receptors | #687 |
| βarrestin | #688 |
| subsets | #689 |
| delayed | #689 |
| foot joints | #689 |
| rendered | #690 |
| early rheumatoid arthritis | #690 |
| production autoantibodies | #691 |
| disease genes | #692 |
| muscle glucose | #695 |
| knockout polymorphism | #695 |
| paam | #696 |
| igg antibodies | #696 |
| anas | #697 |
| luminex | #697 |
| disease hla | #698 |
| mice model | #698 |
| uterus | #700 |
| heavy chain genes | #701 |
| microspectroscopy | #703 |
| inbred | #704 |
| quantitative trait | #704 |
| complete freund | #706 |
| fibroblastlike synoviocytes | #707 |
| histopathological analysis | #707 |
| extracellular trap | #708 |
| estradiol female | #710 |
| specific cells | #710 |
| igl | #712 |
| posttranslational | #713 |
| spleens | #716 |
| predetermined | #716 |
| mice lacking | #717 |
| antibodies patients | #718 |
| acute bout | #718 |
| lymphocyte depletion | #719 |
| regulatory function | #720 |
| proliferative response | #720 |
| buf | #721 |
| deficiency syndromes | #721 |
| surrounding tissues | #722 |
| th1 th17 | #723 |
| human hand | #725 |
| macrophages mice mice | #725 |
| dmaema | #728 |
| cd1d | #728 |
| th2 cytokine | #729 |
| mhc molecules | #729 |
| ccps | #729 |
| cdk6 | #730 |
| administrated | #732 |
| animals antigens antigens | #732 |
| cholesterol metabolism | #732 |
| cns inflammation | #732 |
| excessive inflammation | #734 |
| finding | #735 |
| rats treatment | #736 |
| net formation | #736 |
| locus | #737 |
| cheeks | #739 |
| c57bl | #740 |
| operates | #740 |
| cd5 cells | #741 |
| species specificity | #741 |
| tissue destruction | #742 |
| nkt | #742 |
| vivo mice | #743 |
| immunologic deficiency | #743 |
| cell responses | #743 |
| treatment anti | #744 |
| role disease | #746 |
| mycobacterial infections | #747 |
| nonobese diabetic mice | #749 |
| intensity interval | #749 |
| autoantibodies autoimmunity | #749 |
| keratinocyte | #749 |
| preclinical phase | #751 |
| transferred | #751 |
| control disease | #753 |
| hapten | #755 |
| metabolomic | #755 |
| ere | #755 |
| tlr activation | #755 |
| mice anti | #757 |
| autoantibodies type | #758 |
| phenotypic differences | #758 |
| disease protection | #758 |
| hyperinflammatory | #759 |
| reacted | #759 |
| knockout tlymphocytes | #760 |
| linkage region | #760 |
| ifngamma production | #761 |
| ccp | #761 |
| polycytidylic | #762 |
| immunocap | #763 |
| gamma ifn | #765 |
| glut4 translocation | #767 |
| periarticular | #772 |
| redox signal | #773 |
| cells apcs | #773 |
| hkexchanging | #773 |
| peripheral tolerance | #774 |
| afflicted | #777 |
| diseases cell | #778 |
| fab fragment | #778 |
| interacted | #779 |
| inbred nzb | #780 |
| acid transporters | #781 |
| pathogenic role | #782 |
| nox1 | #782 |
| development autoimmunity | #782 |
| arthritis osteoarthritis | #782 |
| arthritis psa | #783 |
| chronic colitis | #784 |
| clinical scores | #786 |
| transgenic mutation | #789 |
| reduced incidence | #790 |
| peptide fragments | #790 |
| inflammatory lesions | #790 |
| transgenic receptors antigen | #790 |
| pineal gland | #791 |
| polyarthritis | #792 |
| cell gamma | #793 |
| cell humans | #794 |
| antibodies directed | #794 |
| interval training | #796 |
| neutrophil function | #796 |
| neutrophil extracellular | #796 |
| pathogen free | #797 |
| genes immunoglobulin | #798 |
| lymphocyte proliferation | #798 |
| carbohydrate moieties | #800 |
| matrix proteins | #801 |
| polyi | #801 |
| thy1 | #802 |
| blymphocyte chain genes | #802 |
| innate adaptive immunity | #802 |
| monoclonal binding | #802 |
| redox control | #805 |
| count male | #805 |
| helper cells | #805 |
| induces | #805 |
| multinucleated giant cells | #808 |
| backcrossing | #809 |
| bone erosion | #810 |
| function mutation | #811 |
| catabolism | #811 |
| acc1 | #812 |
| strains receptors | #812 |
| resident cells | #812 |
| febuxostat | #813 |
| nonreceptor type | #815 |
| arginines | #817 |
| ctb | #817 |
| leads | #820 |
| auricle | #820 |
| collagen cross | #821 |
| cd8 antigens | #821 |
| leukocyte infiltration | #822 |
| piece | #823 |
| electroporated | #824 |
| humoral immune response | #824 |
| colocalizes | #824 |
| prominently | #825 |
| psoriasis psoriatic arthritis | #825 |
| genetic environmental | #825 |
| muscle training | #826 |
| response animals | #826 |
| chondroid | #827 |
| class antigen | #829 |
| growth factor beta | #829 |
| producing | #830 |
| effects immune | #830 |
| cross reactivity | #834 |
| inbred c57bl | #841 |
| lpr | #841 |
| peyers patches | #842 |
| immunoglobulin mice | #842 |
| therapeutic approaches | #844 |
| diabetic nod | #844 |
| chronic active | #845 |
| il25 | #845 |
| inflammatory arthritis | #846 |
| mice transgenic | #846 |
| induce | #848 |
| intermingled | #850 |
| macroscopically | #851 |
| lymphocyte | #852 |
| antigen cell | #852 |
| new possibilities | #854 |
| leukocyte migration | #854 |
| ms275 | #855 |
| tcell receptors antigen | #855 |
| importantly | #856 |
| strongest association | #856 |
| alveolar mice mice | #856 |
| mcv | #858 |
| post translational | #861 |
| immune defence | #862 |
| treatment reduced | #865 |
| lyme | #866 |
| factor anti | #867 |
| mice reduced | #867 |
| knockin mice | #867 |
| mediated inflammatory | #867 |
| cross reactive | #868 |
| strongest | #868 |
| lentiviral | #869 |
| hinge region | #869 |
| parietal cells | #869 |
| lnc | #872 |
| dextran sulfate | #873 |
| immune tolerance | #873 |
| lower expression | #874 |
| parasitemia | #874 |
| elisas | #875 |
| cells expressing | #876 |
| granulomas | #877 |
| synovial fluid patients | #878 |
| fcγri | #878 |
| arthritis inflammatory | #879 |
| adoptive | #881 |
| antigen4 | #881 |
| systemic autoimmune diseases | #882 |
| pregnancy animal | #882 |
| testosterone treatment | #883 |
| fluid synovial | #884 |
| cartilaginous | #888 |
| standard therapies | #890 |
| psoriasis vulgaris | #891 |
| genetic dissection | #891 |
| basic | #893 |
| regulator | #895 |
| completely | #896 |
| intranasal administration | #897 |
| inflammation mediators | #897 |
| ctla4 antigen | #898 |
| interleukin1alpha | #898 |
| phosphatase receptor | #902 |
| granulocytes | #904 |
| partly | #904 |
| inception cohort | #905 |
| infiltrations | #906 |
| γδ cells | #906 |
| rats inbred | #907 |
| lipocalins | #908 |
| extracellular traps | #909 |
| immunohistochemical analyses | #910 |
| single injection | #911 |
| liu | #911 |
| immunoglobulin levels | #911 |
| chromosome 16 | #912 |
| mitochondrial ros | #913 |
| lectin pathway | #913 |
| pneumonitis | #914 |
| ciita | #914 |
| allelic variation | #915 |
| proliferate | #915 |
| enolase | #915 |
| immunemediated diseases | #916 |
| cytokine response | #923 |
| psoriatic arthritis psa | #924 |
| antibodies antibody | #924 |
| neutrophil chemotaxis | #924 |
| fluorobenzene | #925 |
| chromosome mapping | #925 |
| cd200 | #925 |
| nkt cells | #926 |
| phenotypic analysis | #926 |
| repertoires | #929 |
| burst | #930 |
| tissue transglutaminase | #931 |
| data role | #932 |
| citrulline | #933 |
| hydratase | #933 |
| alpha animals | #935 |
| macropinocytosis | #936 |
| alters | #937 |
| lymphocyte activation | #938 |
| arthritides | #938 |
| 1040 | #939 |
| synovia | #939 |
| analysed | #940 |
| rns | #940 |
| immune reactivity | #940 |
| vitro stimulation | #941 |
| disease model | #941 |
| genetic analysis | #941 |
| collagen structure | #941 |
| mediated autoimmune | #944 |
| association hla | #945 |
| sciatic nerves | #945 |
| mice mice | #947 |
| fluid patients | #948 |
| inflammatory pathways | #948 |
| clinical observations | #948 |
| humanized mice | #949 |
| vivo | #950 |
| riii | #950 |
| l3t4 | #954 |
| environmental determinants | #955 |
| nos1 | #957 |
| carrying | #958 |
| differentiation tlymphocyte antigens | #959 |
| levels ros | #962 |
| mhc peptide | #962 |
| chronic disease | #963 |
| cellular immunization | #965 |
| animals cytokines | #967 |
| cytotoxic tlymphocytes | #967 |
| monoclonal antigens | #967 |
| cells lymphocytes | #967 |
| lower frequency | #969 |
| cell transfer | #969 |
| chromosome 15 | #971 |
| draining lymph nodes | #972 |
| secreting cells | #973 |
| susceptibility locus | #978 |
| cartilage articular | #979 |
| synovial membrane | #981 |
| genes chromosome | #982 |
| lymphocytes | #982 |
| w5 | #982 |
| binding peptides | #983 |
| pain behavior | #984 |
| tbb | #987 |
| tallele | #988 |
| microspectrophotometry | #990 |
| knockout models | #991 |
| macrophages cells | #991 |
| immunodominance | #992 |
| allergic contact dermatitis | #992 |
| cells reactive | #993 |
| 510 | #994 |
| patients rp | #994 |
| transgenic expression | #994 |
| cartilage bone | #995 |
| hej | #995 |
| spontaneously | #997 |
| formyl peptide | #997 |
| knee joints | #997 |
| laminin fibronectin | #998 |
| antigen expression | #999 |
| immunoglobulin fragments | #1000 |
| lymphocyte subpopulations | #1002 |
| multiple loci | #1003 |
| expands | #1004 |
| aggravate | #1004 |
| processing presentation | #1004 |
| protective role | #1007 |
| igg subclasses | #1011 |
| cyclic peptides | #1012 |
| nrc | #1012 |
| interleukin21 | #1013 |
| 95 stroke | #1013 |
| direct comparison | #1015 |
| model multiple | #1015 |
| igg | #1015 |
| cells mast | #1016 |
| cellular composition | #1016 |
| nerve roots | #1016 |
| aged arthritis | #1017 |
| melatonin levels | #1019 |
| patients early | #1019 |
| cd4 antigens | #1020 |
| immunoglobulin variable | #1022 |
| cysteine protease | #1025 |
| diseases animals | #1026 |
| genetic humans | #1027 |
| innate killer cells | #1028 |
| il4 | #1029 |
| dr1 | #1031 |
| baseline 24 months | #1031 |
| mice treated | #1032 |
| oxidase | #1034 |
| major regulator | #1036 |
| species production | #1039 |
| tramp | #1040 |
| arthritis psoriatic | #1041 |
| expression mrna | #1042 |
| complementary genes | #1043 |
| das28 | #1045 |
| myelin proteins | #1050 |
| parental strain | #1050 |
| patients rheumatoid | #1051 |
| chromosome 5 | #1052 |
| inflammatory macrophages | #1055 |
| gamma delta | #1055 |
| antigens differentiation | #1056 |
| immune defense | #1056 |
| mannans | #1057 |
| rat cells | #1060 |
| lymphocytes cells | #1062 |
| morula | #1062 |
| sterile inflammation | #1062 |
| transgenic | #1063 |
| tarsus | #1066 |
| disease humans polymorphism | #1069 |
| decidua | #1069 |
| oxazoles | #1069 |
| role immune | #1069 |
| synovial fluids | #1071 |
| transgenic cells | #1075 |
| fcγ | #1076 |
| radiological | #1077 |
| peptidylarginine deiminase | #1078 |
| epistasis | #1079 |
| adjuvant cfa | #1080 |
| key steps | #1080 |
| lymphoid cells | #1082 |
| reestablishment | #1082 |
| irf1 | #1086 |
| dependent regulation | #1087 |
| al2 | #1088 |
| haplotypes | #1089 |
| uppsala | #1089 |
| enlarged | #1091 |
| inflamed | #1092 |
| osteoclast formation | #1093 |
| 7 weeks | #1096 |
| oligodendrocyte | #1098 |
| inkt cells | #1102 |
| igs | #1103 |
| effector mechanisms | #1104 |
| cells increased | #1105 |
| arginine deiminase | #1114 |
| molecular mimicry | #1115 |
| fibril | #1115 |
| subdominant | #1115 |
| sclerosis myelin | #1116 |
| clinical disease | #1116 |
| cd5 | #1117 |
| animal immunity | #1117 |
| deamidation | #1117 |
| genetic factors | #1117 |
| disulfide | #1117 |
| antitoxin | #1117 |
| antigenic peptides | #1118 |
| pil | #1121 |
| lymphocytes regulatory | #1123 |
| recognizing | #1126 |
| primary immunodeficiency | #1127 |
| foreign antigens | #1128 |
| isomerase | #1128 |
| predisposing | #1128 |
| humans lymphocyte | #1128 |
| cells ifn | #1128 |
| dissected | #1130 |
| skeletal muscle fibers | #1132 |
| treatment day | #1132 |
| superantigen | #1134 |
| immune response | #1135 |
| cryosections | #1135 |
| overlapped | #1136 |
| vivo administration | #1136 |
| glucosyl | #1136 |
| c57 | #1137 |
| peptide sequence | #1138 |
| underline | #1138 |
| anticardiolipin antibodies | #1139 |
| editorial | #1139 |
| cd4foxp3 | #1142 |
| mice rats | #1146 |
| syntenic | #1147 |
| helpers | #1149 |
| treatment animals | #1149 |
| agonist | #1150 |
| cd4 cells | #1151 |
| subcloned | #1155 |
| disease onset | #1157 |
| antibody affinity | #1160 |
| inactivating | #1161 |
| lxr | #1161 |
| respiratory burst | #1163 |
| prolactin rats | #1164 |
| stainings | #1168 |
| demonstrating | #1168 |
| increased severity | #1170 |
| activated cells | #1171 |
| transduction toll | #1174 |
| gp91phox | #1175 |
| nadph oxidoreductases | #1176 |
| inflamed tissues | #1178 |
| models disease | #1178 |
| 10b | #1179 |
| preponderance | #1180 |
| recombinant interferon | #1180 |
| genetic background | #1181 |
| destructive | #1182 |
| chemiluminescent | #1182 |
| arginine residues | #1184 |
| objective investigate | #1186 |
| disease haplotypes humans | #1186 |
| synovial fibroblasts | #1188 |
| lymphocytes cell | #1188 |
| human type | #1190 |
| ileitis | #1191 |
| splenic cells | #1192 |
| rat human | #1192 |
| antiphospholipid | #1193 |
| primary sjögrens syndrome | #1195 |
| infiltrates | #1195 |
| cells rheumatoid | #1199 |
| susceptibility | #1200 |
| antibody | #1200 |
| antibodies mabs | #1200 |
| basic mechanisms | #1200 |
| somatically | #1201 |
| lung mice mice | #1204 |
| protein arginine | #1208 |
| identified loci | #1210 |
| h2k | #1211 |
| predisposition disease | #1212 |
| onset progression | #1212 |
| c5a | #1213 |
| rationales | #1214 |
| singlecell | #1214 |
| hdacs | #1217 |
| chronic inflammation | #1218 |
| critical issues | #1218 |
| igg subclass | #1220 |
| ilc2 | #1221 |
| adaptive immune response | #1223 |
| compared wt | #1223 |
| mononuclear | #1223 |
| subcellular fractionation | #1224 |
| adaptive immune responses | #1225 |
| tlymphocyte antigens | #1226 |
| chromosome 4 | #1227 |
| antimicrobial peptides amps | #1229 |
| linkage analysis | #1229 |
| analyse | #1230 |
| experimental models | #1231 |
| therapeutically | #1232 |
| subsets lymphocytes | #1233 |
| aps | #1233 |
| host defense | #1238 |
| immunological mechanisms | #1240 |
| human cd4 | #1241 |
| cell lymphocytes | #1244 |
| indel | #1247 |
| mouse | #1250 |
| immune inflammatory | #1251 |
| lining | #1252 |
| ltb | #1253 |
| animal | #1253 |
| dead cells | #1254 |
| animal doseresponse relationship | #1259 |
| mesenteric lymph nodes | #1263 |
| differentiation lymphocyte | #1263 |
| antigen presenting cells | #1264 |
| synovium | #1265 |
| pathogenic mechanisms | #1266 |
| adenine dinucleotide | #1269 |
| suppress | #1269 |
| suppressive function | #1270 |
| rheumatoid arthritis patients | #1270 |
| molecular pathogenesis | #1270 |
| synovial fluid | #1271 |
| rat mouse | #1273 |
| claudin4 | #1274 |
| eae model | #1274 |
| chromosomal regions | #1275 |
| rats mice | #1275 |
| inducer | #1279 |
| rattus norvegicus | #1282 |
| becn1 | #1282 |
| hla molecules | #1283 |
| c4a | #1283 |
| staphylococcal | #1283 |
| rodent models | #1284 |
| spreading | #1286 |
| joint destruction | #1287 |
| attacked | #1288 |
| disease response | #1290 |
| pathological processes | #1294 |
| immunochip | #1295 |
| suppressor cells | #1296 |
| day pregnancy | #1297 |
| peripheral cells | #1297 |
| serm | #1297 |
| nadph oxidase activity | #1299 |
| production anti | #1299 |
| publication animals antigens | #1300 |
| data protein | #1300 |
| restimulation | #1305 |
| hdac3 | #1307 |
| model experimental | #1307 |
| peptide library | #1309 |
| social isolation | #1310 |
| ali | #1310 |
| fab2 | #1312 |
| phagocytic cells | #1313 |
| generated | #1313 |
| introgressed | #1314 |
| permissive | #1315 |
| lymphoproliferation | #1315 |
| increased susceptibility | #1316 |
| immune | #1316 |
| detailed characterization | #1316 |
| protects | #1319 |
| estradiol treatment | #1320 |
| immunoglobulin isotypes | #1321 |
| hydrolyzes | #1321 |
| healthy human subjects | #1322 |
| phagocytes | #1322 |
| intrathymic | #1322 |
| submandibular | #1323 |
| collagen types | #1323 |
| aureus infections | #1325 |
| acute phase proteins | #1327 |
| valuable tool | #1327 |
| therapeutic antibodies | #1328 |
| dietary nitrate | #1329 |
| receptor 2 | #1330 |
| human igg | #1330 |
| immunological memory | #1332 |
| pockets | #1333 |
| thymectomy | #1335 |
| identically | #1335 |
| new therapies | #1336 |
| rats rats | #1336 |
| acute phase response | #1338 |
| induction phase | #1341 |
| cells mice | #1341 |
| adjuvants | #1344 |
| increasing evidence | #1348 |
| knockout mutation | #1349 |
| promiscuity | #1350 |
| galactosylceramides | #1356 |
| allergic contact | #1359 |
| position | #1361 |
| alp | #1361 |
| elimination | #1361 |
| regulatory genes | #1362 |
| believed | #1364 |
| disease activity score | #1364 |
| n44 | #1366 |
| hypersensitivity | #1367 |
| 590 | #1368 |
| bacterial arthritis | #1372 |
| ameliorates | #1374 |
| betad | #1375 |
| shared | #1375 |
| membrane glycoproteins | #1375 |
| trait | #1375 |
| rat spinal cord | #1379 |
| il1r | #1381 |
| immunogen | #1383 |
| abrogates | #1383 |
| surface cells | #1384 |
| exacerbation | #1388 |
| rats humans | #1388 |
| variable region | #1389 |
| suffer | #1389 |
| regulatory treg | #1390 |
| cd2 | #1390 |
| clinical signs | #1390 |
| human patients | #1392 |
| squalene | #1392 |
| feto | #1393 |
| phage display | #1393 |
| cd4cd8 | #1394 |
| effects rats | #1396 |
| inbred mice | #1397 |
| disease outcomes | #1397 |
| positional | #1399 |
| submandibular glands | #1400 |
| joint disease | #1403 |
| early patients | #1403 |
| mononuclear phagocytes | #1406 |
| linkage genetic | #1409 |
| disease phenotypes | #1412 |
| animals disease | #1413 |
| antigens humans | #1415 |
| enzymelinked immunosorbent | #1416 |
| humans immune | #1417 |
| activation neutrophils | #1417 |
| cytokine profile | #1424 |
| class switching | #1425 |
| bacterial infections | #1431 |
| genetic heterogeneity | #1436 |
| gene usage | #1438 |
| stages disease | #1439 |
| cells type | #1440 |
| peptide | #1441 |
| guillainbarré syndrome | #1451 |
| arthritis systemic | #1453 |
| inbred strains mice | #1454 |
| alpha1 | #1458 |
| cell activation | #1458 |
| monoclonal | #1460 |
| proinflammatory responses | #1461 |
| knockout rats | #1461 |
| expression genetic | #1462 |
| lupus | #1464 |
| salt concentrations | #1465 |
| ccr6 | #1467 |
| pfp | #1467 |
| opens | #1467 |
| cell origin | #1468 |
| inflammatory properties | #1469 |
| cells pregnancy | #1472 |
| activation status | #1473 |
| cartilage cell | #1474 |
| immune deficiency | #1474 |
| muscle muscle | #1476 |
| cells activated | #1478 |
| allelic variants | #1479 |
| allotype | #1480 |
| responses animals | #1482 |
| specific gene | #1482 |
| blisters | #1483 |
| markers genetic | #1483 |
| inflammatory diseases | #1486 |
| initiate | #1486 |
| cells lung | #1486 |
| genetic regulation | #1486 |
| stroke 95 | #1487 |
| host defence | #1489 |
| hormone release | #1489 |
| donated | #1490 |
| mice day | #1491 |
| inbred rats | #1491 |
| human cartilage | #1491 |
| humoral immune | #1497 |
| emphysematous | #1499 |
| myelin | #1499 |
| treatment inflammatory | #1504 |
| regulatory effects | #1504 |
| monocytes neutrophils | #1504 |
| specific monoclonal | #1505 |
| vivo vitro | #1505 |
| joint arthritis | #1507 |
| eluate | #1507 |
| mimicking | #1507 |
| fls | #1508 |
| mapped | #1509 |
| inflammatory cell | #1510 |
| hindlimbs | #1511 |
| chromosome 6 | #1512 |
| stimulates | #1515 |
| egfp | #1516 |
| induced ali | #1520 |
| human leukocyte antigen | #1524 |
| earlier studies | #1525 |
| lia | #1525 |
| genes dominant | #1528 |
| knockout mitochondria | #1530 |
| sex steroids | #1531 |
| streptococcus pyogenes | #1533 |
| glutamic acid | #1535 |
| malaise | #1536 |
| lysines | #1537 |
| downregulate | #1540 |
| net release | #1545 |
| protein rna | #1546 |
| production macrophages | #1547 |
| unexpectedly | #1547 |
| increased numbers | #1548 |
| acetylglucosaminidase | #1549 |
| chronic phase | #1554 |
| higher level | #1555 |
| mediated diseases | #1559 |
| intraperitoneally | #1560 |
| copy variations | #1563 |
| 4 humans | #1563 |
| neuroimmunomodulation | #1563 |
| activate | #1564 |
| intradermal | #1565 |
| vsg | #1566 |
| matrix components | #1567 |
| guerin | #1567 |
| immunoglobulin humans | #1568 |
| mammalian embryo | #1568 |
| formyl | #1569 |
| sufficient | #1573 |
| cytotoxic lymphocyte | #1574 |
| pineal | #1574 |
| independent | #1577 |
| cochran | #1577 |
| cathelicidin | #1578 |
| glycolipid | #1580 |
| collagens | #1585 |
| fab | #1592 |
| mac1 | #1593 |
| conserved | #1597 |
| directed | #1597 |
| factor beta | #1597 |
| defines | #1598 |
| twins | #1600 |
| cell mediated | #1600 |
| f1 | #1600 |
| adoptive transfer | #1600 |
| reactive nitrogen species | #1603 |
| autoantibodies biomarkers | #1604 |
| cell receptor | #1605 |
| cells th17 | #1607 |
| estriol | #1607 |
| helical | #1611 |
| stromal cells | #1615 |
| chondrocyte | #1616 |
| immunity animals | #1617 |
| chronic inflammatory diseases | #1617 |
| isosteric | #1619 |
| autoimmune diabetes | #1621 |
| humans immunoglobulin | #1622 |
| c57bl 6 | #1622 |
| anaphylatoxin | #1622 |
| differently | #1625 |
| unreactive | #1626 |
| antigen | #1626 |
| rat spinal | #1629 |
| iggs | #1630 |
| complement component | #1632 |
| immunohistology | #1635 |
| c3b | #1635 |
| collagen fibers | #1639 |
| lund | #1639 |
| type interferon | #1641 |
| mice increased | #1642 |
| p6 | #1644 |
| abrogated | #1644 |
| c4b | #1645 |
| aspartic acid | #1647 |
| intracellular ros | #1651 |
| sjl | #1652 |
| opsonization | #1653 |
| complement activation | #1657 |
| defence | #1658 |
| linked | #1658 |
| complement receptors | #1660 |
| commonly | #1660 |
| transporter type | #1661 |
| immune complexes | #1661 |
| staphylococcal enterotoxin | #1661 |
| enterotoxins | #1662 |
| mice knockout | #1664 |
| tcell receptors | #1665 |
| salt intake | #1668 |
| tumor vasculature | #1669 |
| coincided | #1670 |
| primary sjögren | #1671 |
| isopropylacrylamide | #1672 |
| immunologic epitopes | #1673 |
| pathogenic cells | #1673 |
| gamma production | #1678 |
| single nucleotide | #1683 |
| cd206 | #1686 |
| complement c5a | #1686 |
| auto | #1689 |
| cocktail | #1689 |
| igm antibodies | #1691 |
| method analysis | #1693 |
| agouti | #1694 |
| ido1 | #1694 |
| transgenic mice | #1696 |
| classical pathway | #1696 |
| severity | #1701 |
| 5 months | #1704 |
| triple | #1704 |
| precede | #1704 |
| animals autoantigens | #1704 |
| suppressors | #1706 |
| encoded | #1707 |
| disulfiram | #1711 |
| treg cells | #1711 |
| beta chains | #1712 |
| erosions | #1712 |
| mice neutrophils | #1714 |
| sjögrens syndrome | #1719 |
| ankylosis | #1719 |
| evoke | #1720 |
| pulmonary aspergillosis | #1721 |
| tolerance | #1721 |
| skewing | #1725 |
| oophorectomy | #1727 |
| showing | #1728 |
| myelin proteolipid | #1729 |
| mutant mice | #1729 |
| drug targets | #1732 |
| 369 | #1734 |
| analysis protein | #1734 |
| immune responses | #1734 |
| staphylococcal infections | #1736 |
| phagocytic | #1737 |
| sicca | #1737 |
| fmoc | #1739 |
| intranasally | #1740 |
| arthritis patients | #1742 |
| affinity binding | #1743 |
| prophylactic treatment | #1744 |
| 626 | #1744 |
| cd11 | #1745 |
| osteoclasts | #1746 |
| strain mice | #1748 |
| alternative pathway | #1748 |
| zap70 | #1748 |
| new loci | #1749 |
| responded | #1750 |
| neoplastic disease models | #1753 |
| peroxide | #1758 |
| infiltrating | #1762 |
| endoglycosidase | #1764 |
| inhibitory receptors | #1766 |
| dr2 | #1766 |
| triggering | #1770 |
| higher frequency | #1770 |
| multiple genes | #1770 |
| glycosylation | #1774 |
| peptide antigens | #1775 |
| operate | #1776 |
| blocking | #1781 |
| adoptively | #1782 |
| cnbr | #1783 |
| articular cell | #1784 |
| ll37 | #1784 |
| local administration | #1788 |
| immunohistological | #1789 |
| compartmentalized | #1791 |
| carbohydrates | #1792 |
| pathogenesis | #1793 |
| render | #1794 |
| dogma | #1794 |
| competed | #1797 |
| immune recognition | #1800 |
| polymorphism genetic | #1801 |
| disease pathogenesis | #1801 |
| rat models | #1802 |
| cd19 antigens | #1803 |
| rechallenge | #1803 |
| peyer | #1804 |
| obese diabetic | #1805 |
| aureus infection | #1808 |
| immunogenic | #1810 |
| predisposed | #1810 |
| elucidation | #1811 |
| activated lymphocytes | #1811 |
| complement pathway | #1811 |
| psoriatic | #1813 |
| recovery phase | #1814 |
| pregnancy rats | #1817 |
| nonfunctional | #1817 |
| ossification | #1818 |
| il2r | #1818 |
| promoting | #1818 |
| intravenously | #1819 |
| blymphocyte | #1819 |
| crossed | #1823 |
| katpase | #1824 |
| myelin sheath | #1825 |
| hydroxylated | #1825 |
| neurodegenerative diseases | #1827 |
| deplete | #1830 |
| female sex | #1833 |
| genetic susceptibility | #1836 |
| new treatments | #1839 |
| pathogenesis disease | #1841 |
| trif | #1843 |
| resolution inflammation | #1844 |
| clinical score | #1846 |
| subsequently | #1846 |
| inflammation macrophages | #1847 |
| estrogen | #1848 |
| cultured disease | #1849 |
| pyogenes | #1852 |
| specific immunity | #1854 |
| genetic variance | #1854 |
| macrophages neutrophils | #1856 |
| cd8 lymphocytes | #1856 |
| humoral | #1857 |
| rac2 | #1858 |
| barre | #1858 |
| cocktails | #1860 |
| haenszel | #1862 |
| secreting | #1863 |
| structural basis | #1864 |
| aggravation | #1864 |
| lacrimal apparatus | #1865 |
| rats groups | #1871 |
| silastic | #1871 |
| immunoadsorption | #1873 |
| inkt | #1874 |
| carries | #1875 |
| major | #1876 |
| cartilages | #1879 |
| subsequent development | #1879 |
| candidate | #1883 |
| antigen humans | #1890 |
| inflammation lung | #1892 |
| polyclonal | #1893 |
| bacterial clearance | #1894 |
| ovalbumin | #1897 |
| cyanogen | #1900 |
| striking | #1902 |
| tcr repertoire | #1903 |
| lymphatics | #1903 |
| indicating | #1905 |
| complexity | #1905 |
| proteins rats | #1907 |
| model rats | #1908 |
| gammadelta | #1910 |
| mediated | #1910 |
| enzyme linked | #1911 |
| cell maturation | #1912 |
| cells neutrophils | #1912 |
| interferon gamma | #1914 |
| erythematosus sle | #1916 |
| chromosome | #1916 |
| totally | #1918 |
| 6 hours | #1920 |
| cartilage tissue | #1923 |
| anti | #1924 |
| 721 | #1924 |
| gαq | #1926 |
| pronounced | #1927 |
| ears | #1929 |
| isoantigens | #1931 |
| bcell receptors | #1933 |
| expression cytokines | #1934 |
| animals lymphocytes | #1937 |
| trypanosoma brucei | #1937 |
| sialyltransferases | #1939 |
| mice receptors | #1940 |
| antigen tcell receptors | #1944 |
| type plasminogen | #1945 |
| predisposition | #1949 |
| prevented | #1950 |
| subclasses | #1950 |
| constituting | #1955 |
| cardiac allografts | #1956 |
| perforin | #1957 |
| snakes | #1957 |
| agp | #1959 |
| mmc | #1962 |
| levels serum | #1967 |
| iga igg | #1967 |
| edition | #1967 |
| pinocytosis | #1967 |
| fcγ receptor | #1969 |
| possibilities | #1969 |
| strong | #1971 |
| intravenous injection | #1972 |
| react | #1975 |
| mip | #1977 |
| stimulations | #1978 |
| carp | #1979 |
| synovial tissues | #1979 |
| ova | #1980 |
| inbred cba | #1980 |
| cd154 | #1982 |
| pregnant rats | #1983 |
| disease pathology | #1985 |
| cell clone | #1985 |
| milder | #1988 |
| spans | #1997 |
| mast cell | #1999 |
| cd18 | #2000 |
| transgenic rats | #2001 |
| microglia activation | #2002 |
| presenting cell | #2006 |
| heteroplasmy | #2007 |
| contact dermatitis | #2008 |
| rats effects | #2008 |
| reverted | #2008 |
| prototypic | #2011 |
| response infection | #2016 |
| abca1 | #2016 |
| barré syndrome | #2018 |
| knockout | #2020 |
| tissue inflammation | #2021 |
| immunoglobulin | #2023 |
| genes | #2025 |
| cell | #2027 |
| cytokine secretion | #2028 |
| mabs | #2028 |
| demyelination | #2030 |
| chord | #2031 |
| tetramers | #2032 |
| c5ar | #2033 |
| conformational epitopes | #2035 |
| mesenteric lymph | #2035 |
| beta gene | #2035 |
| factor mif | #2041 |
| 4 tlr4 | #2041 |
| mab | #2042 |
| diethyldithiocarbamate | #2043 |
| immunomodulatory properties | #2044 |
| sex chromosome | #2045 |
| cell immunity | #2047 |
| oestrogens | #2050 |
| hypergammaglobulinemia | #2050 |
| species signal | #2053 |
| castration | #2053 |
| cell function | #2053 |
| coinciding | #2055 |
| emphysema | #2056 |
| glycosylation humans | #2057 |
| increased frequency | #2058 |
| innate inflammation | #2058 |
| dramatically | #2059 |
| activation complement | #2061 |
| vitro vivo | #2061 |
| accompanied | #2067 |
| genetic differences | #2068 |
| dominant | #2070 |
| contributors | #2071 |
| hyaluronoglucosaminidase | #2072 |
| proteomics analysis | #2072 |
| mdsc | #2076 |
| mature cells | #2077 |
| polyradiculoneuropathy | #2077 |
| respiratory tract | #2079 |
| lysine residues | #2080 |
| antiphospholipid syndrome | #2081 |
| cell depletion | #2082 |
| mice pregnancy | #2083 |
| complement | #2094 |
| methotrexate mtx | #2094 |
| conditional deletion | #2095 |
| lysine | #2096 |
| addressed | #2097 |
| bioreactor | #2100 |
| αβ | #2100 |
| suggested | #2102 |
| evokes | #2103 |
| led | #2103 |
| antigens hla | #2104 |
| patients rheumatoid arthritis | #2105 |
| human chondrocytes | #2110 |
| nose | #2117 |
| lentiviral vectors | #2120 |
| pulmonary inflammation | #2122 |
| glycan | #2122 |
| immune functions | #2126 |
| pad4 | #2127 |
| oxidants | #2129 |
| total igg | #2130 |
| secondary receptors | #2133 |
| inducing | #2136 |
| occurring | #2139 |
| histopathological | #2140 |
| selective estrogen | #2141 |
| target tissues | #2141 |
| dissection | #2142 |
| plasminogen | #2143 |
| transduction lymphocytes | #2145 |
| subphenotypes | #2146 |
| extracellular calcium | #2146 |
| bound | #2147 |
| h2d | #2147 |
| circulating monocytes | #2149 |
| immunohistochemical analysis | #2151 |
| 129 strain mice | #2151 |
| reality | #2153 |
| clinical aspects | #2157 |
| periphery | #2161 |
| major histocompatibility complex | #2162 |
| moabs | #2165 |
| rheumatoid biomarkers | #2165 |
| late stages | #2165 |
| prone | #2169 |
| entire | #2174 |
| syringes | #2176 |
| mimics | #2177 |
| animal model | #2179 |
| immune regulation | #2180 |
| human leukocytes | #2181 |
| dynorphins | #2184 |
| psoriatic arthritis | #2184 |
| dnp | #2185 |
| native | #2188 |
| injury ali | #2200 |
| dss | #2203 |
| lps stimulation | #2204 |
| structural requirements | #2211 |
| molecular pathways | #2213 |
| confirming | #2214 |
| 12th | #2215 |
| interleukin2 | #2216 |
| therapeutic effects | #2216 |
| activation cells | #2217 |
| animal mice mice | #2217 |
| naïve | #2219 |
| regulates | #2220 |
| galactose | #2220 |
| suggesting | #2221 |
| wt mice | #2224 |
| immunoreactivity | #2225 |
| shrna | #2232 |
| mammalian | #2232 |
| governs | #2233 |
| neutralized | #2233 |
| presentation | #2234 |
| accelerates | #2236 |
| autoimmune conditions | #2239 |
| reduced susceptibility | #2239 |
| ctla4 | #2239 |
| lacked | #2240 |
| graft rejection | #2244 |
| cholera toxin | #2248 |
| inflammatory phenotype | #2248 |
| cell priming | #2252 |
| exacerbated | #2253 |
| monoclonal antibodies | #2254 |
| cell receptors | #2256 |
| tcell proliferation | #2261 |
| sjögren | #2263 |
| regulation immune | #2265 |
| involved pathogenesis | #2267 |
| hla | #2269 |
| progeny | #2274 |
| mph | #2274 |
| immunospot | #2278 |
| antigenic | #2279 |
| murine | #2279 |
| neutrophil apoptosis | #2280 |
| mice treatment | #2280 |
| lymph nodes | #2281 |
| dependent | #2284 |
| inflammatory | #2288 |
| immunizations | #2289 |
| homologous | #2292 |
| plasmatic | #2293 |
| determining | #2296 |
| modified proteins | #2296 |
| histological evaluation | #2296 |
| cba mice | #2297 |
| regulatory mechanisms | #2299 |
| knockout mice | #2300 |
| apocynin | #2302 |
| segregating | #2308 |
| infiltrating macrophages | #2309 |
| presentation antigens | #2310 |
| wounding | #2312 |
| drastically | #2315 |
| genetic basis | #2315 |
| il10 | #2317 |
| healthy donors | #2318 |
| hydroxylation | #2320 |
| barré | #2320 |
| inflammatory mechanisms | #2321 |
| sera | #2325 |
| throughput nucleotide | #2325 |
| p00002 | #2326 |
| antigens histocompatibility | #2328 |
| wild | #2329 |
| cells induced | #2331 |
| demyelinating disease | #2336 |
| n24 | #2338 |
| lewis | #2345 |
| gk | #2347 |
| reciprocal | #2353 |
| receptor α | #2353 |
| specific igg | #2358 |
| ethylenes | #2358 |
| illness stress | #2361 |
| monosaccharide | #2363 |
| hyaline | #2364 |
| biological agents | #2365 |
| acrylamides | #2366 |
| sex hormone | #2366 |
| lectins type | #2366 |
| degradative | #2367 |
| phosphoproteins | #2369 |
| eliminated | #2374 |
| wf | #2374 |
| immunogens | #2375 |
| lymphotoxin | #2375 |
| peptides derived | #2375 |
| genetic selection | #2376 |
| treatment rheumatoid arthritis | #2376 |
| amps | #2382 |
| cxcl1 | #2382 |
| antinociceptive | #2383 |
| nonalcoholic steatohepatitis | #2384 |
| mouse model | #2386 |
| contaminating | #2386 |
| phenotypes | #2391 |
| sidechain | #2391 |
| receptor transforming | #2392 |
| knock | #2394 |
| syngeneic | #2394 |
| septic arthritis | #2396 |
| systemic lupus erythematosus | #2397 |
| hla genes | #2398 |
| inflammatory reaction | #2400 |
| p38 mapk | #2400 |
| serum autoantibodies | #2408 |
| increased incidence | #2409 |
| mice models | #2411 |
| equina | #2413 |
| intraperitoneal injections | #2418 |
| genetic studies | #2420 |
| genetic receptors | #2420 |
| structure analysis | #2423 |
| realtime pcr | #2424 |
| mice expression | #2426 |
| tlr2 tlr4 | #2429 |
| suggestive evidence | #2430 |
| lentivirus | #2430 |
| acute phase | #2430 |
| unmodified | #2431 |
| collagen fibrils | #2432 |
| cko | #2432 |
| cytokines chemokines | #2432 |
| lymphocytes cd4 | #2432 |
| cells antigens | #2434 |
| agents arthritis | #2440 |
| early phases | #2440 |
| inflammatory activity | #2442 |
| mice multiple | #2446 |
| genetic predisposition | #2449 |
| b6 | #2450 |
| receptors complement | #2450 |
| 551 | #2451 |
| lipoxin | #2458 |
| inflammatory demyelinating | #2459 |
| animal disease models | #2463 |
| exemplified | #2466 |
| idiotype | #2468 |
| antibody responses | #2469 |
| strains | #2471 |
| administration intranasal | #2473 |
| animals cd4 | #2473 |
| axotomy | #2477 |
| additively | #2477 |
| translational modifications | #2477 |
| quantitative | #2480 |
| class | #2480 |
| regulatory | #2487 |
| animal experiments | #2492 |
| specific | #2493 |
| organ specific | #2497 |
| transforming growth factor | #2498 |
| negative feedback | #2501 |
| albeit | #2502 |
| alleviated | #2502 |
| cystatin | #2504 |
| mhc class genes | #2505 |
| multiparous | #2511 |
| transgenic microscopy | #2512 |
| bystander | #2515 |
| il17a | #2516 |
| ppd | #2518 |
| dichotomous | #2519 |
| chemokines cytokines | #2519 |
| contribute | #2522 |
| naturally | #2523 |
| treatment rheumatoid | #2524 |
| hyperostosis | #2525 |
| amiloride | #2526 |
| nod mice | #2527 |
| pathogenicity | #2534 |
| microsatellite markers | #2534 |
| infiltration | #2541 |
| resemblance | #2542 |
| undertaken | #2545 |
| postmenopausal osteoporosis | #2546 |
| proteolipid | #2552 |
| dapsone | #2560 |
| similarities | #2561 |
| igm iga | #2562 |
| kynurenine | #2563 |
| plp | #2563 |
| deprotection | #2564 |
| nox | #2566 |
| succeeded | #2567 |
| transferring | #2573 |
| fine | #2573 |
| passive | #2574 |
| rp patients | #2575 |
| dying cells | #2575 |
| tumor models | #2576 |
| incomplete | #2577 |
| quantitative traits | #2577 |
| complementarity | #2580 |
| peptides | #2585 |
| chick | #2589 |
| calgranulin | #2590 |
| antibody levels | #2591 |
| peritoneal macrophages | #2591 |
| misinterpretation | #2593 |
| interferon type | #2595 |
| sex hormones | #2597 |
| fibrinolysin | #2598 |
| onset | #2603 |
| antiinflammatory properties | #2603 |
| unlinked | #2605 |
| zymosan | #2610 |
| induction | #2611 |
| postulated | #2614 |
| exert | #2615 |
| antimicrobial peptides | #2618 |
| surprising | #2621 |
| interferon beta | #2623 |
| proteolipid protein | #2632 |
| ifn α | #2634 |
| single chain | #2639 |
| sialoglycoproteins | #2643 |
| plasmin | #2647 |
| unable | #2649 |
| asparagine | #2651 |
| tlr9 | #2653 |
| antigens | #2656 |
| disease genotype | #2658 |
| hla antigens | #2659 |
| submandibular gland | #2663 |
| antinuclear | #2663 |
| functional impact | #2663 |
| eluted | #2666 |
| osteonectin | #2667 |
| n22 | #2670 |
| invading | #2670 |
| brucei | #2670 |
| microliters | #2671 |
| biological pathways | #2673 |
| bordetella | #2680 |
| ease | #2683 |
| new therapeutic strategies | #2683 |
| leukocyte antigen | #2688 |
| th1 | #2690 |
| acd | #2696 |
| day treatment | #2697 |
| allelic | #2697 |
| igg3 | #2698 |
| genetic variations | #2698 |
| animal encephalomyelitis | #2702 |
| neutrophils macrophages | #2703 |
| gamma mice | #2711 |
| peptides protein | #2714 |
| γδ | #2716 |
| treatment mice | #2717 |
| rat model | #2718 |
| human complement | #2725 |
| patients anti | #2727 |
| polymorphic | #2729 |
| biased | #2730 |
| ifngamma | #2730 |
| lymphocyte subsets | #2730 |
| post partum | #2731 |
| lamina propria | #2735 |
| fumigatus | #2735 |
| serum anti | #2738 |
| fragment | #2743 |
| vav | #2743 |
| mice exposed | #2750 |
| leucocyte | #2754 |
| resemble | #2762 |
| bromocriptine | #2768 |
| transgenic mouse | #2772 |
| depleting | #2773 |
| tyrosine phosphatase | #2774 |
| human leukocyte | #2774 |
| cytolysis | #2777 |
| strong evidence | #2777 |
| qtls | #2777 |
| iga igm | #2780 |
| enigmatic | #2780 |
| detectable | #2780 |
| genetically | #2782 |
| explanation | #2785 |
| finemapping | #2785 |
| treated rats | #2786 |
| alcoholic steatohepatitis | #2786 |
| intraperitoneal | #2787 |
| tolerogenic | #2789 |
| bone cartilage | #2790 |
| sjogren syndrome | #2791 |
| current review | #2798 |
| inbred mrl | #2798 |
| animal encephalomyelitis autoimmune | #2799 |
| hk | #2801 |
| callithrix | #2804 |
| spleen | #2812 |
| 261 | #2813 |
| neuropathology | #2817 |
| genistein | #2819 |
| alpha | #2821 |
| lack | #2822 |
| activated macrophages | #2825 |
| hyaluronidase | #2830 |
| conventionally | #2831 |
| narrowed | #2832 |
| prl | #2835 |
| olive oil | #2838 |
| demyelinating diseases | #2841 |
| resistant | #2842 |
| hallmark | #2843 |
| glucose uptake | #2846 |
| beta receptor | #2847 |
| beta tgf | #2848 |
| bind | #2848 |
| th1 response | #2852 |
| demyelinating | #2852 |
| polymorphonuclear leukocytes | #2856 |
| phases | #2858 |
| treg cell | #2859 |
| dependent cell | #2859 |
| polymorphonuclear | #2864 |
| antibodies antinuclear | #2864 |
| interleukin receptors | #2864 |
| splenocytes | #2865 |
| characterising | #2865 |
| rats inbred strains | #2869 |
| interleukin33 | #2869 |
| cyanogen bromide | #2874 |
| guillain | #2875 |
| disease characterized | #2875 |
| cells cd8 | #2881 |
| periodontitis | #2882 |
| parvalbumin | #2884 |
| clone cells | #2885 |
| reveals | #2885 |
| exacerbate | #2888 |
| igg iga | #2891 |
| migration inhibitory | #2892 |
| costimulatory molecules | #2895 |
| tgfbeta | #2895 |
| innate immune responses | #2896 |
| dce | #2896 |
| antigens class humans | #2898 |
| dq | #2905 |
| antigen hla | #2907 |
| atp synthase | #2909 |
| linked immunosorbent | #2911 |
| enhancement | #2911 |
| studying | #2918 |
| diseases disease | #2920 |
| shortly | #2920 |
| allogenic | #2921 |
| ergometry | #2921 |
| vaccine development | #2925 |
| steadily | #2925 |
| type lectin | #2926 |
| obvious | #2927 |
| ifn γ | #2931 |
| autoimmune disorder | #2935 |
| dextran | #2939 |
| female flow | #2943 |
| expression macrophages | #2944 |
| injections | #2944 |
| ifn gamma | #2945 |
| proteins peptides | #2946 |
| cd68 | #2947 |
| patients antibodies | #2949 |
| interleukin4 | #2950 |
| cells immune | #2955 |
| eventually | #2956 |
| toll receptor | #2961 |
| cell infiltration | #2962 |
| expressions | #2963 |
| calcium ions | #2964 |
| qtl | #2965 |
| suppressed | #2967 |
| histocytochemistry | #2967 |
| hnrnp | #2980 |
| genetics | #2982 |
| ifn response | #2985 |
| cepacia | #2988 |
| antirheumatic agents | #2993 |
| elusive | #2994 |
| hdac | #2995 |
| thymus gland | #2997 |
| swedish | #2998 |
| respective | #3000 |
| lineage commitment | #3003 |
| time points | #3009 |
| indoleamine | #3009 |
| cells female | #3010 |
| innate | #3014 |
| therapeutic strategies | #3014 |
| illustrating | #3017 |
| anthrax | #3019 |
| interferon ifn | #3020 |
| wild type mice | #3026 |
| defensins | #3027 |
| vdr | #3031 |
| lung inflammation | #3033 |
| accelerating | #3033 |
| macrophage migration | #3036 |
| endo | #3039 |
| t‐cell | #3039 |
| synthetic peptides | #3040 |
| appearance | #3045 |
| quinoxalines | #3047 |
| cd8 | #3048 |
| immunomodulator | #3050 |
| model mice | #3051 |
| longterm treatment | #3052 |
| twin studies | #3053 |
| complex traits | #3055 |
| ppt | #3058 |
| interleukin23 | #3061 |
| profound | #3067 |
| sjögren syndrome | #3069 |
| prevailing | #3073 |
| salivary | #3076 |
| mediated immune | #3077 |
| role cell | #3078 |
| beta | #3080 |
| destruction | #3082 |
| irrespective | #3083 |
| model human | #3083 |
| gene expression profiling | #3086 |
| impairing | #3087 |
| nodes | #3091 |
| inhibitory factors | #3092 |
| glutamic | #3092 |
| parvalbumins | #3093 |
| receptor 4 | #3098 |
| inbred balb mice | #3098 |
| genetic deletion | #3100 |
| detailed description | #3101 |
| postpartum period | #3107 |
| germinal | #3108 |
| antirheumatic | #3109 |
| staphylococcus | #3114 |
| type wt | #3120 |
| neuronal cell | #3123 |
| effects treatment | #3124 |
| suspect | #3127 |
| igm igg | #3130 |
| specificity | #3131 |
| glycans | #3136 |
| monoclonal antibody | #3137 |
| receptors tlrs | #3142 |
| psoriasis | #3142 |
| logarithm | #3146 |
| cd4 cd8 | #3147 |
| preformed | #3151 |
| immune systems | #3152 |
| possibility | #3153 |
| cell activity | #3154 |
| molecule | #3155 |
| propria | #3155 |
| cba | #3164 |
| posttranslational modification | #3167 |
| sjogren | #3171 |
| massively | #3172 |
| accumulated | #3180 |
| precedes | #3185 |
| cell specific | #3185 |
| blockage | #3187 |
| dynorphin | #3191 |
| tissue specific | #3191 |
| pertussis toxin | #3192 |
| cells rats | #3193 |
| adult mice | #3193 |
| keratinocytes | #3194 |
| unravel | #3199 |
| reactivity | #3202 |
| helper | #3204 |
| modified | #3205 |
| ovx | #3208 |
| serum levels | #3210 |
| antiinflammatory | #3211 |
| erbeta | #3211 |
| phagosomes | #3212 |
| nitroarginine | #3212 |
| abs | #3216 |
| publication arthritis | #3224 |
| cells animals | #3224 |
| gpi | #3226 |
| chromosome 1 | #3237 |
| class iii | #3239 |
| clarified | #3242 |
| permitting | #3246 |
| macrophage | #3247 |
| collagenous | #3247 |
| lod score | #3252 |
| bacterial antibodies | #3254 |
| backbone | #3257 |
| nonalcoholic steatohepatitis nash | #3260 |
| female gonadal | #3263 |
| treated animals | #3264 |
| acrylic | #3265 |
| chronic inflammatory | #3267 |
| meps | #3270 |
| immunosorbent assay | #3272 |
| implicate | #3274 |
| proteoglycans | #3278 |
| inflammation interferon | #3278 |
| sch | #3280 |
| nephritis | #3283 |
| arthralgia | #3283 |
| gonadal steroid | #3284 |
| normal rats | #3287 |
| abundantly | #3289 |
| models genetic | #3298 |
| igg1 | #3298 |
| immunoglobulin heavy | #3303 |
| erythematosus | #3305 |
| proteins mice | #3309 |
| adaptations | #3309 |
| elicits | #3314 |
| characterise | #3314 |
| blastocyst | #3315 |
| nociception | #3316 |
| absence | #3318 |
| diseases autoimmune | #3321 |
| publication animals | #3325 |
| beta receptors | #3325 |
| mice protein | #3327 |
| anticardiolipin | #3328 |
| confirmed | #3329 |
| gc cells | #3331 |
| serologically | #3332 |
| suppression | #3338 |
| regional lymph nodes | #3341 |
| macromolecular | #3343 |
| clinical phenotypes | #3345 |
| cd62l | #3353 |
| influenced | #3355 |
| trypanosoma | #3358 |
| akr | #3371 |
| vitamin d3 | #3373 |
| editor | #3377 |
| antinuclear antibodies | #3382 |
| sle | #3384 |
| genetic polymorphisms | #3385 |
| ovariectomy | #3386 |
| levels inflammatory | #3395 |
| mechanistic studies | #3395 |
| macroporous | #3395 |
| explains | #3396 |
| mount | #3397 |
| tubercle | #3402 |
| somatic mutations | #3406 |
| receptors transforming | #3410 |
| haptens | #3413 |
| early phase | #3413 |
| positions | #3418 |
| nk cells | #3419 |
| erythematosus systemic | #3419 |
| reacts | #3421 |
| neutrophil activation | #3421 |
| penetrant | #3425 |
| reply | #3432 |
| receptor type | #3434 |
| proving | #3434 |
| dendritic cells | #3436 |
| serum igg | #3437 |
| alleles | #3440 |
| permitted | #3441 |
| cauda | #3443 |
| 4 months | #3444 |
| injection | #3445 |
| superoxide production | #3446 |
| protein tyrosine | #3447 |
| obscure | #3448 |
| humans immunization | #3448 |
| increased sensitivity | #3449 |
| antimicrobial peptide | #3451 |
| diffusely | #3459 |
| characterised | #3469 |
| h5n1 | #3470 |
| patients sle | #3470 |
| flow cytometry | #3476 |
| modifying | #3477 |
| multimers | #3491 |
| inflammatory mediators | #3491 |
| proteoglycan | #3496 |
| successes | #3497 |
| il21 | #3500 |
| ly | #3501 |
| elucidate | #3503 |
| classical | #3505 |
| developed | #3505 |
| protein processing | #3506 |
| salivary gland | #3507 |
| publication animals animals | #3509 |
| neutrophilic | #3510 |
| pathobiology | #3511 |
| pathological features | #3517 |
| specific cd4 | #3519 |
| globulins | #3526 |
| 267 | #3528 |
| deoxyguanosine | #3528 |
| phenotypically | #3529 |
| germline | #3529 |
| predispose | #3532 |
| lacrimal | #3534 |
| micrometer | #3534 |
| transglutaminases | #3535 |
| radiolabelled | #3539 |
| cyclosporins | #3540 |
| regulatory cells tregs | #3540 |
| mbq | #3541 |
| dominantly | #3548 |
| histological examination | #3554 |
| investigate | #3559 |
| infections staphylococcus | #3561 |
| mast cells | #3563 |
| cultured disease models | #3568 |
| socs1 | #3570 |
| humans interferon | #3571 |
| histological | #3574 |
| homogenate | #3576 |
| gamma | #3580 |
| interesting | #3580 |
| negative patients | #3583 |
| artificially | #3584 |
| role development | #3585 |
| cytolytic | #3589 |
| hindlimb | #3590 |
| il33 | #3593 |
| compared wild | #3597 |
| triggered | #3597 |
| usage | #3601 |
| immunohistochemical staining | #3608 |
| upregulation | #3612 |
| previous findings | #3617 |
| intranasal | #3619 |
| tcr | #3622 |
| potential roles | #3624 |
| cleave | #3624 |
| genetic association | #3629 |
| rp | #3633 |
| attenuate | #3633 |
| mapping chromosomes | #3634 |
| valuable | #3637 |
| genetic | #3637 |
| adhere | #3638 |
| today | #3645 |
| cultured culture media | #3651 |
| allele | #3655 |
| gene deletion | #3657 |
| enhances | #3657 |
| cd4 positive | #3659 |
| exerts | #3663 |
| clinical severity | #3665 |
| tolllike receptor | #3665 |
| luminol | #3667 |
| 95 association | #3671 |
| cd44 | #3678 |
| il23 | #3690 |
| tgf beta | #3691 |
| female genes | #3694 |
| fibronectins | #3697 |
| toll receptors | #3700 |
| igg igm | #3702 |
| heavy chain | #3705 |
| publication animals humans | #3708 |
| synovitis | #3708 |
| cyclohexanecarboxylic | #3709 |
| aggregated | #3717 |
| inbred nod mice | #3730 |
| systemic male | #3735 |
| sequence deletion | #3740 |
| dh | #3742 |
| 378 | #3746 |
| cells produce | #3750 |
| therapeutic benefit | #3752 |
| macrophage cell | #3753 |
| contributing | #3754 |
| mediate | #3754 |
| complement c4 | #3758 |
| immunochemistry | #3759 |
| biomedicine | #3763 |
| type 4 | #3763 |
| lymphocytes tumor | #3766 |
| epitope mapping | #3767 |
| identification | #3771 |
| partum | #3772 |
| mtdna | #3773 |
| d3 | #3775 |
| jakob | #3786 |
| th17 | #3786 |
| reduced expression | #3787 |
| diphtheria | #3803 |
| immunohistochemical | #3805 |
| hind | #3808 |
| skewed | #3820 |
| superoxide | #3822 |
| integrins | #3822 |
| ribonucleoprotein | #3823 |
| new opportunities | #3831 |
| models immunological | #3834 |
| encompassing | #3838 |
| mmp9 expression | #3839 |
| puerperal | #3839 |
| noncoding rna | #3840 |
| unclear | #3847 |
| amelioration | #3854 |
| il17 | #3858 |
| postulate | #3858 |
| identical | #3859 |
| housed | #3861 |
| genetic dna | #3867 |
| cells treg | #3873 |
| genetic promoter regions | #3880 |
| glycoside | #3887 |
| kinase2 | #3887 |
| prominent | #3887 |
| reacting | #3888 |
| dinucleotide | #3894 |
| decreased levels | #3896 |
| synoviocytes | #3900 |
| microsatellite repeats | #3903 |
| superoxides | #3904 |
| dominate | #3907 |
| recognition | #3912 |
| endogenous | #3918 |
| established | #3919 |
| animal studies | #3926 |
| rats messenger | #3931 |
| hladr | #3934 |
| immunophenotyping | #3941 |
| manifestations | #3942 |
| nerves | #3944 |
| toes | #3946 |
| neutrophils | #3947 |
| affect | #3947 |
| polymorphism | #3949 |
| gingivalis | #3957 |
| nets | #3958 |
| mechanisms involved | #3961 |
| involvement | #3973 |
| disrupted | #3975 |
| associate | #3975 |
| 297 | #3982 |
| adult arthritis | #3988 |
| stimulate | #3992 |
| heavy chains | #3992 |
| question | #3999 |
| ifn β | #3999 |
| broader | #4001 |
| patients osteoarthritis | #4009 |
| elevated levels | #4012 |
| sinuses | #4016 |
| superoxide dismutase | #4018 |
| chondrocytes | #4018 |
| individual patients | #4028 |
| ags | #4029 |
| inflammatory processes | #4033 |
| higher expression | #4034 |
| influences | #4034 |
| efficiently | #4050 |
| glycoproteins | #4054 |
| hla alleles | #4059 |
| expression cell | #4063 |
| conferred | #4065 |
| c1q | #4069 |
| produce | #4072 |
| fragments | #4072 |
| hinge | #4074 |
| eliciting | #4075 |
| requirement | #4076 |
| stat4 | #4076 |
| plethora | #4077 |
| glycoprotein | #4077 |
| contrast | #4085 |
| llc | #4089 |
| upregulated | #4090 |
| systemic lupus | #4092 |
| expression type | #4098 |
| fine mapping | #4102 |
| atpases | #4103 |
| leukocyte | #4105 |
| glands | #4107 |
| conferring | #4108 |
| neutrophil | #4113 |
| creutzfeldt | #4115 |
| current concepts | #4116 |
| gelatin | #4120 |
| absent | #4121 |
| therapy genetic | #4122 |
| sclerosis animals | #4124 |
| regulatory cells | #4126 |
| drives | #4126 |
| protect | #4131 |
| mycobacterial | #4133 |
| promoter polymorphism | #4137 |
| stat1 | #4144 |
| functionally | #4147 |
| articular cartilage | #4161 |
| lupus erythematosus | #4162 |
| hla dq | #4165 |
| motor neurons | #4166 |
| polygenic | #4169 |
| placenta pregnancy | #4173 |
| tumour necrosis factor | #4177 |
| stimulatory | #4178 |
| early pregnancy | #4180 |
| immunology | #4183 |
| effector | #4184 |
| systemic disease | #4187 |
| superoxide anion | #4191 |
| infiltrating lymphocytes | #4192 |
| spe | #4193 |
| monocyte | #4201 |
| breeders | #4203 |
| enterotoxin | #4206 |
| ici | #4207 |
| porphyromonas gingivalis | #4207 |
| beads | #4213 |
| antigens cd8 | #4214 |
| animal drug | #4222 |
| depletion | #4223 |
| cytometric analysis | #4224 |
| parathyroid | #4225 |
| long noncoding | #4227 |
| mutant | #4232 |
| inbred balb | #4239 |
| treated mice | #4242 |
| macrophage infiltration | #4244 |
| kidneys | #4244 |
| granulocytic | #4249 |
| chondrosarcoma | #4250 |
| continuously | #4250 |
| witnessed | #4252 |
| conjunction | #4256 |
| immunological | #4257 |
| immunity innate | #4258 |
| bout | #4260 |
| igh | #4262 |
| lymphoid | #4264 |
| cell repertoire | #4268 |
| day1 | #4270 |
| denominator | #4270 |
| complex | #4272 |
| suggestive | #4276 |
| dermatitis | #4285 |
| experimental mice | #4285 |
| clues | #4286 |
| gene targeting | #4290 |
| cd4 | #4291 |
| balb | #4292 |
| disease genetic | #4294 |
| repertoire | #4302 |
| molecular modeling | #4303 |
| provocation | #4303 |
| sciatic | #4307 |
| shares | #4307 |
| tuberculin | #4308 |
| positive cells | #4309 |
| functional role | #4310 |
| receptors interleukin2 | #4317 |
| cell populations | #4317 |
| suppressive effects | #4320 |
| hydroxy2deoxyguanosine | #4331 |
| pparγ | #4350 |
| new insight | #4353 |
| trypanosomiasis | #4358 |
| fungal infection | #4364 |
| glutamine | #4364 |
| peritonitis | #4365 |
| wildtype | #4370 |
| immunoassays | #4373 |
| swelling | #4375 |
| caused | #4381 |
| penetrance | #4381 |
| cell clones | #4396 |
| mucous | #4402 |
| disease chronic | #4402 |
| prevents | #4414 |
| restored | #4417 |
| joint | #4420 |
| modulating | #4426 |
| closer | #4434 |
| receptor beta | #4434 |
| disturbed | #4434 |
| buprenorphine | #4435 |
| model systems | #4443 |
| early | #4453 |
| acute chronic | #4454 |
| aspartic | #4458 |
| parathyroid glands | #4470 |
| confers | #4473 |
| inflammatory pain | #4477 |
| disease duration | #4480 |
| thymocytes | #4481 |
| calmette | #4488 |
| strains rats | #4489 |
| synthase type | #4490 |
| treg | #4493 |
| neutralizing antibodies | #4503 |
| thickened | #4503 |
| human cell | #4505 |
| genetic loci | #4510 |
| extensively | #4516 |
| colitis | #4526 |
| derived cells | #4532 |
| therapeutic implications | #4534 |
| immunotoxins | #4535 |
| beta cells | #4539 |
| cells th2 | #4541 |
| challenged | #4542 |
| lymphocytes cd8 | #4545 |
| 101 | #4546 |
| cytotoxic lymphocytes | #4547 |
| articular chondrocytes | #4553 |
| interleukin5 | #4558 |
| messenger rats rats | #4564 |
| beta cell | #4566 |
| extracellular ca2 | #4576 |
| homing | #4576 |
| hydrolases | #4577 |
| fasl | #4578 |
| cell separation | #4580 |
| proliferative | #4581 |
| neurosecretory | #4585 |
| immunologic | #4592 |
| production inflammatory | #4593 |
| suggests | #4596 |
| inbred shr rats | #4607 |
| modulatory | #4608 |
| igg antibody | #4613 |
| ros levels | #4613 |
| interact | #4613 |
| confer | #4616 |
| depleted | #4639 |
| conditioned medium | #4642 |
| environmental factors | #4643 |
| fashion | #4658 |
| positive selection | #4658 |
| porphyromonas | #4666 |
| visualized | #4667 |
| endorphins | #4669 |
| implicated | #4670 |
| determinant | #4675 |
| causing | #4678 |
| chains | #4681 |
| langerhans | #4681 |
| monocytes macrophages | #4683 |
| animals antigens | #4693 |
| 259 | #4696 |
| female rats | #4699 |
| lymph | #4707 |
| protecting | #4707 |
| inherited | #4709 |
| defined | #4710 |
| destabilization | #4716 |
| facs | #4718 |
| human studies | #4720 |
| orthomyxoviridae infections | #4725 |
| humans inflammation | #4729 |
| cell population | #4734 |
| positive patients | #4736 |
| α1 | #4739 |
| clone | #4741 |
| mediating | #4744 |
| factor 88 | #4750 |
| panel | #4753 |
| gout | #4757 |
| new drugs | #4764 |
| histopathology | #4767 |
| orchiectomy | #4773 |
| cellular localization | #4775 |
| e4 | #4776 |
| alveolar macrophages | #4776 |
| purified | #4778 |
| differing | #4793 |
| eralpha | #4798 |
| male membrane | #4800 |
| rodents | #4801 |
| displaying | #4809 |
| osteoclastogenesis | #4809 |
| hydrolyzed | #4815 |
| tumor antigens | #4816 |
| effector cells | #4819 |
| paw | #4821 |
| cd4 cd8 cells | #4821 |
| cytokines | #4821 |
| cholera | #4822 |
| distinct | #4831 |
| coincides | #4833 |
| litters | #4843 |
| stress rats | #4846 |
| tissue injury | #4847 |
| rats receptors | #4850 |
| matrix ecm | #4852 |
| interferon γ | #4852 |
| stemness | #4860 |
| articular | #4861 |
| venules | #4863 |
| infiltrate | #4868 |
| th17 cells | #4872 |
| tlr2 | #4880 |
| hpa axis | #4882 |
| ifn | #4885 |
| exocrine | #4888 |
| multifactorial | #4889 |
| 116 | #4891 |
| lod | #4892 |
| specific binding | #4893 |
| ige | #4896 |
| humoral immunity | #4897 |
| induced lung | #4899 |
| preimplantation | #4905 |
| essential roles | #4915 |
| discuss | #4916 |
| immunosorbent | #4917 |
| correlating | #4923 |
| interleukins | #4927 |
| deacetylases | #4928 |
| closely | #4932 |
| timepoints | #4940 |
| humans multiple | #4945 |
| deficiency | #4946 |
| disease process | #4962 |
| naturally occurring | #4962 |
| monitored | #4964 |
| elicit | #4966 |
| forelimb | #4967 |
| contradictory | #4975 |
| point mutation | #4976 |
| cell antigen | #4990 |
| understand | #4995 |
| male rats | #4998 |
| kupffer cells | #5001 |
| thymic | #5003 |
| eosinophilia | #5004 |
| innate immune | #5004 |
| modulates | #5011 |
| isotype | #5012 |
| wt | #5012 |
| upa | #5014 |
| opened | #5018 |
| sh3 | #5019 |
| granuloma | #5021 |
| gland | #5024 |
| enhancing | #5026 |
| expand | #5026 |
| vimentin | #5026 |
| poliomyelitis | #5041 |
| explaining | #5042 |
| il5 | #5044 |
| diamines | #5048 |
| heterozygous | #5049 |
| coculture techniques | #5051 |
| cd8 cells | #5055 |
| caveolin | #5065 |
| th1 cells | #5067 |
| linkage | #5067 |
| phospholipid | #5071 |
| arthritis juvenile | #5072 |
| sitedirected mutagenesis | #5076 |
| molecular basis | #5084 |
| cells blood | #5085 |
| bcg | #5086 |
| autologous | #5087 |
| alum | #5087 |
| olive | #5088 |
| new treatment | #5089 |
| multiple sclerosis | #5098 |
| master regulator | #5100 |
| osteopontin | #5109 |
| aged anti | #5110 |
| elispot | #5112 |
| occurs | #5112 |
| sulfasalazine | #5115 |
| isoantibodies | #5120 |
| dq antigens | #5134 |
| contributes | #5139 |
| lesser | #5145 |
| traditionally | #5148 |
| cytosolic | #5152 |
| epidermis | #5158 |
| connection | #5165 |
| cytokines female | #5170 |
| titrated | #5171 |
| preceded | #5175 |
| antigen receptor | #5178 |
| lymphocytes cytotoxic | #5179 |
| binding | #5185 |
| sex characteristics | #5186 |
| transfer | #5187 |
| polymorphism single | #5188 |
| phenotypic | #5191 |
| complement proteins | #5192 |
| molecular level | #5196 |
| ovariectomized | #5210 |
| popliteal | #5224 |
| ers | #5235 |
| beta2 | #5238 |
| serves | #5238 |
| chimeric | #5241 |
| immunosuppressive | #5246 |
| epidermal | #5250 |
| cognate | #5258 |
| mucus | #5258 |
| cd86 | #5261 |
| tested | #5262 |
| deleterious effects | #5266 |
| progenitors | #5270 |
| costimulation | #5275 |
| detects | #5277 |
| osteoclast | #5277 |
| erosion | #5278 |
| prolactin | #5280 |
| therapeutic intervention | #5280 |
| maternally | #5289 |
| gels | #5292 |
| leu | #5294 |
| plasmapheresis | #5298 |
| clinical findings | #5299 |
| key component | #5301 |
| neutralization | #5301 |
| drug humans | #5301 |
| amino | #5310 |
| staphylococcus aureus | #5312 |
| suggestion | #5312 |
| anhydrases | #5315 |
| manner | #5320 |
| c57bl 6j | #5320 |
| spontaneous | #5321 |
| lipopolysaccharides macrophages | #5345 |
| genetic mapping | #5348 |
| ketoglutarate | #5350 |
| opposing | #5352 |
| proinflammatory | #5365 |
| clathrin | #5369 |
| multiplexed | #5371 |
| glomerulonephritis | #5377 |
| modifies | #5379 |
| cultured human | #5386 |
| expansion | #5387 |
| il1α | #5391 |
| tolllike receptors | #5397 |
| oxidation reduction | #5398 |
| new strategies | #5401 |
| positive lymphocytes | #5402 |
| mice molecular | #5402 |
| tnf α | #5411 |
| epigenetic mechanisms | #5417 |
| antiinflammatory agents | #5417 |
| adversely | #5418 |
| activation | #5420 |
| fulvestrant | #5420 |
| dendritic | #5428 |
| antigens surface | #5429 |
| compartments | #5429 |
| signaling molecules | #5432 |
| mif | #5457 |
| cell culture | #5458 |
| wide spectrum | #5473 |
| sideeffects | #5478 |
| multitude | #5482 |
| located | #5499 |
| immunoglobulins | #5500 |
| histological analysis | #5507 |
| reproduced | #5507 |
| lactating | #5515 |
| cytotoxic | #5519 |
| cytokines humans | #5525 |
| balb mice | #5542 |
| therapeutic | #5547 |
| thymus | #5551 |
| immunosuppressive agents | #5559 |
| sexual dimorphism | #5560 |
| pv | #5560 |
| nociceptive | #5565 |
| redox | #5572 |
| cell expansion | #5578 |
| acute lung | #5583 |
| t1d | #5585 |
| percentage | #5588 |
| allergic reactions | #5592 |
| typed | #5596 |
| lipopolysaccharide lps | #5598 |
| potently | #5600 |
| acute lung injury | #5603 |
| oxidase activity | #5613 |
| control animals | #5614 |
| structural homology | #5616 |
| sequence amino | #5621 |
| synthases | #5633 |
| biotinylation | #5642 |
| bead | #5645 |
| pemphigus | #5649 |
| urgent | #5650 |
| type ifn | #5655 |
| proliferative responses | #5658 |
| abolished | #5660 |
| explants | #5660 |
| regarded | #5663 |
| 198 | #5671 |
| directing | #5676 |
| lung mice | #5677 |
| heterotrimeric | #5684 |
| numbers | #5685 |
| antioxidant defense | #5685 |
| aetiology | #5687 |
| triggers | #5689 |
| keratins | #5695 |
| cytokine expression | #5697 |
| progression disease | #5697 |
| skeletal muscle | #5698 |
| experimental animals | #5700 |
| immune mediated | #5710 |
| avenues | #5715 |
| effective treatments | #5735 |
| altogether | #5737 |
| variable | #5759 |
| integrases | #5760 |
| hfd | #5762 |
| ecm | #5776 |
| mechanisms | #5794 |
| mast | #5802 |
| b16 | #5808 |
| linking | #5808 |
| frozen | #5808 |
| inflammatory disorders | #5809 |
| diabetes t1d | #5814 |
| allergic | #5820 |
| splenic | #5829 |
| bal | #5830 |
| hampered | #5832 |
| toxoid | #5835 |
| earliest | #5837 |
| key regulators | #5844 |
| gabapentin | #5847 |
| type receptors | #5850 |
| large proportion | #5851 |
| proteinases | #5862 |
| cfa | #5868 |
| stronger | #5871 |
| disease genotype humans | #5872 |
| hyaluronan receptors | #5875 |
| deleted | #5875 |
| vitro experiments | #5880 |
| microtomography | #5882 |
| single cells | #5896 |
| evidence role | #5898 |
| modulation | #5900 |
| ace2 | #5917 |
| standardization | #5918 |
| abp | #5919 |
| synthetic | #5920 |
| bronchoalveolar lavage fluid | #5925 |
| low doses | #5925 |
| ics | #5932 |
| subclass | #5941 |
| identifying | #5941 |
| genomic regions | #5947 |
| depend | #5947 |
| explain | #5951 |
| interfere | #5953 |
| biobank | #5960 |
| cytokine production | #5962 |
| expression humans | #5965 |
| nerve regeneration | #5966 |
| factor 1 | #5968 |
| avidin | #5970 |
| foxp3 | #5975 |
| costimulatory | #5977 |
| clarify | #5980 |
| symptom onset | #5983 |
| denaturation | #5986 |
| inability | #5988 |
| knee joint | #5990 |
| eosinophils | #5991 |
| cell subset | #6000 |
| glyburide | #6010 |
| immunity | #6010 |
| 88 | #6014 |
| tetanus | #6019 |
| stress induced | #6022 |
| consisting | #6023 |
| fluorescent dyes | #6044 |
| cnvs | #6045 |
| stimulated | #6056 |
| nih | #6065 |
| igm | #6073 |
| tumor infiltrating | #6074 |
| cleared | #6074 |
| laminin | #6075 |
| genetic therapy | #6077 |
| relapsing remitting | #6083 |
| sle patients | #6089 |
| responsible | #6091 |
| undertook | #6097 |
| messengers | #6100 |
| cages | #6103 |
| stat6 | #6105 |
| ligated | #6107 |
| bone diseases | #6115 |
| uncoupling | #6115 |
| telomeric | #6122 |
| infection mice | #6127 |
| unique | #6140 |
| replacing | #6149 |
| plasma cells | #6150 |
| lowers | #6156 |
| inguinal | #6166 |
| susceptibility gene | #6171 |
| responses | #6171 |
| prophylactic | #6183 |
| genomewide association studies | #6193 |
| instances | #6210 |
| cell functions | #6210 |
| models human | #6217 |
| interferon | #6220 |
| translation | #6222 |
| humans lupus | #6235 |
| characterized | #6236 |
| progesterone | #6253 |
| introduction | #6260 |
| cell type | #6265 |
| exclusively | #6269 |
| protective | #6270 |
| microarray | #6272 |
| serum concentration | #6278 |
| sexes | #6280 |
| immune cell | #6285 |
| myelomonocytic | #6286 |
| histone | #6287 |
| biological evaluation | #6290 |
| difficult | #6298 |
| dermis | #6313 |
| sheath | #6316 |
| monolithic | #6318 |
| allowed | #6320 |
| minor | #6320 |
| tracheal | #6322 |
| estrus | #6336 |
| immunomodulatory | #6337 |
| lymphocyte count | #6339 |
| localize | #6347 |
| tumor immune | #6348 |
| remitting | #6355 |
| cell biology | #6355 |
| borrelia burgdorferi | #6355 |
| microsatellite | #6356 |
| virgin | #6356 |
| signs | #6360 |
| tears | #6363 |
| tryptic | #6370 |
| pertussis | #6372 |
| unresolved | #6378 |
| ros generation | #6379 |
| cells cell | #6381 |
| metalloproteinase | #6392 |
| human subjects | #6394 |
| nicotinamide | #6408 |
| registers | #6410 |
| prodromal | #6450 |
| gonadal | #6451 |
| neuropathological | #6454 |
| models molecular | #6455 |
| peritoneum | #6460 |
| express | #6470 |
| biologic | #6473 |
| transgenes | #6474 |
| c4 | #6475 |
| immunity mucosal | #6476 |
| inoculation | #6477 |
| genetic variants | #6477 |
| severe | #6501 |
| gene function | #6502 |
| demonstrates | #6508 |
| organ specificity | #6511 |
| cell numbers | #6513 |
| stages | #6515 |
| nitrite | #6523 |
| synergy | #6523 |
| chronic | #6523 |
| share | #6539 |
| played | #6540 |
| proteins animals | #6559 |
| apc | #6559 |
| antibody titers | #6572 |
| cytotoxicity immunologic | #6575 |
| pace | #6583 |
| proteases | #6588 |
| rheumatic | #6588 |
| toll | #6603 |
| expression genes | #6603 |
| stain | #6604 |
| major source | #6614 |
| translocating | #6615 |
| parturition | #6635 |
| hpa | #6636 |
| whitney | #6639 |
| solid phase | #6644 |
| affinity | #6645 |
| parenchyma | #6650 |
| regulation | #6650 |
| presently | #6651 |
| sclerosis | #6655 |
| memory cell | #6657 |
| cystine | #6658 |
| cells cd4 | #6665 |
| subfamily | #6672 |
| animals antioxidants | #6683 |
| melatonin | #6683 |
| current understanding | #6687 |
| burgdorferi | #6696 |
| macrophages alveolar | #6701 |
| long noncoding rnas | #6715 |
| histone deacetylases | #6742 |
| normal levels | #6747 |
| pups | #6747 |
| estrogens | #6749 |
| demonstration | #6755 |
| relevant | #6761 |
| comparative genomics | #6768 |
| elastase | #6774 |
| cd8 positive | #6776 |
| helpful | #6782 |
| interleukin18 | #6782 |
| cytometric | #6804 |
| demonstrate | #6812 |
| study role | #6813 |
| glucose transport | #6814 |
| crystal structure | #6819 |
| intra articular | #6825 |
| induced acute | #6825 |
| cd19 | #6829 |
| eosinophil | #6829 |
| cterminal | #6829 |
| conflicting | #6830 |
| lname | #6833 |
| antilymphocyte | #6836 |
| molecules | #6840 |
| aspergillosis | #6852 |
| case control | #6852 |
| lymphoid tissues | #6854 |
| participates | #6855 |
| periodontal disease | #6855 |
| vascular endothelium | #6862 |
| sciatic nerve | #6863 |
| alter | #6865 |
| bioreactors | #6867 |
| activating | #6871 |
| facial nerve | #6873 |
| cell communication | #6882 |
| tool | #6883 |
| cytokine release | #6887 |
| lethality | #6889 |
| inflammatory responses | #6893 |
| lung injury | #6900 |
| ankle joint | #6907 |
| harboring | #6908 |
| gastritis | #6915 |
| tumour necrosis | #6921 |
| recessive | #6922 |
| acetaldehyde | #6925 |
| induced pulmonary | #6931 |
| alternative | #6934 |
| microarray analysis | #6937 |
| cyclic | #6951 |
| inflammatory response | #6953 |
| sulfones | #6960 |
| player | #6974 |
| likewise | #6976 |
| exacerbations | #6984 |
| cdr | #6993 |
| equally | #7001 |
| rac1 | #7013 |
| biological function | #7014 |
| mapping | #7016 |
| translational | #7020 |
| degrade | #7020 |
| mimic | #7025 |
| assay elisa | #7033 |
| fewer | #7033 |
| suppressing | #7047 |
| th1 th2 | #7048 |
| histology | #7056 |
| nucleotide | #7060 |
| target cells | #7063 |
| genome wide | #7063 |
| heterogeneous | #7071 |
| subjected | #7072 |
| aureus | #7072 |
| immune cells | #7075 |
| serine proteases | #7082 |
| proportion | #7083 |
| reduced | #7086 |
| glomeruli | #7088 |
| finally | #7092 |
| atherosclerotic lesions | #7094 |
| orthomyxoviridae | #7108 |
| lyme disease | #7115 |
| thp1 cells | #7121 |
| apoptotic cells | #7124 |
| dividing | #7134 |
| mounted | #7137 |
| autophagy | #7144 |
| extracellular | #7153 |
| immunity cellular | #7161 |
| genetic markers | #7162 |
| messenger rats | #7166 |
| cascades | #7175 |
| synteny | #7188 |
| moiety | #7194 |
| promoted | #7198 |
| higher incidence | #7202 |
| lymphoid tissue | #7205 |
| bovine serum albumin | #7219 |
| dependency | #7223 |
| amino acid | #7225 |
| relevance | #7233 |
| mtx | #7237 |
| recognised | #7238 |
| polysaccharides | #7242 |
| sirt1 | #7251 |
| participate | #7253 |
| prevalent | #7262 |
| immuno | #7265 |
| role pathogenesis | #7272 |
| breeding | #7286 |
| inheritance | #7292 |
| rolling | #7300 |
| prime | #7313 |
| dissecting | #7326 |
| avidity | #7332 |
| expressed genes | #7334 |
| adhesins | #7335 |
| inflammasome | #7342 |
| potential targets | #7343 |
| secreted | #7347 |
| disease specific | #7350 |
| uncontrolled | #7353 |
| metalloendopeptidases | #7355 |
| microglobulin | #7363 |
| adulthood | #7369 |
| transduction animals | #7370 |
| oxide nitric | #7377 |
| array | #7387 |
| analyses | #7391 |
| nervous | #7406 |
| transglutaminase | #7410 |
| chemokines | #7411 |
| interleukin6 | #7411 |
| proven | #7418 |
| supernatants | #7428 |
| genotyping | #7446 |
| immunocytochemistry | #7453 |
| fusion protein | #7456 |
| cells peripheral | #7461 |
| β2 | #7467 |
| airways | #7489 |
| adjuvant | #7493 |
| inhibitory factor | #7500 |
| cytotoxic cells | #7518 |
| disease incidence | #7535 |
| anchor | #7536 |
| eliminate | #7540 |
| early disease | #7541 |
| il1 beta | #7545 |
| lesser extent | #7547 |
| interleukin1beta | #7549 |
| necrotic | #7550 |
| activity relationship | #7553 |
| responder | #7562 |
| elevations | #7589 |
| interacting | #7594 |
| micrograms | #7596 |
| appeared | #7610 |
| hydrocarbon | #7610 |
| arginine | #7621 |
| evident | #7628 |
| cytometry | #7630 |
| unexplained | #7632 |
| allogeneic | #7640 |
| peripheral nervous | #7645 |
| sustain | #7654 |
| receptors immunologic | #7659 |
| component | #7661 |
| graft survival | #7661 |
| murine model | #7665 |
| considerable | #7704 |
| histone deacetylase | #7707 |
| placental | #7712 |
| differentially expressed | #7721 |
| chromosomes | #7722 |
| activators | #7728 |
| motifs | #7730 |
| critical roles | #7731 |
| bacterial toxins | #7735 |
| diagnostics | #7735 |
| initiation | #7745 |
| 325 | #7749 |
| rodent | #7751 |
| chain | #7753 |
| granulocyte | #7754 |
| leukocytes mononuclear | #7766 |
| candidate genes | #7769 |
| activates | #7772 |
| mer | #7772 |
| 37°c | #7773 |
| manuscript | #7780 |
| resolving | #7797 |
| carbonic | #7798 |
| cells tregs | #7800 |
| cell surface receptors | #7807 |
| diet fat | #7810 |
| tgf beta1 | #7831 |
| lipopolysaccharides | #7836 |
| patients levels | #7843 |
| strain | #7844 |
| cells pbmcs | #7853 |
| sirtuin | #7854 |
| retinoid | #7862 |
| interleukin1 | #7866 |
| ifnγ | #7872 |
| gene therapy | #7878 |
| amenable | #7895 |
| analyze | #7897 |
| illness | #7901 |
| lymphopenia | #7909 |
| 2nd | #7917 |
| th2 | #7918 |
| fact | #7925 |
| mann | #7929 |
| myocarditis | #7932 |
| discoveries | #7955 |
| cellular immune | #7957 |
| immunodiffusion | #7959 |
| transform infrared | #7960 |
| positive | #7982 |
| nitrites | #7983 |
| candidate gene | #7987 |
| scoring | #7989 |
| direct effects | #7991 |
| tregs | #7991 |
| unknown | #7993 |
| immune function | #7994 |
| oxidative | #7996 |
| fertilized | #8002 |
| identifies | #8007 |
| haplotypes humans | #8011 |
| polymorphisms | #8012 |
| psa | #8015 |
| essential | #8017 |
| hydroxy | #8030 |
| capacity | #8031 |
| raised | #8040 |
| lncrna | #8047 |
| macroscopic | #8049 |
| myeloid differentiation | #8054 |
| respiratory distress | #8063 |
| address | #8064 |
| drive | #8066 |
| evaluation preclinical | #8067 |
| factor signal | #8077 |
| ascertained | #8077 |
| spanning | #8085 |
| hypophyseal | #8087 |
| tetramer | #8088 |
| appearing | #8088 |
| clinical evaluation | #8089 |
| suboptimal | #8101 |
| physiological | #8105 |
| homozygosity | #8108 |
| prolongation | #8108 |
| considerably | #8109 |
| intronic | #8113 |
| prerequisite | #8120 |
| reasons | #8130 |
| nash | #8133 |
| bovine | #8133 |
| latest | #8134 |
| macrophages peritoneal | #8141 |
| definition | #8141 |
| dying | #8148 |
| trachea | #8156 |
| peripheral nerve | #8160 |
| relapses | #8166 |
| conditioned | #8167 |
| elevated | #8167 |
| characterize | #8170 |
| harbor | #8170 |
| bacterial infection | #8176 |
| expression | #8180 |
| member | #8181 |
| induced inflammation | #8186 |
| rescue | #8192 |
| sacrificed | #8197 |
| cassette | #8198 |
| analysing | #8209 |
| underlying | #8214 |
| preferential | #8216 |
| genetic associations | #8225 |
| sulphate | #8225 |
| defective | #8238 |
| ors | #8241 |
| marginal zone | #8244 |
| foster | #8245 |
| wide | #8261 |
| cultured cytokines | #8268 |
| ppar | #8274 |
| fibrinogen | #8275 |
| bone resorption | #8290 |
| clinical manifestations | #8294 |
| differ | #8295 |
| disease genome | #8295 |
| subcutaneous injection | #8300 |
| streptococcal | #8302 |
| oxygen | #8304 |
| combined treatment | #8309 |
| monoester | #8310 |
| remodeling | #8311 |
| 11 | #8316 |
| aspergillus fumigatus | #8316 |
| peptide1 | #8316 |
| genetically modified | #8320 |
| tlr | #8339 |
| cov2 infection | #8349 |
| vh | #8363 |
| boronic | #8363 |
| frequency | #8364 |
| parietal | #8367 |
| firstly | #8379 |
| fibrils | #8388 |
| migrate | #8391 |
| expressed | #8400 |
| poly | #8401 |
| residue | #8401 |
| p001 | #8404 |
| cd11b | #8408 |
| unaffected | #8411 |
| hydrophilicity | #8420 |
| advancement | #8424 |
| notion | #8424 |
| macrophage activation | #8429 |
| highlights | #8433 |
| defense | #8436 |
| viable | #8460 |
| 14 | #8468 |
| lamina | #8472 |
| manifestation | #8482 |
| protein conformation | #8485 |
| damaging | #8500 |
| promotes | #8502 |
| booster | #8512 |
| inflammatory process | #8516 |
| involves | #8520 |
| cells express | #8525 |
| mildly | #8527 |
| phenotype | #8539 |
| drug development | #8539 |
| burkholderia | #8540 |
| forkhead transcription | #8544 |
| human neutrophils | #8545 |
| estradiol | #8546 |
| copy | #8554 |
| tubule | #8558 |
| adaptive | #8568 |
| inflammatory cytokines | #8576 |
| responsive | #8580 |
| cellular functions | #8582 |
| marginal | #8600 |
| productive | #8609 |
| region | #8618 |
| stress reactive | #8622 |
| chickens | #8638 |
| xanthine | #8641 |
| positivity | #8659 |
| uncovered | #8689 |
| inducers | #8705 |
| outline | #8708 |
| experimental mice mice | #8716 |
| constitutive expression | #8717 |
| vigorous | #8717 |
| ccaat | #8720 |
| staphylococci | #8725 |
| regulatory cell | #8734 |
| cytokine | #8750 |
| recovered | #8751 |
| resorption | #8757 |
| rejection | #8759 |
| larynx | #8761 |
| subset | #8775 |
| chemokine receptor | #8777 |
| impaired | #8781 |
| highlight | #8782 |
| promoter | #8789 |
| cells human | #8790 |
| 4 weeks | #8792 |
| homozygous | #8792 |
| generate | #8799 |
| fungal infections | #8807 |
| human serum | #8808 |
| occasionally | #8808 |
| parotid | #8809 |
| chemically | #8809 |
| generates | #8811 |
| female male | #8812 |
| cytokine levels | #8825 |
| correlated | #8830 |
| kupffer | #8836 |
| cell phenotype | #8866 |
| pathway | #8867 |
| precisely | #8877 |
| bovis | #8882 |
| pathways | #8883 |
| unidentified | #8885 |
| frequencies | #8890 |
| deletion | #8893 |
| key regulator | #8903 |
| endopeptidases | #8922 |
| flow cytometric | #8932 |
| strengthen | #8941 |
| hypothalamo | #8941 |
| and or | #8942 |
| staining | #8944 |
| chemiluminescence | #8945 |
| modulate | #8948 |
| pge2 | #8966 |
| subpopulation | #8967 |
| pitfalls | #8967 |
| attack | #8975 |
| neonatal | #8981 |
| gene | #8983 |
| endosomal | #8987 |
| 129 | #8990 |
| vasculature | #9008 |
| rna long | #9017 |
| chemoattractant | #9019 |
| adrenocorticotropic | #9019 |
| discriminate | #9043 |
| thp1 | #9068 |
| leading | #9074 |
| positioned | #9075 |
| specific role | #9081 |
| glut4 | #9084 |
| hl60 | #9115 |
| cd4 cell | #9129 |
| human | #9131 |
| differentially | #9131 |
| cell surface | #9135 |
| pad | #9136 |
| ongoing | #9160 |
| reconstitution | #9166 |
| negative | #9175 |
| causative | #9182 |
| preincubation | #9186 |
| secrete | #9196 |
| tnf | #9198 |
| lethal | #9205 |
| serologic | #9213 |
| respiratory syndrome | #9222 |
| innate immunity | #9233 |
| started | #9233 |
| sequence | #9238 |
| cells isolated | #9241 |
| glomerulus | #9242 |
| immortalized | #9244 |
| severely | #9250 |
| orphan | #9255 |
| offer | #9255 |
| millions | #9268 |
| ubiquitous | #9272 |
| matrix | #9273 |
| killer | #9278 |
| crystal structures | #9313 |
| clear | #9315 |
| smoking status | #9329 |
| sdspage | #9335 |
| copolymers | #9346 |
| carbohydrate | #9368 |
| neutralizing | #9381 |
| immunoblot | #9395 |
| sweden | #9420 |
| functionality | #9425 |
| cysteine | #9458 |
| ifnα | #9459 |
| lacks | #9460 |
| treatment strategies | #9463 |
| immunomodulation | #9473 |
| luminescent | #9474 |
| molecular | #9484 |
| endotoxins | #9487 |
| tlr4 | #9501 |
| immobilized | #9505 |
| cyclosporin | #9519 |
| hormonal | #9519 |
| immunofluorescence | #9519 |
| sensitized | #9523 |
| detrimental | #9524 |
| heritable | #9530 |
| preexisting | #9543 |
| neuroinflammation | #9558 |
| factor beta1 | #9560 |
| interferon regulatory | #9572 |
| regulated | #9576 |
| culture techniques | #9577 |
| analogous | #9593 |
| entering | #9608 |
| affinities | #9614 |
| steroid hormones | #9615 |
| pretreated | #9624 |
| vaccinated | #9638 |
| gestation | #9639 |
| mammalian cells | #9643 |
| attached | #9647 |
| genetic models | #9655 |
| basement membrane | #9657 |
| key | #9658 |
| vehicle | #9670 |
| cell adhesion | #9678 |
| dramatic | #9694 |
| slight | #9694 |
| accessible | #9708 |
| snp | #9709 |
| azathioprine | #9721 |
| ear | #9723 |
| environment interaction | #9730 |
| humanized | #9753 |
| livers | #9753 |
| maintenance | #9756 |
| metabolic syndrome mets | #9758 |
| functional analysis | #9772 |
| blocked | #9776 |
| cleavage | #9781 |
| adhesion cell | #9784 |
| microscopic | #9784 |
| nasal | #9786 |
| plasminogen activator | #9788 |
| structure activity | #9789 |
| infectious | #9804 |
| lowered | #9804 |
| sterile | #9810 |
| driven | #9836 |
| fibronectin | #9846 |
| delineation | #9856 |
| rheumatology | #9870 |
| phage | #9872 |
| memory cells | #9874 |
| nonhuman primates | #9876 |
| pathogens | #9902 |
| serological | #9907 |
| coculture | #9927 |
| interleukin8 | #9936 |
| healthy control | #9938 |
| reactions | #9953 |
| monkeys | #9973 |
| anticipated | #9993 |
| nucleic acids | #10007 |
| flare | #10014 |
| inflammatory cytokine | #10023 |
| genotype | #10053 |
| serum | #10061 |
| leukocytes | #10067 |
| administered | #10070 |
| differentiation factor | #10076 |
| inflammation male | #10091 |
| generating | #10093 |
| surface receptors | #10102 |
| fibrin | #10105 |
| virulence factors | #10110 |
| cells patients | #10110 |
| activated | #10122 |
| ccl4 | #10125 |
| il1beta | #10131 |
| edge | #10132 |
| new strategy | #10136 |
| host cells | #10139 |
| mitogens | #10140 |
| cell signaling | #10143 |
| kappa | #10143 |
| th2 cells | #10147 |
| retroviridae | #10157 |
| postmenopausal | #10172 |
| traps | #10177 |
| hydrogen peroxide | #10184 |
| placenta | #10185 |
| named | #10188 |
| tlrs | #10207 |
| delta | #10218 |
| summarize | #10236 |
| day | #10244 |
| molecular biology | #10259 |
| rats spraguedawley receptors | #10277 |
| arg | #10279 |
| reproducible | #10283 |
| animals anti | #10304 |
| germ | #10305 |
| gene environment | #10307 |
| tendency | #10317 |
| scid | #10324 |
| lectins | #10329 |
| dismutase | #10332 |
| avian influenza | #10343 |
| reductive | #10347 |
| complete | #10365 |
| mediators | #10378 |
| nterminal | #10392 |
| partially | #10400 |
| lasting | #10406 |
| promote | #10424 |
| determine | #10429 |
| cterminus | #10432 |
| refined | #10437 |
| kill | #10441 |
| cattle | #10446 |
| assays | #10447 |
| indirectly | #10460 |
| mediates | #10474 |
| thioredoxin | #10475 |
| occur | #10477 |
| motif | #10479 |
| redundant | #10502 |
| receptor binding | #10504 |
| developing | #10513 |
| behavior animal | #10515 |
| promoter regions | #10545 |
| phosphate | #10548 |
| produced | #10552 |
| exception | #10554 |
| dysregulated | #10557 |
| critical | #10564 |
| influence | #10568 |
| understood | #10572 |
| converting enzyme | #10584 |
| progressive | #10597 |
| rise | #10608 |
| female | #10609 |
| shortened | #10612 |
| small molecule | #10616 |
| nf kappa | #10617 |
| extracellular matrix | #10620 |
| paralysis | #10632 |
| primers | #10636 |
| collectively | #10637 |
| underlie | #10642 |
| testosterone | #10659 |
| macrophage colony | #10664 |
| selective inhibitor | #10667 |
| aged osteoarthritis | #10675 |
| summary | #10684 |
| repeats | #10685 |
| pbs | #10702 |
| respond | #10705 |
| cerebrospinal fluid | #10708 |
| 17 | #10713 |
| disruption | #10729 |
| issue | #10762 |
| conformation | #10767 |
| il18 | #10770 |
| generation | #10781 |
| cleaved | #10800 |
| 103 | #10811 |
| conditional | #10821 |
| capture | #10822 |
| operated | #10824 |
| seropositive | #10826 |
| cellular mechanisms | #10838 |
| belonging | #10857 |
| saline | #10857 |
| restraint | #10864 |
| phosphatase | #10866 |
| immunoblotting | #10872 |
| factor1 | #10880 |
| base | #10885 |
| connective tissue | #10896 |
| multifunctional | #10904 |
| phagocytosis | #10904 |
| avoid | #10909 |
| ineffective | #10909 |
| luciferase | #10915 |
| bronchoalveolar | #10916 |
| promise | #10920 |
| secondary | #10926 |
| pivotal | #10926 |
| mulatta | #10929 |
| mannose | #10934 |
| persisted | #10939 |
| concluded | #10955 |
| methotrexate | #10967 |
| myeloid cells | #10978 |
| airway inflammation | #10982 |
| degrading | #10983 |
| immunoassay | #10984 |
| subcutaneously | #10984 |
| characterization | #10986 |
| governing | #10998 |
| ethanol | #11000 |
| septic | #11000 |
| tnfα | #11003 |
| mpo | #11010 |
| cell subsets | #11012 |
| originally | #11016 |
| 263 | #11027 |
| immunohistochemistry | #11028 |
| occurrence | #11030 |
| scid mice | #11030 |
| messenger | #11037 |
| hyper | #11040 |
| optical imaging | #11045 |
| skin | #11056 |
| establish | #11066 |
| calcitriol | #11067 |
| tumor progression | #11088 |
| paternal | #11094 |
| add | #11096 |
| freezing | #11102 |
| systemic | #11112 |
| infection animals | #11117 |
| focusing | #11144 |
| genetic polymorphism | #11161 |
| innate immune response | #11167 |
| male | #11167 |
| osteoarthritis | #11176 |
| influx | #11177 |
| receptors | #11177 |
| subsequent | #11177 |
| affinity chromatography | #11186 |
| genes involved | #11187 |
| ankylosing spondylitis | #11197 |
| article | #11201 |
| directly | #11208 |
| bsa | #11210 |
| limited | #11223 |
| sorting | #11229 |
| elicited | #11230 |
| interleukin10 | #11232 |
| disulfides | #11233 |
| contributed | #11248 |
| peptidase | #11251 |
| human blood | #11281 |
| ability | #11284 |
| extensive | #11297 |
| humans influenza | #11314 |
| genotyped | #11318 |
| compared controls | #11322 |
| depends | #11323 |
| oxidant | #11344 |
| caution | #11347 |
| addressing | #11351 |
| tissue damage | #11352 |
| correlate | #11354 |
| extra | #11356 |
| histopathologic | #11376 |
| neuroglia | #11384 |
| modifications | #11385 |
| experimental evidence | #11409 |
| increased expression | #11410 |
| pharmacology | #11413 |
| oxidative phosphorylation | #11428 |
| eosinophilic | #11432 |
| interleukin12 | #11437 |
| quantified | #11438 |
| receptor | #11445 |
| hla class | #11447 |
| cell death | #11460 |
| enhance | #11461 |
| reduces | #11466 |
| governed | #11476 |
| initiating | #11479 |
| contrasting | #11480 |
| melanoma cells | #11488 |
| compared healthy | #11489 |
| cd8 cell | #11498 |
| ankle | #11508 |
| serine | #11525 |
| cytosol | #11542 |
| recipient | #11546 |
| ca2 | #11559 |
| therapeutic interventions | #11561 |
| mets | #11566 |
| jurkat | #11569 |
| backgrounds | #11570 |
| inflammatory effects | #11595 |
| culture medium | #11599 |
| differential expression | #11606 |
| frequently | #11627 |
| alteration | #11627 |
| chicken | #11649 |
| swiss | #11652 |
| enhanced | #11661 |
| exerted | #11663 |
| immunologic memory | #11672 |
| transforming growth | #11678 |
| relief | #11691 |
| synergism | #11703 |
| psychotic | #11730 |
| controls | #11730 |
| toxin | #11735 |
| aiming | #11737 |
| innovative | #11751 |
| amyotrophic | #11769 |
| cell lineage | #11773 |
| constitutes | #11774 |
| inoculated | #11781 |
| commentary | #11785 |
| multiple | #11805 |
| selective | #11814 |
| display | #11817 |
| moderately | #11819 |
| altered | #11829 |
| insufficient | #11830 |
| sequence homology | #11840 |
| 9 | #11857 |
| graft | #11866 |
| analogues | #11871 |
| forkhead | #11888 |
| stained | #11890 |
| enzyme | #11942 |
| augmentation | #11943 |
| classic | #11944 |
| supplied | #11946 |
| gastrointestinal tract | #11958 |
| reveal | #11966 |
| animals bone | #11966 |
| maternal fetal | #11968 |
| adherent | #11980 |
| stress response | #11991 |
| contribution | #11998 |
| tgf | #12005 |
| biomarker | #12016 |
| antiserum | #12017 |
| cricetulus | #12021 |
| deacetylase | #12050 |
| encoding | #12051 |
| plasma cell | #12059 |
| aethiops | #12067 |
| propose | #12072 |
| fat diet | #12104 |
| immunologic factors | #12106 |
| downstream | #12107 |
| protection | #12107 |
| il2 | #12111 |
| tyrosine | #12113 |
| lung | #12116 |
| effectively | #12118 |
| replaced | #12144 |
| induced cell | #12147 |
| bromide | #12152 |
| humans | #12155 |
| switched | #12181 |
| quiescent | #12181 |
| genetic vectors | #12203 |
| oligodeoxyribonucleotides | #12204 |
| myd88 | #12222 |
| histologic | #12222 |
| lectin | #12223 |
| therapeutics | #12230 |
| toxic | #12231 |
| mesenteric | #12231 |
| represents | #12233 |
| receptors estrogen | #12236 |
| corticosterone | #12242 |
| noncoding | #12244 |
| diabetic mice | #12257 |
| fibroblasts humans | #12268 |
| recombinant | #12270 |
| splice | #12271 |
| involving | #12273 |
| fluorescent antibody | #12276 |
| mineral | #12297 |
| tnf alpha | #12300 |
| streptococcus | #12310 |
| harmful | #12319 |
| depending | #12361 |
| acid | #12363 |
| leukocyte count | #12369 |
| syndromes | #12371 |
| tradeoff | #12389 |
| interplay | #12412 |
| origin | #12416 |
| clonal | #12420 |
| microfilament | #12423 |
| reversed | #12439 |
| publication adaptor proteins | #12462 |
| weaker | #12464 |
| protein expression | #12503 |
| pain | #12532 |
| hydrochloride | #12535 |
| drug design | #12567 |
| functional | #12573 |
| suppressor | #12596 |
| rats treated | #12596 |
| binding site | #12597 |
| monomeric | #12605 |
| medullary | #12637 |
| cells natural | #12637 |
| explained | #12643 |
| macaca | #12645 |
| notably | #12664 |
| fetuses | #12665 |
| chronic diseases | #12665 |
| cdnas | #12679 |
| adenine | #12679 |
| 6 weeks | #12681 |
| p38 mitogen | #12681 |
| investigation | #12697 |
| instance | #12709 |
| persistent | #12729 |
| alveolar | #12729 |
| receptor alpha | #12743 |
| modulators | #12770 |
| interactions | #12785 |
| aimed | #12791 |
| nature | #12795 |
| influencing | #12800 |
| diminished | #12804 |
| tibia | #12813 |
| initiated | #12813 |
| sole | #12814 |
| metalloproteinases | #12819 |
| thought | #12823 |
| twin | #12854 |
| isolated | #12871 |
| solely | #12882 |
| disadvantages | #12886 |
| sulfhydryl | #12921 |
| sustained | #12922 |
| assay | #12926 |
| breakdown | #12984 |
| cell division | #13004 |
| embryonic development | #13020 |
| damage | #13056 |
| removing | #13067 |
| tryptophan | #13079 |
| tightly | #13087 |
| crystallography | #13101 |
| hyaluronic | #13102 |
| enabling | #13133 |
| time pcr | #13141 |
| publications | #13143 |
| receptors cell | #13145 |
| stereoisomerism | #13158 |
| distress syndrome | #13175 |
| ancestral | #13179 |
| retained | #13203 |
| valine | #13205 |
| division | #13213 |
| suffering | #13215 |
| single nucleotide polymorphisms | #13234 |
| opportunity | #13243 |
| opportunities | #13258 |
| 1 protein | #13270 |
| chemotaxis | #13279 |
| modulator | #13283 |
| lavage fluid | #13293 |
| transgene | #13297 |
| ascending | #13302 |
| regulators | #13320 |
| elucidated | #13323 |
| purity | #13330 |
| bronchoalveolar lavage | #13334 |
| nk | #13353 |
| fisher | #13357 |
| inhibitory effects | #13362 |
| lymphoproliferative | #13372 |
| amyotrophic lateral | #13377 |
| facilitating | #13380 |
| overexpressed | #13383 |
| scattered | #13389 |
| borrelia | #13393 |
| intact | #13410 |
| independently | #13433 |
| thiol | #13434 |
| fibroblast | #13447 |
| oocytes | #13463 |
| embryos | #13465 |
| marrow derived | #13484 |
| spraguedawley receptors | #13488 |
| overcome | #13489 |
| endopeptidase | #13500 |
| aspect | #13523 |
| lateral sclerosis | #13577 |
| tail | #13589 |
| selectively | #13591 |
| lipopolysaccharide | #13598 |
| elisa | #13612 |
| heritability | #13616 |
| vertebrates | #13627 |
| renal disease | #13634 |
| cure | #13674 |
| peripheral | #13689 |
| reproductive | #13755 |
| clones | #13757 |
| requires | #13783 |
| profiling gene | #13808 |
| lavage | #13811 |
| exon | #13822 |
| arising | #13831 |
| secretory | #13835 |
| techniques | #13873 |
| 6 | #13879 |
| killer cells | #13891 |
| exposed | #13917 |
| cloned | #13927 |
| iga | #13936 |
| hepatocytes | #13938 |
| tolerant | #13992 |
| lncrnas | #14002 |
| anti inflammatory | #14010 |
| killed | #14033 |
| selectin | #14034 |
| sensitization | #14035 |
| environmental | #14057 |
| insertion | #14063 |
| recombinant proteins | #14070 |
| neighboring | #14098 |
| reflects | #14102 |
| great | #14120 |
| preclinical | #14123 |
| highlighting | #14145 |
| preventing | #14148 |
| healthy individuals | #14159 |
| administration | #14164 |
| vaccination | #14176 |
| potent | #14183 |
| retroviral | #14208 |
| multigene | #14246 |
| advances | #14275 |
| amino acids | #14298 |
| ester | #14310 |
| oxidative stress | #14315 |
| cord | #14319 |
| incidence | #14322 |
| impairs | #14323 |
| domain | #14325 |
| psychosis | #14326 |
| p38 | #14329 |
| bovine serum | #14329 |
| isolation | #14334 |
| differentiation | #14342 |
| multiprotein | #14366 |
| mineral density | #14406 |
| #14414 | |
| differentiation cells | #14414 |
| resolve | #14420 |
| colony stimulating | #14421 |
| consistently | #14448 |
| paracrine | #14452 |
| kinases animals | #14452 |
| adenoviridae | #14472 |
| chlorocebus | #14481 |
| marrow transplantation | #14485 |
| targeted | #14490 |
| pathology | #14492 |
| il1 | #14500 |
| integrative | #14510 |
| cells vitro | #14537 |
| monocytes | #14540 |
| bone density | #14589 |
| infectious diseases | #14593 |
| biomedical | #14605 |
| nitrate | #14616 |
| nf kappab | #14627 |
| recombinant human | #14632 |
| divergent | #14638 |
| pathological | #14640 |
| enzyme activation | #14658 |
| lupus nephritis | #14661 |
| smoking | #14673 |
| transforming | #14675 |
| gfp | #14681 |
| inborn | #14696 |
| hand | #14698 |
| green fluorescent | #14703 |
| scarce | #14718 |
| substances | #14724 |
| risk developing | #14724 |
| nitrates | #14728 |
| oxide synthase | #14731 |
| p005 | #14732 |
| particulate | #14751 |
| oxidoreductases | #14753 |
| protein binding | #14757 |
| blood vessels | #14759 |
| human cells | #14768 |
| interferon alpha | #14780 |
| il1β | #14800 |
| degenerative | #14815 |
| proteinase | #14817 |
| originating | #14824 |
| vitro | #14829 |
| overlapping | #14835 |
| biocompatible | #14851 |
| prostaglandins | #14881 |
| controlled | #14895 |
| interaction | #14916 |
| chronically | #14923 |
| genomic dna | #14929 |
| potential therapeutic | #14939 |
| colleagues | #14950 |
| plays | #15011 |
| cross | #15041 |
| implications | #15063 |
| escape | #15078 |
| granule | #15079 |
| receptor gene | #15089 |
| phosphoric | #15090 |
| converting | #15126 |
| acute respiratory | #15173 |
| spinal cord | #15185 |
| seroepidemiologic | #15205 |
| bmd | #15213 |
| proliferation cells | #15219 |
| covalently | #15234 |
| preferentially | #15252 |
| adhesion | #15299 |
| fetus | #15300 |
| processed | #15329 |
| allografts | #15337 |
| synthase | #15339 |
| bone mineral density | #15340 |
| accelerate | #15346 |
| neurodegenerative | #15377 |
| pretreatment | #15379 |
| blood mononuclear | #15414 |
| interleukin6 il6 | #15440 |
| comparative | #15474 |
| selected | #15486 |
| antigens bacterial | #15511 |
| cells dcs | #15513 |
| locally | #15521 |
| transcriptase polymerase | #15530 |
| influenza human | #15537 |
| basis | #15540 |
| hormone | #15542 |
| central nervous | #15566 |
| estrogen receptor | #15572 |
| transduction | #15579 |
| vaccines | #15623 |
| responsiveness | #15647 |
| rna interference | #15649 |
| binds | #15651 |
| accelerator | #15673 |
| limitation | #15675 |
| pyruvate | #15682 |
| sequenced | #15696 |
| conformational | #15701 |
| cd28 | #15708 |
| connective | #15748 |
| gastric | #15775 |
| single | #15789 |
| fluorescent | #15793 |
| bone loss | #15832 |
| induced expression | #15835 |
| protein structure | #15849 |
| spinal | #15861 |
| vasculitis | #15884 |
| treating | #15887 |
| kappab | #15894 |
| gcsf | #15908 |
| competitive | #15910 |
| positron emission | #15913 |
| downregulation | #15914 |
| systemic inflammation | #15944 |
| neurodegeneration | #15945 |
| methylated | #15945 |
| involve | #15980 |
| ap1 | #15985 |
| plasmon resonance | #15986 |
| reflected | #15993 |
| chromatographic | #16019 |
| cnv | #16065 |
| oligonucleotide array | #16092 |
| 106 | #16097 |
| responding | #16105 |
| pluripotent | #16135 |
| bone mineral | #16141 |
| undetectable | #16148 |
| skeletal | #16151 |
| neurons | #16154 |
| tissue distribution | #16155 |
| disequilibrium | #16156 |
| beta1 | #16172 |
| exhibited | #16189 |
| response treatment | #16236 |
| grafted | #16238 |
| array sequence | #16239 |
| glandular | #16252 |
| functional studies | #16273 |
| responders | #16278 |
| new class | #16282 |
| subunit | #16293 |
| required | #16309 |
| animals base | #16310 |
| subclinical | #16311 |
| linkage disequilibrium | #16342 |
| receptor signaling | #16351 |
| difference | #16367 |
| remarkably | #16382 |
| molecular structure | #16391 |
| form | #16409 |
| signalling | #16414 |
| molecular mechanism | #16419 |
| publication antibodies | #16433 |
| cd40 | #16468 |
| shr | #16471 |
| capable | #16496 |
| grouped | #16512 |
| subcutaneous | #16522 |
| fibroblasts | #16525 |
| revealing | #16544 |
| targeting | #16552 |
| node | #16585 |
| respiratory | #16585 |
| organs | #16586 |
| tumor cells | #16600 |
| antibodies bacterial | #16603 |
| subunits | #16626 |
| profiling | #16651 |
| necrosis | #16655 |
| negatively | #16709 |
| establishing | #16709 |
| uric | #16743 |
| irradiated | #16757 |
| nick | #16765 |
| intramolecular | #16795 |
| deeper | #16801 |
| instrumental | #16812 |
| detected | #16851 |
| clinically | #16859 |
| immunoreactive | #16859 |
| serve | #16878 |
| inhibitory | #16881 |
| documented | #16904 |
| greatly | #16907 |
| colony | #16928 |
| turn | #16941 |
| immunosuppression | #16942 |
| mmps | #16957 |
| inhibition | #16959 |
| receptor 1 | #16964 |
| additionally | #16970 |
| humans hydrogen | #16982 |
| structurally | #16985 |
| prior | #16994 |
| additional | #17005 |
| binding protein | #17006 |
| recombinant fusion | #17013 |
| sulfate | #17069 |
| b7 | #17077 |
| count | #17083 |
| il12 | #17096 |
| sex factors | #17111 |
| consist | #17113 |
| minimal | #17116 |
| alpha subunit | #17119 |
| lysosomal | #17126 |
| unexpected | #17137 |
| tissue | #17148 |
| pluripotent stem | #17151 |
| receptors tumor | #17172 |
| csf | #17185 |
| activator | #17202 |
| lymph node | #17208 |
| underlying mechanisms | #17217 |
| stimulation | #17249 |
| starting | #17298 |
| peritoneal | #17299 |
| cell proliferation | #17318 |
| fluid | #17330 |
| propensity | #17345 |
| generations | #17377 |
| humans immunity | #17410 |
| constitute | #17425 |
| demonstrated | #17444 |
| membrane | #17466 |
| muscle skeletal | #17479 |
| types | #17505 |
| allowing | #17505 |
| transcriptase | #17515 |
| fibrous | #17515 |
| type iii | #17546 |
| localization | #17547 |
| constitutive | #17559 |
| cytometry humans | #17570 |
| discovery | #17583 |
| treatments | #17596 |
| peripheral blood | #17615 |
| variation | #17616 |
| packed | #17678 |
| differed | #17683 |
| expanded | #17687 |
| proved | #17691 |
| plasmon | #17698 |
| longitudinally | #17713 |
| pbmcs | #17728 |
| stimulating factor | #17743 |
| somatic | #17805 |
| inflammatory bowel disease | #17815 |
| dcs | #17827 |
| relating | #17861 |
| alpha tnf | #17880 |
| neuroendocrine | #17920 |
| oligonucleotide | #17954 |
| homology | #17962 |
| surface plasmon | #17971 |
| pregnancy | #17985 |
| chromosomal | #17994 |
| post | #17998 |
| inhibit | #18002 |
| labelled | #18004 |
| damaged | #18064 |
| osmolar | #18107 |
| 2 4 | #18130 |
| creating | #18142 |
| cytoplasm | #18155 |
| released | #18157 |
| trigger | #18161 |
| corticosteroids | #18164 |
| species | #18168 |
| endocrine | #18192 |
| vertebrate | #18206 |
| labeled | #18208 |
| subcellular | #18231 |
| rna messenger | #18235 |
| protein serine | #18279 |
| limiting | #18281 |
| reverse transcriptase | #18325 |
| evidenced | #18329 |
| truncated | #18336 |
| avian | #18345 |
| net | #18345 |
| males | #18375 |
| critically | #18389 |
| assumed | #18433 |
| modulated | #18444 |
| rats wistar | #18448 |
| pathogen | #18464 |
| immunogenicity | #18486 |
| acids | #18490 |
| reaching | #18494 |
| nonparametric | #18512 |
| constitutively | #18518 |
| processing | #18609 |
| hyaluronan | #18609 |
| sulfonamides | #18643 |
| investigating | #18651 |
| 15 | #18656 |
| 22 | #18658 |
| verify | #18669 |
| signal transduction | #18682 |
| agents steroidal | #18685 |
| remaining | #18721 |
| cerebrospinal | #18788 |
| aim | #18788 |
| created | #18803 |
| cultured | #18823 |
| balanced | #18823 |
| carry | #18829 |
| pathophysiological | #18830 |
| production | #18927 |
| nerve | #18943 |
| nested | #18957 |
| nfκb | #18987 |
| failed | #18988 |
| sequence analysis | #19002 |
| specific antigen | #19050 |
| observations | #19062 |
| provided | #19067 |
| bone marrow | #19084 |
| lungs | #19111 |
| stimulating | #19136 |
| protein | #19164 |
| bearing | #19167 |
| publication administration | #19185 |
| gained | #19200 |
| mitochondrial | #19260 |
| symptoms | #19288 |
| lost | #19298 |
| majority | #19304 |
| intra | #19311 |
| interacts | #19344 |
| hormones | #19441 |
| fatal | #19464 |
| interferons | #19489 |
| analyzing | #19515 |
| exogenous | #19526 |
| adrenal | #19553 |
| cytoskeletal | #19553 |
| rapidly | #19574 |
| inducible | #19616 |
| etiology | #19652 |
| environment | #19668 |
| implanted | #19680 |
| lps | #19681 |
| mice scid | #19683 |
| vesicular | #19701 |
| lineage | #19719 |
| markers | #19789 |
| histologically | #19817 |
| offers | #19826 |
| cutaneous | #19834 |
| precise | #19836 |
| pharmacological | #19854 |
| fetal | #19862 |
| shifted | #19875 |
| newly | #19892 |
| supporting | #19915 |
| vitro techniques | #19945 |
| yielded | #19948 |
| 8 | #19978 |
| cns | #19979 |
| 28 | #19979 |
| response relationship | #20014 |
| transient | #20038 |
| modify | #20055 |
| designated | #20056 |
| reverse | #20057 |
| casecontrol study | #20088 |
| mutagenesis | #20118 |
| illustrated | #20126 |
| downregulated | #20133 |
| ultimately | #20202 |
| κb | #20256 |
| 1 diabetes | #20263 |
| hypothalamic | #20285 |
| primary | #20303 |
| entered | #20310 |
| nitric | #20316 |
| gene expression | #20364 |
| markedly | #20453 |
| genotype humans | #20460 |
| mature | #20491 |
| microglia | #20561 |
| circulating | #20574 |
| overexpressing | #20593 |
| human pair | #20604 |
| polyacrylamide | #20612 |
| marrow | #20651 |
| defining | #20660 |
| pregnant | #20665 |
| equal | #20678 |
| resting | #20729 |
| injured | #20739 |
| mild | #20819 |
| local | #20825 |
| discovered | #20835 |
| cricetinae | #20839 |
| reduction | #20847 |
| illustrate | #20874 |
| lactic | #20908 |
| hypothesized | #20913 |
| tended | #20919 |
| successful | #20952 |
| 10 | #20952 |
| cell derived | #20955 |
| aberrant | #20961 |
| animals biomarkers | #21033 |
| 2 | #21085 |
| attractive | #21228 |
| acute | #21279 |
| produces | #21297 |
| transfected | #21316 |
| marked | #21340 |
| decreased | #21383 |
| maternal | #21389 |
| emerged | #21445 |
| survived | #21524 |
| confirms | #21558 |
| membrane proteins | #21585 |
| forming | #21593 |
| preserved | #21732 |
| contained | #21802 |
| previous | #21805 |
| 16 | #21813 |
| doses | #21835 |
| immunodeficiency | #21852 |
| electrophoresis | #21867 |
| mellitus type | #21871 |
| natural killer | #21877 |
| cell count | #21898 |
| prolonged | #21903 |
| heavy | #21965 |
| increasing | #21979 |
| polymeric | #22042 |
| gradually | #22067 |
| glial | #22202 |
| selecting | #22242 |
| extremely | #22248 |
| 4 | #22274 |
| opportunistic | #22307 |
| accepted | #22356 |
| emission tomography | #22395 |
| enable | #22402 |
| humans models | #22445 |
| initially | #22458 |
| microscopy confocal | #22466 |
| physiologic | #22470 |
| appears | #22488 |
| releasing | #22497 |
| suitable | #22522 |
| humans immunosuppressive | #22529 |
| confirm | #22553 |
| chemokine | #22558 |
| metabolic | #22585 |
| actins | #22597 |
| loss | #22611 |
| nf | #22756 |
| reactive protein | #22834 |
| utilizing | #22899 |
| transformed | #22917 |
| progression female | #22918 |
| detailed | #23005 |
| natural | #23089 |
| cell types | #23132 |
| sex | #23234 |
| null | #23277 |
| untranslated | #23305 |
| signaling | #23324 |
| syndrome | #23335 |
| bone | #23397 |
| necrosis factor | #23407 |
| rich | #23430 |
| cells tumor | #23467 |
| nucleic | #23501 |
| continued | #23663 |
| cellular | #23667 |
| expression gene | #23728 |
| attenuated | #23757 |
| mitogen | #23814 |
| serine threonine | #23835 |
| examine | #23864 |
| fusion proteins | #23968 |
| organ | #23990 |
| remained | #23998 |
| prevent | #24026 |
| confined | #24245 |
| oxidized | #24325 |
| called | #24330 |
| discussed | #24334 |
| genomic | #24394 |
| covering | #24485 |
| embryonic | #24490 |
| interleukin | #24583 |
| varying | #24640 |
| weeks | #24698 |
| mechanistic | #24796 |
| putative | #24897 |
| detect | #24963 |
| sarcoidosis | #24963 |
| remains | #25082 |
| controversial | #25175 |
| implies | #25192 |
| stromal | #25269 |
| type 1 diabetes | #25410 |
| enriched | #25470 |
| relation | #25543 |
| attributed | #25618 |
| 7 | #25632 |
| proteins | #25644 |
| tumor necrosis | #25683 |
| dysregulation | #25711 |
| cytoplasmic | #25732 |
| inflammatory agents | #25735 |
| energetic | #25813 |
| healthy | #25887 |
| representing | #25917 |
| challenging | #25976 |
| threonine | #25988 |
| mechanisms underlying | #26094 |
| signal | #26163 |
| tnfalpha | #26432 |
| frequent | #26487 |
| individuals | #26568 |
| antibodies viral | #26579 |
| growth factor | #26602 |
| validated | #26686 |
| lower | #26708 |
| treat | #26713 |
| 3 | #26751 |
| tolerated | #26780 |
| pathophysiology | #26782 |
| explored | #26850 |
| tumor necrosis factor | #26925 |
| comparable | #26955 |
| normal | #27016 |
| define | #27055 |
| exist | #27121 |
| presented | #27123 |
| consists | #27152 |
| intracellular | #27233 |
| invariant | #27331 |
| animals cells | #27339 |
| adaptor proteins | #27447 |
| chromosomes human | #27524 |
| associations | #27560 |
| kda | #27648 |
| tract | #27680 |
| possess | #27765 |
| exclude | #27824 |
| cell tumor | #27826 |
| attributable | #28018 |
| proteins humans | #28150 |
| heterozygote | #28266 |
| treated | #28436 |
| observe | #28472 |
| remain | #28560 |
| regulation humans | #28667 |
| threonine kinases | #28809 |
| hypothesis | #28819 |
| require | #28838 |
| examined | #29041 |
| infection | #29082 |
| 5 | #29247 |
| animals apoptosis | #29491 |
| intracellular signaling | #29517 |
| easily | #29557 |
| effective | #29656 |
| 005 | #29706 |
| fully | #29936 |
| exhibit | #29947 |
| gtp binding | #29997 |
| intravenous | #30185 |
| cell movement | #30520 |
| oxide | #30546 |
| reached | #30655 |
| active | #30908 |
| versus | #30963 |
| 1 | #31228 |
| cell differentiation | #31374 |
| vary | #31548 |
| blotting western | #31843 |
| free | #32409 |
| expression regulation | #32516 |
| needed | #32543 |
| objectives | #32805 |
| generally | #33368 |
| inhibited | #33394 |
| clinical | #33439 |
| sought | #34008 |
| reduce | #34128 |
| biological | #34247 |
| reflect | #34701 |
| separately | #34818 |
| agents | #34868 |
| assess | #34935 |
| polymerase | #35201 |
| nuclear | #35715 |
| polymerase chain | #36180 |
| formed | #36819 |
| chain reaction | #36949 |
| 001 | #36954 |
| measured | #42007 |
レポートを実行します | |
Prominent publications by Rikard Holmdahl
KOL-Index: 15284
The purpose of the study was to map the dominant T cell epitope of the CB11 sequence of CII in RTlu haplotype rats and to determine if, when used as a synthetic peptide, it would induce tolerance to protect against CIA. A dominant epitope corresponding to residues 184-198 included in the sequence of the CB11 fragment of bovine CII was identified in proliferation assay using peptides in an epitope scanning system using synthetic peptides of 15 amino acids, overlapping by 12 amino acids. ...
| で知られている Mucosal Tolerance | Synthetic Peptide | Cell Epitope | Cia Cii | Collagen‐induced Arthritis |
KOL-Index: 14658
An antibody response to defined epitopes located on the triple helical portion of type II collagen (CII) is associated with the development of collagen-induced arthritis (CIA) and rheumatoid arthritis (RA). Monoclonal antibodies to epitopes associated with arthritis, but not antibodies specific for epitopes not associated with arthritis, induce arthritis in mice, the so-called collagen antibody induced arthritis (CAIA) model. We have selected monoclonal IgG antibodies specific for four ...
| で知られている Collagen Antibody | Induced Arthritis | Monoclonal Antibodies | Mice Inbred | Specific Epitopes |
KOL-Index: 13984
The Aq major histocompatibility complex (MHC) class II molecule is associated with susceptibility to murine collagen-induced arthritis (CIA), whereas the closely related H-2Ap molecule is not. To understand the molecular basis for this difference, we have analyzed the ability of H-2Aq and H-2Ap molecules (referred to as Aq and Ap) to bind and present collagen type II (CII)-derived glycosylated and non-glycosylated peptides. T cell clones specific for the immunodominant CII 256-270 ...
| で知られている Collagen‐induced Arthritis | Transgenic Models | Aq Molecule | Structural Basis | C3h Mice |
KOL-Index: 13727
BACKGROUND: Autoantibodies to cyclic citrullinated peptides (anti-CCP) are present in most patients with rheumatoid arthritis (RA), and associate with HLA-DRB1 shared epitope (SE) alleles.
OBJECTIVE: To investigate reactivities of anti-CCP to various citrullinated proteins/peptides, which represent potential autoantigens in RA, and to examine the relationship between such antibodies, and their association with genetic variants within HLA-DRB1 SE alleles.
METHODS: Serum samples from 291 ...
| で知られている Citrullinated Antigens | Rheumatoid Arthritis | Drb1 Alleles | Ccp Patients | Antibody Reactivities |
Localization of a critical restriction site on the I-A beta chain that determines susceptibility to collagen-induced arthritis in mice
[ PUBLICATION ]
Type II collagen-induced arthritis (CIA) in mice is an autoimmune experimental model for rheumatoid arthritis. Susceptibility to CIA is associated with certain major histocompatibility complex class II haplotypes. The two very closely related haplotypes H-2q and H-2p differ in susceptibility to CIA. Only mice of H-2q (DBA/1, B10G strains) but not mice of H-2p-expressing strains (like strain B10P) develop CIA and an autoimmune response to type II collagen (CII) after immunization with ...
| で知られている Mice Cia | Beta Chain | Rheumatoid Arthritis | H2q Haplotype | Type Collagen Cii |
KOL-Index: 13513
INTRODUCTION: It has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent ...
| で知られている Citrullinated Peptides | Onset Symptoms | Development Rheumatoid Arthritis | Combination Acpa | Hlase Smoking |
Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients
[ PUBLICATION ]
OBJECTIVE: High titers of specific anti-citrullinated protein antibodies (ACPAs) are frequently present in the serum of rheumatoid arthritis (RA) patients, but their presence in synovial fluid is less well characterized. The purpose of this study was to compare the levels of antibody to 4 well-defined citrullinated candidate RA autoantigens in serum and synovial fluid and to determine whether antibodies to one citrullinated antigen are dominant over another. Furthermore, we studied their ...
| で知られている Citrullinated Antigens | Synovial Fluid | Rheumatoid Arthritis Patients | Type Collagen | Antibodies Acpas |
Toll-like receptor 3 upregulation in macrophages participates in the initiation and maintenance of pristane-induced arthritis in rats
[ PUBLICATION ]
INTRODUCTION: Toll-like receptors (TLRs) are involved in both innate and adaptive immune responses and are likely to play a complex role in the pathogenesis of human rheumatoid arthritis (RA) and experimental arthritis. The objective of this study was to identify the key TLR in pristane-induced arthritis (PIA), a rat model for RA, and to clarify its roles in the initiation and maintenance of arthritis.
METHODS: Arthritis in DA rats was induced by pristane and the severity was evaluated ...
| で知られている Induced Arthritis | Tlr3 Expression | Rats Pristane | Receptor 3 | Inbred Strains Severity |
KOL-Index: 12776
Multiple sclerosis (MS) is a complex chronic neurologic disease with a suspected autoimmune pathogenesis1,2. Although there is evidence that the development of MS is determined by both environmental influences and genes, these factors are largely undefined3,4, except for major histocompatibility (MHC) genes. Linkage analyses and association studies have shown that susceptibility to MS is associated with genes in the human histocompatibility leukocyte antigens (HLA) class II region, but ...
| で知られている Multiple Sclerosis | Transgenic Mice | Hla Dr2 | Humanized Model | Spontaneous Disease |
KOL-Index: 12721
Polymorphism of the major histocompatibility complex (MHC) influences susceptibility to experimental autoimmune encephalomyelitis (EAE) induced by myelin basic protein (MBP) in rats. Current concepts relate such influences to the capacity of class II molecules to present relevant peptides to autoreactive T cells. We have here analyzed the MHC influence on the immune response and the development of EAE after immunization with the immunodominant peptide MBP-63-88. Analysis of MHC-congenic ...
| で知られている Myelin Basic Protein | Experimental Autoimmune | Major Histocompatibility | Rats Eae | Immune Response |
Multiplex Analyses of Antibodies Against Citrullinated Peptides in Individuals Prior to Development of Rheumatoid Arthritis
[ PUBLICATION ]
OBJECTIVE: The presence of antibodies against cyclic citrullinated peptides has been demonstrated to precede the onset of symptoms of rheumatoid arthritis (RA) by several years. The aim of this study was to analyze antibodies against 10 citrullinated autoantigen-derived peptides for reactivity before the onset of RA symptoms.
METHODS: A case-control study was conducted within the Medical Biobank of Northern Sweden. The study was performed in 409 individuals, 386 of whom donated 717 blood ...
| で知られている Citrullinated Peptides | Rheumatoid Arthritis | Onset Symptoms | Antibodies Cep1 | Type Collagen |
KOL-Index: 12510
Antibodies against type II collagen (anti-CII) are arthritogenic and have a crucial role in the initiation of collagen-induced arthritis. Here, we have determined the dependence of T and B cells in collagen-antibody-induced arthritis (CAIA) during different phases of arthritis. Mice deficient for B and/or T cells were susceptible to the CAIA, showing that the antibodies induce arthritis even in the absence of an adaptive immune system. To determine whether CII-reactive T cells could have ...
| で知られている Collagen Type | Arthritis Mice | Antigen Tcell | Antibodies Cii | Adaptive Immune |
KOL-Index: 12427
The nonobese diabetic (NOD) mouse spontaneously develops autoimmune-mediated diseases such as diabetes and Sjögren's syndrome. To investigate whether NOD genes also promote autoimmune-mediated arthritis we established a NOD strain with an MHC class II fragment containing the A(q) class II gene predisposing for collagen induced arthritis (NOD.Q). However, this mouse was resistant to arthritis in contrast to other A(q) expressing strains such as B10.Q and DBA/1. To determine the major ...
| で知られている Genetic Control | Complement Factor | Induced Arthritis | Locus Chromosome | Mice Inbred |
のための重要な人々 Rheumatoid Arthritis
世界のトップコル
Rikard Holmdahl:専門家の影響
その概念Rikard Holmdahl直接的な影響があります:Rheumatoid arthritis, Induced arthritis, Experimental arthritis, Collagen type, Type collagen, Animal models, Reactive oxygen species, Autoimmune diseases.
Rikard Holmdahl:KOLインパクト
他の著者の仕事に関連する概念for which Rikard Holmdahl 影響力があります:Rheumatoid arthritis, Multiple sclerosis, Autoimmune diseases, Oxidative stress, Animal models, Reactive oxygen species, Nadph oxidase.
Tools
これはあなたのプロフィールですか？ あなたのプロフィールを主張します URLをコピーします プロフィールへのリンクを埋め込みます |